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Abstract
Overall, this doctoral study aimed to contribute to the existing knowledge and clinical
practice regarding male infertility, especially in relation to the potential sources and clinical
impact of sperm apoptosis and reactive oxygen species (ROS) in the context of assisted
reproductive technology (ART).
This thesis encompasses three independent studies, each of which addresses a single aim
related to different aspects of male infertility and ART practices.
Study 1 examined the relationship between sperm apoptosis and ROS levels and ART
outcomes. On the day of oocyte retrieval, the levels of sperm apoptosis (measured using
Annexin V staining) and intracellular ROS (measured using dihydroethidium staining) were
measured in neat and processed semen samples from a total of 170 male patients whose
partners were undergoing in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI)
treatment cycles. In general, higher levels of apoptosis and ROS were associated with lower
sperm motility, sperm count and advanced paternal age. No correlation was observed between
sperm apoptosis and fertilisation rate, blastulation rate, day 5 embryo quality (D5EQ) and
clinical pregnancy. Similarly, there was no correlation between sperm ROS levels and
fertilisation rate and clinical pregnancy. However, higher levels of ROS might be associated
with poorer early stages of embryonic development, as indicated by blastulation rate and D5EQ.
Together, the findings suggest that although sperm apoptosis and ROS had an adverse effect on
sperm parameters, the effect on clinical outcomes was minimal.
Study 2 compared the efficacy of three sperm preparation methods, namely density gradient
centrifugation (DGC), the swim-up method and SeaforiaTM, in reducing the levels of sperm
apoptosis and ROS. The measurement of sperm apoptosis and ROS levels were performed on a
total of 17 pooled semen samples before and after sperm preparation. The main findings suggest
that all three methods effectively reduced sperm apoptosis levels in the neat samples. However,
only swim-up and SeaforiaTM were effective in reducing the ROS levels. Compared with DGC
and swim-up, SeaforiaTM also produced samples with a higher total yield.
Study 3 investigated the effects of different time intervals during ART sperm preparation on
clinical outcomes. Three time intervals including pre-wash interval (time between ejaculation
and sperm preparation), post-wash interval (time between sperm preparation and
insemination/sperm injection) and total interval (time between ejaculation and
insemination/sperm injection) were calculated and retrospectively analysed from a total of 8,079
IVF/ICSI cycles. The results showed that prolonged pre- and post-wash and total intervals had
an adverse effect on sperm motility and clinical outcomes including fertilisation rate and
pregnancy outcomes. Intracellular ROS production during prolonged incubation was considered
to be the most likely facilitator of this observed effect.
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In summary, this thesis demonstrates that although their effect on ART outcomes were at
low levels, higher levels of sperm apoptosis and ROS were associated with poorer sperm
parameters, and suggestive of, a lower chance of natural conception. The cumulative findings of
this thesis are indicative of the central role of ROS levels in sperm physiological functions and
suggest that minimising intracellular ROS production through sperm preparation techniques and
time optimisation may be beneficial to improving ART outcomes.
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Chapter 1: Literature review
Human infertility and Assisted Reproductive Technology (ART)
Infertility is defined by the lack of clinical pregnancy following regular unprotected sexual
intercourse over 12 or more months (Zegers-Hochschild et al., 2017). Considered as a global
health issue, infertility is estimated to affect 48.5 million, or 15%, of couples worldwide
including one in six Australian couples (Agarwal et al., 2015; Mascarenhas et al., 2012;
Australian Bureau of Statistics [ABS], 2015). The cause of infertility may arise from either the
male or female partner, a combination of both, or may also be unexplained (Macaldowie et al.,
2015). Assisted reproductive technology (ART) has progressively become the preferred
infertility treatment (Fitzgerald et al., 2018).
According to the International Committee for Monitoring Assisted Reproductive
Technology (ICMART) and the World Health Organization (WHO), the term ART refers to all
procedures that aim to achieve pregnancy and involve the laboratory-based treatment of human
oocytes and sperm or embryos (Zegers-Hochschild et al., 2009). Among others, the three main
ART procedures include IUI, which involves the introduction of laboratory-processed sperm to
the uterus; conventional IVF, which involves extracorporeal fertilisation; and ICSI, which
involves injection of a single spermatozoon into an oocyte (Zegers-Hochschild et al., 2017).
Since the first successful human IVF birth in 1978, the number of babies born from IVF
continues to increase (Macaldowie et al., 2015). It was recently reported that in 2016, Australian
and New Zealand fertility clinics carried out 74,357 and 6,705 ART treatment cycles,
respectively. These figures showed an increase of 4.0% in Australia and 7.4% in New Zealand
from the previous year. Of these treatment cycles, however, a clinical pregnancy and a live
birth were only recorded in 22.5% and 17.9% of instances, respectively (Fitzgerald et al., 2018).

Male infertility
Male infertility contributes to half of total infertility cases and alone, is responsible for 20
to 30% of the ART cases (Agarwal et al., 2015). Globally, male infertility is experienced by 7%
of men (Bui et al., 2018) and a trend of gradual decrease in sperm quality associated with male
infertility has been observed over the past few decades (Durairajanayagam, 2018). As in
women, male fertility declines with age (Johnson, 2018). However, men do not experience a
sudden reproductive deterioration associated with senescence as women do in the form of
menopause, and therefore, most men are capable of producing functional spermatozoa after the
age of 40. Nevertheless, a progressive decline in semen volume and sperm count, motility and
quality is observed after the age of 20 (Johnson, 2018). Aside from the natural ageing process,
the factors underlying male infertility range from congenital birth defects, genetic, anatomic and
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immunological disorders to lifestyle and environmental factors (Singh et al., 2014;
Tahmasbpour et al., 2014), with varicocele (37 to 40%) and genetic disorders (15 to 30%) being
the most common factors (Tahmasbpour et al., 2014). However, approximately 15 to 25% of
male infertility is idiopathic, where there are no reported abnormalities in semen analysis and no
other observable influencing factors (Tahmasbpour et al., 2014).
Semen analysis is commonly performed as a first-line approach to diagnosing male
infertility (Alshahrani et al., 2017). A routine semen analysis assesses the quality of semen
samples according to several parameters which include sperm concentration, sperm motility,
sperm morphology, semen volume and pH (World Health Organization [WHO], 2010). The
results of the assessment can then be compared with the WHO reference range values, as shown
in Figure 1.1, to give an indication of whether the sample is considered fertile or whether the
problem comes primarily from the man (Wang & Swerdloff, 2014). Despite the attempt to
provide universal guidelines and standardised procedures, the recommended reference values
have been reported to be associated with several limitations, which include the lack of
consideration of unobservable abnormalities such as deoxyribonucleic acid (DNA)
fragmentation, immature chromatin and interrupted capacitation and acrosome reaction within
the female reproductive tract (Cooper et al., 2010; Wang & Swerdloff, 2014). Accordingly,
semen analysis may provide an indication of male infertility, but it may not provide sufficient
information regarding sperm physiological fertilising capacity, and therefore, a conclusive
diagnosis of male infertility (Alshahrani et al., 2017; Cooper et al., 2010; Wang & Swerdloff,
2014).
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Figure 1.1 The WHO Lower Reference Limits for Semen Characteristics.

Figure 1.1 is not available in this version of the thesis

Note. Values are 5th centiles and their 95% confidence intervals. Adapted from “WHO
Laboratory Manual for the Examination and Processing of Human Semen” by the World Health
Organization [WHO], 2010, p. 224. Copyright 2010 by World Health Organization.
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Male reproductive system
The male reproductive system involves an interplay between the testes, where male sex
hormones and spermatozoa are produced; accessory ducts, which are responsible for storage and
transport of the spermatozoa; accessory glands, which secrete fluids that comprise the bulk of
the seminal fluid; and external genitalia, which includes the penis and the scrotum that contains
and supports the testes (Marieb & Hoehn, 2016). Each lobule within the testis contains one to
three seminiferous tubules, where Sertoli cells and male germ cells are found. Sertoli or
sustentacular cells are pyramid-shaped and play a major role in nurturing and providing
structural support to germ cells at various stages of differentiation. Sertoli cells also provide a
blood-testis barrier which protects spermatids and spermatocytes from host immunological
attack and allows for tight regulation of testicular fluid composition within the seminiferous
tubules (Jones & Lopez, 2014).
Gametogenesis, or reproductive cell production exclusively takes place in the gonads, testis
for men and ovary for women. In men, gametogenesis involves spermatogenesis and
spermiogenesis (Hogarth, 2019). During spermatogenesis spermatogonia (singular =
spermatogonium; 46 chromosomes) mature into primary spermatocytes (46 chromosomes),
which will then undergo the first meiotic division and give rise to secondary spermatocytes (23
chromosomes). Each secondary spermatocyte will then undergo the second meiotic division and
form spermatids (23 chromosomes) (Jones & Lopez, 2014). During spermiogenesis, an
immature spermatid gains its motility and matures into a spermatozoon (or sperm), which will
reside in the epididymis and ductus deferens until ejaculation (Figure 1.2). The ejaculate or
semen is composed of spermatozoa and components of seminal plasma (Hogarth, 2019).
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Figure 1.2 Stages of Spermatogenesis and Spermiogenesis.

Figure 1.2 is not available in this version of the thesis

Note. Adapted from “The Male Reproductive System,” by R. E. Jones, and K. H. Lopez, 2014,
Human Reproductive Biology, p.70. Copyright 2014 by Elsevier Inc.

Seminal plasma
While the role of seminal plasma is traditionally thought to assist sperm transit in the
female reproductive tract, it has also been shown to have significant importance in improving
pregnancy outcomes by assisting fertilisation and nurturing and protecting the developing
embryo (Bromfield, 2014; McGraw et al., 2015). Seminal plasma is composed of secretions
from the male accessory glands including seminal vesicles, prostate gland and bulbourethral
gland (McGraw et al., 2015) as well as various proteins secreted from the testis and epididymis
(Kanannejad & Gharesi-Fard, 2018). Seminal vesicle secretion makes up the majority of the
seminal plasma volume (Jones & Lopez, 2014) and is rich in fructose and other nutrients
required to meet sperm metabolic needs and to maintain their viability (Bromfield, 2014;
Johnson, 2018). Secretions from both the prostate and bulbourethral glands act as buffers to
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counteract acidity in the male urethra and in the female reproductive tract. The bulbourethral
gland also secretes mucus that lubricates and aids the transport of semen during ejaculation
(Jones & Lopez, 2014). Seminal plasma also contains various enzymatic antioxidants including
superoxide dismutase (SOD) and catalase, as well as non-enzymatic antioxidants such as
vitamin E, selenium, melatonin and Coenzyme Q10, which have a protective role in preventing
oxidative stress (Agarwal et al., 2014). In addition, seminal plasma is enriched with substances
responsible for silent phagocytosis and suppress excessive generation of reactive oxygen
species (ROS) (Aitken et al., 2015) and other seminal proteins that are thought to play a
significant role in semen liquefaction and sperm motility, capacitation and the acrosome
reaction (Kanannejad & Gharesi-Fard, 2018).

The spermatozoon
The main responsibility for transferring genetic information to the oocyte through
fertilisation lies within the spermatozoa (Fortes et al., 2014). A mature spermatozoon consists of
the head, neck, middle piece and the tail (Figure 1.3). Contained within the head is a nucleus,
which is encapsulated by a nuclear membrane. The tip of the sperm head is also covered by the
acrosome, a membrane-bound vesicle that contains enzymes required for successful
fertilisation. Continuous with the neck, the middle piece houses mitochondria that supply
energy for the movement of the tail (Jones & Lopez, 2014). The middle piece and the tail are
assembled through microtubules, which are derived from centrioles contained in the tail (Marieb
& Hoehn, 2016).
The plasma membrane of spermatozoa is rich in polyunsaturated fatty acids (PUFAs),
which consequently makes it more susceptible to lipid peroxidation (Patricio et al., 2016). This
vulnerability is exaggerated by the lack of enzymatic antioxidants as most sperm cytoplasm,
where the antioxidants are contained is shed during its maturation process (Aitken et al., 2016;
Sabeti et al., 2016). Anticipating the oxidative damage, during spermiogenesis, the chromatin of
the nucleus undergoes structural modification that involves the replacement of histones with
protamines (Johnson, 2018). Protamines are chemically composed of an arginine-rich core and
cysteine residues that are linked by disulphide bonds. This allows the DNA to be organised and
packed in a stable rigid arrangement, which confers a greater protection from damage during its
transport to the female reproductive tract (Fortes et al., 2014). Another uniquely designed sperm
structure that has a protective role is the isolation of the nucleus in the sperm head which is
physically separated from the middle piece where endonucleases will be released when
apoptosis is triggered. This arrangement, however, still permits ROS to penetrate the nuclear
membrane and cause DNA damage (Aitken, Bronson, et al., 2013).
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Figure 1.3 Anatomical Structure of a Human Spermatozoon.

Figure 1.3 is not available in this version of the thesis

Note. Adapted from “Gamete Transport and Fertilization,” by R. E. Jones, and K. H. Lopez,
2014, Human Reproductive Biology, p.161. Copyright 2014 by Elsevier Inc.

Oxidative stress in sperm
Production of reactive oxygen species (ROS)
Reactive oxygen species (ROS) are derived from molecular oxygen of cellular metabolism
and can be further classified into free radicals and non-free radicals. Free radicals, such as
superoxide anion (O2-) and hydroxyl radical (OH-), exhibit their reactivity from one or more
unpaired electrons; whereas non-free radicals, including hydrogen peroxide (H2O2), are formed
by a pair of free radicals that share one electron (Birben et al., 2012). Reactive nitrogen species
including nitric oxide (NO-) and peroxynitrite anion (ONOO-), are also present in normal
cellular activities (Agarwal et al., 2014). Within the context of human sperm, superoxide anion,
hydrogen peroxide and peroxyl (ROO-) radical as well as hydroxyl radical (OH-) are considered
to hold a clinically important role in normal sperm physiological functions (Wagner et al.,
2018). Highly reactive superoxide anion results from reduction of diatomic oxygen (O2) through
a regular aerobic cellular respiration to produce adenosine triphosphate (ATP) in the
mitochondria (Du Plessis et al., 2015; Wagner et al., 2018). Similarly, hydrogen peroxide is
produced as a by-product of many metabolic reactions as well as through dismutation of
superoxide (Du Plessis et al., 2015). Intracellular sperm ROS can also arise from Glucose-6phosphate dehydrogenase (G6PD) and nicotinamide adenine dinucleotide phosphate (NADPH)
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oxidase, enzymes that are contained in the cytoplasm (Du Plessis et al., 2015). Tight regulation
of redox reactions involving a ROS-antioxidant balance is key to sperm’s fertilising capacity
and successful fertilisation events such as sperm capacitation, hyperactivation, acrosome
reaction and sperm binding to zona pellucida (Agarwal et al., 2008; Bejarano et al., 2014;
Buzadzic et al., 2015). The physiological roles of ROS in sperm are attributed to the oxidative
properties of ROS that allows the inhibition of tyrosine phosphatase and Ca2+ influx, leading to
increased cyclic adenosine monophosphate (cAMP) and protein kinase A (PKA) (Dutta et al.,
2019; Moazamian et al., 2015).
An oxidative stress state results from the imbalance between levels of ROS and antioxidant
capacity when ROS are abundant or when antioxidant reserve is deficient or both (Bui et al.,
2018; Ko et al., 2014; Sabeti et al., 2016; Sharma et al., 2017). Therefore, as the condition is
defined, the levels of intracellular ROS production can be a good indicator of oxidative stress
status in sperm (Sabeti et al., 2016). Detrimental effects of high levels of ROS have been
postulated in relation to sperm conventional parameters such as concentration, motility and
morphology, and thus male infertility. This concern also extends to more complex sperm
functions and clinical outcomes such as fertilisation, embryonic development, pregnancy loss
and the health of the offspring (Ko et al., 2014).
ROS can occur endogenously or exogenously. Endogenous ROS come primarily from
leukocytes and abnormal or immature sperm (Agarwal et al., 2014; Bejarno et al., 2012; Bui et
al., 2018; Gharagozloo & Aitken, 2011; Treulen et al., 2015), and also as by-products of normal
cellular metabolism such as from functioning mitochondria of the electron transport chain and
other cellular enzymatic reactions (Agarwal et al., 2014; Dutta et al., 2019). Activated
leukocytes produce up to 1,000 times more ROS than regular aerobic metabolism (Wagner et
al., 2018). An abundance of leukocytes in the semen poses a threat of oxidative damage (Du
Plessis et al., 2015). The WHO suggests 1.0 × 106 leukocytes per mL of semen as a threshold
value of leukocytes in the ejaculate (leukocytospermia); and this is associated with poor sperm
quality (WHO, 2010). Consequently, the presence of subclinical inflammation and infection
activates leukocytes, increases intracellular ROS levels, and is estimated to underlie 10 to 35%
of male infertility cases (Bui et al., 2018; Du Plessis et al., 2015; Wagner et al., 2018). ROS
levels are also higher in patients with pre-existing reproductive related conditions such as male
accessory gland infections (MAGI) and varicocele and non-reproductive related conditions such
as hyperglycaemia (Wagner et al., 2018). Similarly, excess residual cytoplasm containing G6PD
and NADPH found in immature sperm can stimulate mitochondrial ROS production (Bui et al.,
2018). This residual cytoplasm is normally removed during sperm differentiation and
maturation processes (Du Plessis et al., 2015).
Exogenously, ROS can occur as a result of environmental and lifestyle factors including
alcohol, cigarette smoking and radiation (Agarwal et al., 2008; Bui et al., 2018). Substantial
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increases in seminal leukocytes and inflammation that accompany increased ROS levels have
been observed with cigarette smoking; whereas increased ROS generation associated with
excessive alcohol intake is thought to result from the interaction of the by-products of ethanol
metabolism with protein and lipids (Wagner et al., 2018). Similarly, although other pathways
may be involved, sperm dysfunction associated with exposure to heavy metals (e.g Fe, Pb, and
Cu), pesticides and other environmental pollutants is thought to be facilitated by increased ROS
production (Wagner et al., 2018). Through the Fenton and Haber Weiss reaction, Ferrous ions
(Fe2+ or iron) catalyse the formation of extremely reactive hydroxyl radical from superoxide
anion and hydrogen peroxide. To achieve stability, these free radicals take the electrons from,
and consequently disrupt the stability of, the neighbouring structure (Du Plessis et al., 2015). In
relation to clinical practice, processes involved in ART pose greater exposure to endogenous
and exogenous ROS, which can both equally contribute to oxidative stress and compromised
ART outcomes (Gupta et al., 2010). One of the main reasons for this is the lack of endogenous
mechanisms that regulate adequate production of ROS and that are balanced with antioxidant
production as found in vivo under normal conditions (Agarwal et al., 2014).

The antioxidants
Antioxidants can be classified into enzymatic and non-enzymatic types. Enzymatic
antioxidants are produced in male reproductive glands and are secreted into the seminal plasma.
Clinically important enzymatic antioxidants in male reproductive functions include superoxide
dismutase (SOD), glutathione peroxidase (GPx), and catalase. Superoxide dismutase catalyses
the conversion of superoxide to hydrogen peroxide and oxygen. Catalase will then further
convert hydrogen peroxide into water and oxygen (Wagner et al., 2018). Alternatively, nonenzymatic antioxidants such as Ascorbic acid (Vitamin C), Tocopherol (Vitamin E), Selenium
and Zinc can either be obtained endogenously, through food consumption or supplementation
(Wagner et al., 2018). Antioxidant supplements exist in natural or synthetic form. Natural
antioxidants are derived from food sources and naturally produced in the body; whereas
synthetic antioxidants are chemically synthesised and are thought to deliver suboptimal benefits
compared to the natural forms (Ko et al., 2014). Overdosing of antioxidants through unregulated
supplementation may disturb the oxidation-reduction balance and impede oxidative mechanisms
required for normal sperm physiological and fertilisation functions (Wagner et al., 2018).
However, the appropriate dosage and regime for supplementation has not been well established.
Hence, testing for ROS may help in determining patients who may benefit from antioxidant
supplementation (Practice Committee of the American Society for Reproductive Medicine
[PCASRM], 2013; Wagner et al., 2018).
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Measurement of reactive oxygen species (ROS) levels
Measuring the levels of ROS, in conjunction with conventional semen analysis, may
provide couples and clinicians with additional diagnostic and prognostic information on
whether male factor dominates and whether fertility treatment (e.g. IVF or ICSI) and
antioxidant supplementation will improve the likelihood of conception (Ko et al., 2014).When
ROS are measured on the whole unprocessed ejaculate, the ROS levels are indicative of the
initial ROS status in the sample, which take into consideration the sperm as well as secretions
from the accessory glands and other cellular components including leukocytes (Sharma et al.,
2017). However, when measurement of ROS levels is performed following sperm preparation,
the method used should be considered in interpreting the results. Following a simple wash, for
example, only the seminal fluid is removed whereas other cellular components such as
leukocytes and cellular debris are still present. The determination of ROS levels in processed (or
washed) sperm can be clinically meaningful as it indicates the level of ROS originating from the
mature sperm and reflects the state of oxidative stress in the sample that is to be used for ART,
and thus, may serve some predictive value of the clinical outcomes (Sharma et al., 2017).
The levels of ROS can be measured directly or indirectly (Ko et al., 2014). Direct ROS
measurements, including chemiluminescence, nitro blue tetrazolium (NBT) test, and flow
cytometry, detect and measure the interaction of ROS species such as superoxide with a reagent
(Gosalvez et al., 2017). A flow cytometric analysis of dihydrofluorescein diacetate (DCFH) and
dihydroethidium (DHE), for example, can be used to measure the level of intracellular hydrogen
peroxide radicals and superoxide anions, respectively (Sharma et al., 2017). Indirectly, ROS can
be measured by evaluating the impact of oxidative stress including DNA damage and the level
of lipid peroxidation (Ko et al., 2014), by using a myeloperoxidase test and by measuring the
redox potential and the level of antioxidants (Sharma et al., 2017). With regard to the latter
approach, an indirect estimation of the seminal antioxidant capacity can be made by measuring
the level of an individual antioxidant present in the seminal plasma or by collectively measuring
the total antioxidant capacity (TAC) of the seminal plasma. The latter is indicative of an overall
antioxidant capacity and is considered to be a more cost effective and practical approach (Ko et
al., 2014). With over 30 different types of ROS testing currently available, convenience and
more importantly, the lack of consensus of an acceptable method and reference range value
remain a concern (Gosalvez et al., 2017). In addition, the additional cost, equipment and
training to run these tests may be substantial for a smaller laboratory/ fertility clinic compared
to a more established research centre facility (Ko et al., 2014). As a result, to date, routine ROS
testing is yet to be recommended by any clinical guidelines regarding male infertility and ART
(Wagner et al., 2018).
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Apoptosis in sperm
Apoptosis is controlled or programmed cell death that involves a series of events
encompassing morphological, biochemical and cellular changes (Grunewald et al., 2017). As
observed in somatic cells, apoptosis also takes place in sperm as part of cellular regulatory
mechanisms (Barroso et al., 2006). Apoptosis in sperm may involve two mechanisms: intrinsic
and extrinsic, both of which are involved in selective differentiation and maturation during
spermatogenesis under the regulation of follicle-stimulating hormone (FSH) and testosterone
level (Hichri et al., 2018). Extrinsic apoptosis requires binding of FasL, an extracellular death
ligand, to Fas-expressing spermatozoa (Bejarno et al., 2012). As part of its physiological roles
during the differential state of germ cells in the testes, extrinsic apoptosis helps to maintain a
proportional ratio between germ cells and Sertoli cells. This will not only restrict clonal
expansion but will also ensure exclusive maturation of non-defective germ cells (Aitken et al.,
2016; Bejarno et al., 2012). Sperm apoptosis through the Fas/FasL pathway can also be
triggered by external toxicants such as cocaine, bisphenol A (BPA) and dexamethasone.
According to the abortive apoptosis theory, incompletion of this elimination process will result
in the presence of immature or apoptotic sperm in the ejaculate (Bejarno et al., 2012). Unlike in
the oocytes, the sperm DNA repair mechanisms are limited to spermatogenesis when chromatin
remodelling takes place (Wagner et al., 2018). Toward the later stages of spermiogenesis,
maturing sperm progressively lose their ability to undergo complete apoptosis, resulting in the
presence of abnormal sperm in the ejaculate (Bui et al., 2018). A high proportion of sperm with
such characteristics is negatively correlated with sperm concentration in the ejaculate (Taylor et
al., 2004). Similarly, intrinsic (mitochondrial) apoptosis serves normal physiological functions
as well as pathological roles. The intrinsic (mitochondrial) apoptosis mechanism involves
alteration of the mitochondria, leading to the release of mitochondrial proteins and the
activation of caspases (e.g. caspase-3 and caspase-9) that are responsible for cellular apoptosis
(Bejarno et al., 2012).
Apoptosis is commonly characterised by several apoptotic markers, which include the
externalisation of phosphatidylserine (PS), caspase activation, the loss of integrity of the
mitochondrial membrane potential and DNA fragmentation (Aziz et al., 2007).
Phosphatidylserine is located in the inner leaflet of the sperm plasma membrane and is an
essential component in maintaining the integrity of the membrane. Annexin V detects apoptosis
in sperm based on the presence of PS externalisation and is commonly used in conjunction with
propidium iodide (PI) staining, which can be used to identify plasma membrane permeability as
it stains the nucleus after penetrating a poorly integrated membrane (Rieger et al., 2011). The
analytical results of apoptosis using Annexin V is presented in the classification of cells into
four subpopulations: (i) Annexin V-negative & PI-negative (AnnV-PI-); (ii) Annexin V-positive
& PI-negative (AnnV+PI-); (iii) Annexin V-positive & PI-positive (AnnV+PI+); (iv) Annexin V-
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negative & PI-positive (AnnV-PI+). The interpretation of each population is based on the
assumption that PS externalisation occurs in the early stage of apoptosis, followed by loss of
membrane integrity and apoptosis or necrosis (Hingorani et al., 2011).
In relation to male infertility, however, close association between PS externalisation
evident in early apoptotic sperm (AnnV+PI-) and in capacitated sperm has previously raised a
debate regarding the interpretation of the markers (Moustafa et al., 2004; Tavalaee et al., 2012).
A significant positive correlation between the proportion of AnnV+PI- sperm and fertilisation
rate has been observed in an experimental study (Tavalaee et al., 2012). Conversely, another
study observed reduced sperm motility in both AnnV+PI+ and AnnV+PI- sperm (Zhang et al.,
2008). In agreement with the latter study, successful capacitation, indicated by Western blot
tyrosine phosphorylation analyses, and acrosome reaction, as shown by CD46 marker detection,
was observed in magnetic activated cell sorting (MACS) -sorted non-apoptotic (Annexin V-)
sperm (Grunewald et al., 2006). In relation to this, a review by Aitken (2017) suggests that ROS
possess physiological roles in facilitating capacitation, which is reversible through addition of a
catalase that inhibits tyrosine phosphorylation. Once the antioxidative capacity is overwhelmed
by the excessive ROS, however, the favourable effects will shift towards the initiation of
mitochondrial apoptosis and eventually DNA damage (Aitken, 2017).

DNA damage in sperm
The relationship between sperm DNA fragmentation (SDF) and male infertility was
first postulated in the 1970s, soon after the unique structural characteristics of spermatozoon
DNA were discovered. Since then, different techniques to measure SDF, including the terminal
deoxynucleotidyl transferase nick end labelling (TUNEL) assay, the sperm chromatin structure
assay (SCSA), the sperm chromatin dispersion (SCD) test, and the Comet assay were developed
(Rex et al., 2017). The consequences of SDF in clinical outcomes, including poor fertility rate,
implantation and pregnancy rate, have been observed in recent studies (Bareh et al., 2016;
Simon et al., 2017; Zhao et al., 2014). Although there is a lower probability, successful
fertilisation and pregnancy from spermatozoa with defective DNA can still be achieved and is
even more likely with the help of ART (Johnson et al., 2013; Yamauchi et al., 2012).
Depending on the oocyte quality and severity of the DNA damage, oocytes may allow DNA
repair or prevent fertilisation by sperm with defective DNA in natural conception (Sakkas &
Alvarez, 2010; Yamauchi et al., 2012). Expectedly, ART, especially ICSI, bypasses this natural
defence mechanism, and therefore, increases the risk of birth defect if successful pregnancy is
achieved (Bach & Schlegel, 2016; Davies et al., 2012; Xiong et al., 2017). Altogether, this
makes SDF an attractive parameter to complement semen analysis in predicting ART outcomes
(Lopez et al., 2013; Pabuccu et al., 2017).
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Aetiology of sperm DNA damage
While the effects of sperm DNA damage on clinical outcomes have been well documented,
the aetiology and the mechanisms involved are still poorly understood (Rex et al., 2017). An
earlier study proposed six causes of DNA damage: (i) apoptosis during spermatogenesis; (ii)
DNA strand breaks during spermiogenesis; (iii) ROS-induced post-testicular DNA
fragmentation; (iv) DNA fragmentation induced by endogenous caspases and endonucleases;
(v) DNA damage that results from radiotherapy and chemotherapy; and (vi) DNA damage
induced by environmental toxicants (Sakkas & Alvarez, 2010). In an attempt to explain the
common underlying mechanisms of these causes, more recent studies suggest that sperm DNA
damage involves apoptosis, defective maturation and oxidative stress (Muratori et al., 2015; Ni
et al., 2016; Zheng et al., 2017). A simultaneous analysis of these three factors (Muratori et al.,
2015) agrees with the two-step model of sperm DNA damage, where impaired chromatin
maturation during spermatogenesis results in nuclear protamine deficiency that is more prone to
oxidative DNA damage (Rex et al., 2017).
Looking more closely into the direct mechanism of DNA damage in sperm, Aitken, Smith,
et al. (2013) narrowed down the possible explanations into (1) enzymatic reaction and (2) free
radicals attack, with oxidative damage being the central problem. Enzymatic DNA strand
breakage can take place if there is faulty chromatin remodelling during spermiogenesis. During
this process, almost all histones will be replaced by protamine, leaving about 15% of the
remaining structures as histones (Garolla et al., 2015). The torsional pressure produced during
this histone-to-protamine replacement is anticipated by topoisomerase II-induced DNA strand
breaks, which will eventually be repaired. Improper regulation of this maturation process may
lead to the presence of unrepaired DNA nicks that are prone to oxidative damage and apoptosis
(Aitken, Smith, et al., 2013; Ni et al., 2016). Alternatively, free radicals may induce sperm
DNA damage by two mechanisms: by causing a direct oxidative attack on the purine and
pyrimidine bases of the DNA; and by the induction of the apoptotic cascade. It is believed that
oxidative damage is the predominant DNA damage in human spermatozoa (Aitken, Bronson, et
al., 2013). In relation to enzymatic reaction, despite the protective compaction of the sperm
chromatin within the nucleoprotamines, deficient protamination that is often found in infertile
men increases its vulnerability to direct oxidative damage (Wagner et al., 2018). This rationale
is further strengthened by the observed unique characteristics of the human sperm. In somatic
cells, induction of apoptosis is followed by the mitochondrial release of endonucleases and their
activation in the cytosol. Once activated, these enzymes can easily access the nucleus and bring
about enzymatic DNA cleavage (Aitken & Baker, 2013). In contrast, the middle piece of human
spermatozoa, where the mitochondria and most of the cytoplasm are located, is structurally
isolated from the nucleus-containing head. This physical barrier impedes nucleases from
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penetrating the nucleus whilst allowing the mitochondrial ROS to attack the chromatin and to
initiate an intrinsic mitochondrial apoptosis pathway (Aitken, Bronson, et al., 2013).
Although the interaction between oxidative stress and apoptosis may appear to be a
causative relationship, the two factors, in fact, are linked in a very complex and almost cyclic
manner in causing DNA damage. In an oxidative stress state, ROS can easily cause lipid
peroxidation, which is particularly likely to happen in human spermatozoa, as they are rich in
polyunsaturated fatty acid (PUFAs) and lack of cytoplasm containing powerful intracellular
antioxidants (Moazamian et al., 2015). Once the cascade is triggered, lipid peroxidation
generates lipid aldehydes such as 4-hydroxynonenal (4HNE) whose positive charge can bind to
and disrupt mitochondrial proteins, leading to electron leakage from the electron transport chain
(ETC) and yield more intracellular ROS. As more ROS production continues to increase lipid
aldehyde production, the cycle repeats itself and eventually brings about oxidative DNA
damage and cellular apoptosis (Moazamian et al., 2015). In addition to this intrinsic ROS
production cycle, extrinsic sources such as exposure to heat and environmental toxicants can
equally create an oxidative state and initiate an intrinsic mitochondrial apoptosis pathway
(Aitken, Smith, et al., 2013). The activation of the lipid peroxidation cascade may also affect
sperm motility by causing ATP depletion and by direct aldehyde binding with the structural
proteins essential for its motility (Aitken et al., 2016). A thorough analysis of different lipid
aldehydes confirms that alkylation of structural proteins in sperm flagella can directly cause a
loss in motility independent of oxidative stress (Moazamian et al., 2015).

Measurement of sperm DNA damage
Whilst conventional semen analysis has been traditionally used as a diagnostic tool for
male infertility, its implication in the ART clinic has been associated with a number of
limitations; and its application in predicting ART outcomes has not been confirmed (Simon et
al., 2017). This predicates the need for a reliable test to diagnose male infertility and to predict
clinical outcomes (PCASRM, 2013). Among others, presently the most clinically used methods
are SCSA, TUNEL, Comet and the SCD tests, all of which provide an estimation of an overall
quality of the sperm DNA (PCASRM, 2013). These methods were developed either to directly
measure the DNA fragmentation (e.g. TUNEL and Comet assays) or to measure the
susceptibility of DNA to fragmentation (e.g. SCSA and SCD) (Agarwal et al., 2016).
A systematic literature review of 56 studies involving 8,068 treatment cycles reported a
detrimental effect of sperm DNA damage measured by SCSA, TUNEL, SCD or Comet assays
on clinical pregnancy rate following IVF and/or ICSI cycles (Simon et al., 2017). The statistical
significance of this effect, however, was only observed when sperm DNA damage was
measured with TUNEL, SCD and Comet, but not with SCSA. Further, when the types of
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treatment were considered, the significant adverse effect of sperm DNA damage measured by
TUNEL was consistently observed in studies that involved IVF, ICSI and IVF/ICSI patients;
whereas when SCSA and SCD were used, the negative effect was only observed in studies
involving IVF/ICSI patients. This suggests that direct measurement of DNA damage may be
more predictive of an overall quality of the sperm DNA integrity and may provide a better
predictive value for the clinical outcomes (Simon et al., 2017).
The TUNEL assay principally identifies DNA fragmentation by incorporating a
modified nucleotide deoxynucleotidyl transferase (dUTP) to the 3’ hydroxyl of the single or
double-stranded DNA break-ends (Sharma et al., 2016), which is labelled with either
fluorochrome or biotin, which makes it possible to quantify DNA breaks through the intensity
of the signals being produced (Hekmatdoost et al., 2009). The ability to measure the actual
fragmentation present in single and double-stranded DNA presents the main advantage of using
the TUNEL assay (Sharma et al., 2016). Similarly, the presence and the migration of
fragmented DNA out of the sperm head can be visualised using the Comet assay. The intensity
and the length of the ‘comet’ tail around the sperm head are indicative of the severity of the
sperm DNA fragmentation (Agarwal et al., 2016). In comparison, SCSA and SCD test for
susceptibility of sperm DNA to denaturation by heat or acid (Agarwal et al., 2016; Henkel et al.,
2010). MACS, a novel technique, has also been developed for diagnosis and treatment purposes
(Rex et al., 2017). This technique utilises Annexin V-conjugated microbeads to label and
separate sperm cells with an apoptotic marker based on its high affinity to PS (Esbert et al.,
2017; Rex et al., 2017).
Despite the rapid advancement in the innovation of these techniques, the association
between suboptimal DNA integrity and poor clinical outcomes has not been consistently
supported in the existing literature. Accordingly, the use of these tests alone does not accurately
predict clinical outcomes both in natural and in ART conceptions (PCASRM, 2013; Simon et
al., 2017). The lack of validation of the predictive value of these tests can be due to the
heterogenicity of the assays, the protocols used and, consequently, the threshold or cut-off
values to measure DNA damage. In addition, although extensive study has been undertaken in
this field, the exact aetiology of sperm DNA damage is still poorly understood. Together, these
present some challenges involved in incorporating these tests into the clinical practice (Bui et
al., 2018; Simon et al., 2017).

Sperm preparation
Sperm preparation is an important early step in some ART treatments. To satisfy the
primary objective of sperm preparation an ideal preparation method should not only increase the
proportion of morphologically normal motile sperm, but also isolate sperm with intact DNA and
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good fertilising capacity whilst removing the seminal plasma. Although seminal plasma
contains protective natural antioxidants (Aitken & De Iuliis, 2010), it also contains potential
sources of ROS including cellular debris, leukocytes and abnormal or immature sperm (Henkel,
2013; Malvezzi et al., 2014). As discussed previously, the imbalance between these two factors
leads to oxidative stress, which combined with defective maturation and sperm apoptosis have
been demonstrated as the cause of DNA damage in sperm (Muratori et al., 2015; Ni et al., 2016;
Rex et al., 2017).
Simple washing is the simplest and the first sperm preparation procedure that was
introduced to aid in ART (Henkel & Schill, 2003). Given that the pre-wash semen quality is
considerably good, simple washing gives the highest yield and can be suitable for IUI. With this
method, the semen sample is diluted in a medium such as human tubal fluid (HTF), preferably
supplemented with human serum albumin (HSA) or serum; and is washed or centrifuged twice,
the pellet is collected, and the supernatant is discarded (WHO, 2010). Over time, the search for
an ideal processing method to suit the increasing demand for ART continued to rise. It is
proposed that an ideal sperm preparation method should, in no particular order: (i) be costeffective, less skill-intensive and can be practically implemented in clinical situations; (ii)
produce a good yield; (iii) eliminate non-germ cells, immature or abnormal sperm, ROS and
other potentially toxic substances; (iv) not damage the healthy sperm; and (v) be able to process
a large volume of semen sample (Henkel & Schill, 2003).

The conventional sperm preparation methods
To date, two of the most recognised and clinically used sperm selection methods are
density gradient centrifugation (DGC) and the swim-up technique (Malvezzi et al., 2014;
Takeshima et al., 2017). DGC is performed by layering the semen sample over either a
continuous or discontinuous gradient, followed by centrifugation and a final washing step in a
fresh medium (Henkel & Schill, 2003). Both continuous and discontinuous gradients utilise
different concentration gradients to fractionate the sperm population based on its density, as
mature and morphologically normal spermatozoa have a higher density (1.10 g/mL) compared
to immotile (1.06 g/mL) or immature sperm (1.09 g/mL) and cellular debris (Malvezzi et al.,
2014; Takeshima et al., 2017). In addition, the ability of motile sperm to actively migrate
through the concentration gradient contributes to achieving a yield with high motility
percentage (Henkel & Schill, 2003). On the contrary, the swim-up method, in general, relies on
the ability of highly motile spermatozoa to actively migrate towards a layer of medium on top of
the semen layer following incubation, normally at 37oC (Sharma et al., 2015). With the
conventional swim-up method, an additional step of centrifugation can be added following
incubation and processed-sperm collection to adjust the concentration of the sample. In
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comparison to conventional swim-up, the direct swim-up method involves another step of
centrifugation prior to the incubation period (Rappa et al., 2016). The WHO (2010) guidelines,
however, suggest that the preceding centrifugation step in the direct swim-up method may
expose sperm to peroxidative damage, and therefore, should not be the preferred method.
Attributed to its ability to yield high sperm concentrations and its standardised procedure,
DGC is considered an ideal processing method for ART and to complement other methods such
as swim-up and MACS (Nadalini et al., 2014; WHO, 2010). In comparison, the swim-up
method has a relatively lower recovery rate, especially in samples with abnormal parameters
(e.g. samples with low sperm count and abnormal viscosity), which are often found in ART
cases (Malvezzi et al., 2014; Nadalini et al., 2014; Wang et al., 2014; WHO, 2010). Further,
compared to DGC, the swim-up method has been shown to have a high seminal component
contamination as indicated by zinc concentration in the swim-up media, which is thought to
inhibit the acrosome reaction in vivo (Bjorndahl et al., 2005). Whilst considering the detrimental
effect of ROS on sperm and its fertilising capacity, DGC effectively eliminates non-germ cells
including leukocytes and other cellular debris that can be sources of ROS (WHO, 2010) but
requires repeated centrifugation, which can be equally harmful (Agarwal et al., 1994; Agarwal
et al., 2014; Aitken & Clarkson, 1988; Malvezzi et al., 2014; Nadalini et al., 2014). Transition
metal contamination in gradient media has also been shown to induce ROS (Aitken et al., 2014)
and accelerate lipid peroxidation (Aitken, 2017). Despite its lower yield, swim-up may present
less potential damage as it may not require centrifugation (direct swim-up) (Malvezzi et al.,
2014; Nadalini et al., 2014; Wang et al., 2014; WHO, 2010). Nevertheless, cell-to-cell contact
with non-germ cells and abnormal or immature spermatozoa during sperm migration
(Takeshima et al., 2017) and prolonged in vitro incubation with the sperm medium involved in
the swim-up method (Li et al., 2012; Muratori et al., 2003) may still be a potential source of
ROS.

SeaforiaTM: An alternative sperm preparation method
The concern regarding detrimental effects of sperm preparation on sperm DNA integrity
underlies the consideration of using SeaforiaTM as an alternative. This product offers the
advantage of the swim-up method with modifications, which include the use of a disposable
separator and a heating device. These features are expected to provide a more standardised, less
detrimental sperm preparation procedure that requires minimal equipment such as a centrifuge
and an incubator. The manufacturer reported an increase of 98.43% and 80.56% in motility and
morphologically normal spermatozoa, respectively, following processing using SeaforiaTM.
Furthermore, it is reported to produce less motile sperm than DGC (13.0 ± 6.7% vs 18.0 ±
6.2%), but significantly higher than the direct swim-up technique (23.5 ± 10.1% vs 2.6 ± 2.6%)
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(LotusBio, 2009). In comparison, a study by Irving et al. (2013) observed an increase of 27.98%
in mean total motility and a decrease of 88.95% in mean SCSA DNA fragmentation following
processing using SeaforiaTM. So far there are very few studies that assess the efficacy of this
product, and therefore, further study is required to compare the efficacy of DGC, swim-up
methods, and SeaforiaTM, not only in obtaining highly motile sperm, but also in reducing levels
of sperm apoptosis and ROS, which has not been reviewed in the existing studies.

Time intervals during ART sperm preparation
ART procedures including IVF and ICSI are carefully designed to mimic the natural
conception process in vivo including the environment which gametes and the developing
embryo are exposed to. The lack of natural antioxidants and exposure to elevated levels of ROS
during ART preparation, including those from the culture media and prolonged incubation
interval, are thought to be one of the explanations for suboptimal ART outcomes (Gupta et al.,
2010). Based on this concern, the advantage of short gamete co-incubation, as opposed to the
standard gamete co-incubation has been studied, where oocytes are exposed to sperm for 2 h
instead of 16-18 h in an attempt to minimise ROS exposure and to optimise IVF clinical
outcomes (Bras et al., 2017; Li et al., 2016; Liu et al., 2016). Although some studies have
shown the adverse effects of prolonged incubation interval on sperm parameters and DNA
integrity (Drake-Brockman et al., 2018; Koyun et al., 2014; Nabi et al., 2013), the effects on
IVF and ICSI clinical outcomes are poorly understood. Aside from the guidelines recommended
by the WHO (2010), to date, there are no published data regarding IVF/ICSI protocols and
common practices in fertility clinics. Of interest to this project are the time intervals that happen
during the preparation for the procedure, including between ejaculation and sperm preparation
(pre-wash interval); between sperm preparation and insemination/ sperm injection (post-wash
interval); and between ejaculation and insemination/ sperm injection (total interval).

Time intervals in clinical practice: Significance and consequences
The timing and location of sample collection and processing for ART are commonly
arranged according to the convenience of both the patients and staff of the clinics. This,
however, should not compromise the ART outcome. For convenience, most couples undergoing
IVF and ICSI arrive at the clinic at the same time and semen sample collection is done almost at
the same time as the oocyte collection. With this arrangement, there is a 4-6 h interval between
semen sample collection and insemination time, which corresponds with the required incubation
time for the oocytes in some clinics (P. Burton, personal communication, n.d.). Sample
collection may also be carried out at home when collection at the clinic is not preferable. In this
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case, the WHO laboratory guidelines recommend protection of the sample from extreme
temperatures (below 20oC and above 37oC) and that the sample should be transported to the
laboratory within 1 h. Further, prior to sperm functionality analysis, it is recommended that
sperm preparation is performed within 1 h after ejaculation (WHO, 2010). This one-hour
allowance, however, has been shown to be applicable only for diagnostic purposes, but not for
therapeutic purposes. In other words, the one-hour interval may not affect the macroscopic and
microscopic characteristics of the sample, but may affect the fertilising capacity, and therefore,
the ART outcomes (Koyun et al., 2014; Yavas & Selub, 2004). The interval between sperm
preparation and insemination may also be an important factor that influences ART outcomes,
yet, to date, this has not been discussed in any guidelines (Fauque et al., 2014; Jansen et al.,
2017).
Previous studies found mixed results regarding the possible effects of a prolonged interval
or incubation time on sperm fertilising capacity and ART outcomes. While looking at the
effects of pre- and post-wash and total intervals, Yavas and Selub (2004) observed a negative
correlation between pregnancy rate and pre-wash, post-wash and total intervals in human
menopausal gonadotropin – intrauterine insemination (hMC- IUI) patients. Similarly, in a recent
study, conception rates in IUI cases were higher when the post-wash interval was within 30
minutes compared to more than 30 minutes (Agrawal et al., 2018). Nevertheless, a retrospective
study involving 1,136 IUI cycles found no significant difference in pregnancy rates between
insemination performed within 1 h and within 24 h of the post-wash interval (Jansen et al.,
2017). Alternatively, a prospective cohort study of 862 IUI cycles from seven fertility clinics
observed a non-linear relationship between clinical pregnancy and post-wash interval,
represented by an inverted u-shaped curve. These findings suggest the optimum clinical
pregnancy to be associated with 40-80 minutes of post-wash interval, with the highest clinical
pregnancy at ~60 minutes (Fauque et al., 2014). As most studies involved IUI cases, further
research is required to review the effects of pre- and post-wash and total intervals on the ART
outcomes in IVF and ICSI cases.

Summary
Recent statistics have shown an increasing occurrence of infertility both globally and in
Australia, which is accompanied by a rising demand for ART. Male infertility, independent of
female factors, contributes to 20% to 30% of infertility cases among couples. Existing
knowledge highlights the role of sperm apoptosis and ROS production in sperm DNA damage,
which in turn can adversely affect clinical outcomes. This may make both parameters suitable
complements to conventional semen analysis for male infertility diagnosis and potential
predictors for ART outcomes. The methods and the timing of sperm preparation involved in
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ART preparation have also been of interest in optimising ART outcomes. Whilst the efficacy of
both DGC and swim-up methods in isolating good quality sperm have been extensively studied,
the adverse effects of the processing itself remain debatable. Given this concern, SeaforiaTM may
be a good alternative to the traditional methods. The timing of sample collection and sperm
preparation for ART are commonly scheduled to accommodate the convenience of the patients
and the workload of the staff of the clinics. Whilst some studies have shown adverse effects of
prolonged incubation or time intervals during ART preparation on sperm parameters and DNA
integrity, the effects on the clinical outcomes, especially in IVF/ICSI cases are poorly
understood. Further study, therefore, is needed to assess whether prolonged pre- and post-wash
and total intervals will affect ART outcomes.
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Chapter 2: Aims and research design
Study overview and aims
The overall focus of this doctoral thesis concerns the potential source and clinical impact
of sperm apoptosis and ROS in the context of ART. To meet this main objective, three
independent studies were designed, each addressing a single aim. The aim, hypotheses and the
summary of the methodological approach formulated for each of these three independent studies
are outlined in this chapter. Detailed statistical analyses and methodologies including rationales
and inclusion or exclusion criteria will be elaborated within the relevant chapters (see Chapters
3-5). The outcome measures applied for the three independent studies comprise sperm quality
parameters including sperm motility and concentration; and clinical outcomes including
fertilisation rate, embryo quality and pregnancy rates. The definition and application of these
outcome measures in relevant studies will be discussed in this chapter. Further, this chapter also
covers common clinical protocols including semen sample collection, semen analysis, sperm
preparation and ovarian cycles that were applied in one or more of the three studies.

Outcome measures
Each of the three independent studies comprising this doctoral thesis focus on different
aspects of male infertility in the context of ART. Study 1 reviewed the role of apoptosis and
ROS in sperm DNA damage and in ART outcomes; Study 2 examined the efficacy of different
sperm preparation methods; and Study 3 investigated the effect of time intervals during sperm
preparation for IVF/ICSI cycles on the clinical outcomes. With sperm quality as the core of
attention, the contribution of this doctoral study to the existing knowledge and clinical practice
is projected to help couples to achieve optimal ART outcomes.
Clinical outcomes that were used as outcome measures, particularly in Study 1 and Study
3 include: fertilisation, embryo quality, human chorionic gonadotropin (hCG) pregnancy,
clinical pregnancy and biochemical pregnancy. A successful fertilisation was marked by the
presence of two pronuclei; and fertilisation rate was calculated as a percentage of the number of
oocytes fertilised (number of oocytes fertilised/number of oocytes inseminated × 100%). In
Study 1, day 5 embryo quality (D5EQ) was used as an indicator of embryo quality. The grading
criteria and scoring system used for this indicator, as well as the classification of “good”
embryo is discussed later in this thesis (see Section 3.3.3). hCG pregnancy was indicated by
blood hCG level > 9 IU/L at 14 days post oocyte retrieval; whereas clinical pregnancy was
characterised by detectable fetal heartbeat at 6 weeks post oocyte retrieval. Biochemical
pregnancy, also known as preclinical spontaneous abortion or miscarriage, was defined as an
hCG pregnancy that was not followed by a successful clinical pregnancy (Zegers-Hochschild et
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al., 2009). hCG pregnancy, clinical pregnancy and biochemical pregnancy rates were calculated
per embryo transfer and were expressed as percentages. A live birth was not used as one of the
outcome measures in the studies because follow-up data on the pregnancy after the examination
of fetal heartbeat at 6 weeks post oocyte retrieval was not available at the time of data collection
of this study.
The analysis of these clinical outcomes was interpreted in conjunction with other sperm
quality parameters including sperm concentration (million/mL), sperm total motility
(million/mL) and sperm progressive motility percentage. The analysis and calculation for these
parameters were performed according to the clinic protocol as listed in Section 2.3.2. In addition
to these sperm parameters, total motile sperm per yield was used to compare the efficacy of
three sperm preparation methods in Study 2. The total motile sperm per yield was calculated as
a product of the number of motile sperm (million/mL) and final volume of processed sample.

Study 1: The correlation between sperm apoptosis, ROS and ART outcomes
Aim: To investigate the relationship between sperm apoptosis, reactive oxygen species (ROS)
and ART outcomes.
Hypothesis 1: Sperm apoptosis and ROS will negatively correlate with fertilisation and
pregnancy rates but will positively correlate with biochemical pregnancy rate.
Hypothesis 2: Sperm apoptosis and ROS will negatively correlate with sperm motility.
Methods: A total of 201 semen samples collected from men whose partners were undergoing
IVF/ICSI at Concept Fertility Centre and with sperm concentrations above the minimum
requirement for the analysis (1 × 106 cells/mL) were included in the study regardless of their
quality. Once clinical use was assured, an aliquot of neat and processed samples was taken and
were tested for apoptosis (by Annexin V) and oxidative stress (by dihydroethidium). The neat
samples were analysed immediately following liquefaction for 20 minutes at room temperature;
whereas processed samples were analysed approximately 4-6 h after semen sample collection,
coinciding with insemination (IVF) or sperm injection (ICSI). Information regarding clinical
outcomes including fertilisation rate, embryo quality and pregnancy rates and other relevant
variables were extracted from the female de-identified patients’ records. General linear models
(GLMs) were performed to investigate the independent effect of sperm apoptosis and ROS on
fertilisation rate. An independent t-test or Mann-Whitney U test (non-parametric) and linear
mixed regression models were then performed to further explore the effect of sperm apoptosis
and ROS on embryo quality. Finally, a two-way analysis of variance and a proportional hazard
(Cox) regression were used to confirm the association between sperm apoptosis and ROS with
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pregnancy outcomes. Figure 2.1 summarises the experimental design of Study 1 and presents
specific thesis sections that elaborate each process in detail.
Figure 2.1 Experimental Design of Study 1.

Semen sample
collection
(see Section 2.3.1)

Semen analysis
(see Section 2.3.2)

Sperm preparation
(see Section 2.3.3)

Neat
samples

Processed
samples

Apoptosis
detection
(see Section 2.4.1)
and
ROS detection
(see Section 2.4.2)

Statistical
analyses
(see Section
3.3.4)

Clinical use

Clinical outcomes
(see Section 2.1.1)

Note. Once sufficient volume for clinical use was assured, an aliquot of neat (unprocessed) and
processed samples were tested for apoptosis and ROS. Statistical analyses were then performed
to investigate the effect of sperm apoptosis and ROS on clinical outcomes including fertilisation
rate, pregnancy rates and embryo quality.
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Study 2: The effects of three different sperm preparation methods on sperm apoptotic
markers and ROS
Aim: To compare the efficacy of DGC, swim-up and SeaforiaTM in reducing the levels of sperm
apoptosis and ROS.
Hypothesis 1: Sperm preparation using DGC will produce a final sample with higher proportion
of apoptotic sperm and sperm ROS compared to swim-up and SeaforiaTM.
Hypothesis 2: SeaforiaTM could produce a sample with sperm concentration and progressive
motility that are comparable to the swim-up method.
Methods: Excess semen samples were pooled following sample collection by masturbation and
routine semen analysis. Each pooled sample (N = 17) was aliquoted for processing using DGC,
swim-up and SeaforiaTM. Conventional semen parameters analysis including sperm motility and
concentration, intracellular ROS production (by dihydroethidium) and apoptotic markers (by
Annexin V) were then measured on neat and processed specimens of each pooled sample
(Figure 2.2). Statistically significant differences among processing methods were determined
using one-way repeated measure analysis of variance (ANOVA) and Friedman’s two-way
analysis of variance with a statistically significant value set at a P < 0.05.

Study 3: The effect of time intervals on ART outcomes
Aim: To examine the effects of prolonged pre-wash, post-wash and total intervals on ART
outcomes in IVF/ICSI cycles.
Hypothesis 1: Prolonged pre-wash, post-wash and total intervals will be negatively correlated
with sperm motility.
Hypothesis 2: Prolonged pre-wash, post-wash and total intervals will be associated with lower
fertilisation and pregnancy rates, and with higher biochemical pregnancy rate.
Methods: The independent effect of prolonged pre-wash, post-wash and total intervals on sperm
motility and clinical outcomes were retrospectively analysed from IVF and ICSI cycles
commenced between January 1995 to December 2016 (Figure 2.3). GLMs were constructed to
investigate the independent effect of the time intervals on sperm progressive motility and
fertilisation rate. Further, logistic regression models were constructed to assess the association
between the time intervals and the chance of having an hCG pregnancy, clinical pregnancy and
biochemical pregnancy.
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Figure 2.2 Experimental Design of Study 2.

Clinical use

Semen sample collection
(see Section 2.3.1)

Semen analysis
(see Section 2.3.2)

Inclusion criteria
(see Section 3.3.1)

Criteria
not met

Samples
excluded

Criteria met

Pooled semen samples

Neat
samples

DGC
(see Section 2.3.3.1)

Swim-up
(see Section 2.3.3.2)

SeaforiaTM
(see Section 2.3.3.4)

Apoptosis detection (see Section 2.4.1) and ROS detection (see Section 2.4.2)

Statistical analyses
(see Section 4.3.2)

Note. The remaining semen samples that met the inclusion criteria were pooled into an
individual semen sample. From this individual pooled sample, three different sperm preparation
methods: DGC, swim-up and SeaforiaTM were performed, and the resulting sperm apoptosis and
ROS were compared between sperm preparation methods and relative to the neat (unprocessed)
samples.
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Figure 2.3 Experimental Design of Study 3.
Data extraction:
(see Section 5.3.1)

Inclusion criteria
(see Section 5.3.1)

Criteria
not met

Cases
excluded

Criteria met

Cases included:
IVF (N = 5,033) & ICSI
(N = 3,046)

Data analysis

Time intervals calculation
(see Section 5.3.2)

Clinical outcomes
measures
(see Section 2.1.1)

Statistical analyses
(see Section 5.3.3)

Note. Pre-wash, post-wash and total intervals in IVF/ICSI cycles that met the inclusion criteria
were retrospectively analysed with reference to the clinical outcomes including fertilisation rate
and the chance of hCG pregnancy, clinical pregnancy and biochemical pregnancy (or
miscarriage).
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Ethics approval
The ethics approval for this study was granted by the University of Western Australia
Ethics Committee on the 7th November 2016 under reference number RA/4/1/7403 with
associated title ‘Study of the Role of Sperm Apoptosis & DNA Damage in Male Infertility’ and
by the Human Research Ethics Committee of Edith Cowan University on the 20th February 2017
under project code 17472.

Clinical protocols
Semen sample collection
Prior to sample collection, participants were provided with an information sheet
regarding the details of the study, and a participation consent form (Appendix A). Along
with these, a questionnaire on personal information and relevant lifestyle factors (e.g. days of
abstinence, current medication taken, alcohol intake, etc.) was also given as part of a
standard procedure at Concept Fertility Centre (Appendix B). All semen samples were
collected through ejaculation in a pre-weighed sterile container in a private sample collection
room.

Semen analysis
As a regular proceeding step in ART, all semen analyses were performed by
embryologists according to the clinic’s protocol, which is adapted from the WHO (5th ed)
guidelines (WHO, 2010). Macroscopic examination including liquefaction, semen appearance,
consistency, pH and volume as well as microscopic examination such as sperm concentration,
motility and morphology, were performed and recorded. The assessment of sperm concentration
and motility were performed on both the neat (unprocessed) sample and the processed sample
following sperm preparation, each in duplicate.
Following collection, the semen sample was allowed to liquefy at room temperature for
10 to 30 minutes. Delayed (longer than 60 minutes) or absence of liquefaction was noted.
Following liquefaction, the consistency of the sample was observed by aspirating and gently
dispensing the sample using a glass pipette. Semen samples with normal consistency should
form drops while being dispensed, and it was considered ‘viscous’ if there was an observed
formation of thread longer than 2 cm upon withdrawal of the pipette. With the same glass
pipette, one drop of sample was placed on the centre square of the pH strip (Macherey-Nagel,
Germany). The change in colour was observed after 30 seconds before it was compared to the
references. Another drop of sample was place in the middle of a labelled microscope slide for
morphologic examination.
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Sperm concentration and motility assessment were performed simultaneously using a
Makler Counting Chamber (Sefi-Medical Instrument, Israel). Following liquefaction, the semen
sample was mixed well and 10 µL of sample was placed onto a Makler Chamber. Using a cell
counter, the number of sperm with progressive motility (PR), non-progressive motility (NP) and
immotility (IM) were counted across the row until the total counted sperm reached a minimum
of 200 and all sperm in the whole row had been counted. PR was indicated by active movement
of sperm regardless of direction and speed; NP represented other patterns of movement with
lack of progression; and IM was the absence of movement (WHO, 2010). Sperm concentration,
total motility and progressive motility percentage were calculated as follows:

Total sperm count
Number of rows

Sperm concentration (106 cells/mL)

=

Total motility (million/mL)

= PR + NP

Progressive motility (%)

=

PR
× 100%
Total sperm count

Sperm preparation
Sperm preparation for Study 1 and Study 3 was performed by embryologists as part of
preparation for IVF/ICSI procedures. Depending on the quality of the individual semen sample
and the types of procedure (IVF/ICSI), density gradient centrifugation (DCG), swim-up, spin
direct or a combination of these methods might be used. Semen samples were prepared to 5-15
× 106 cells/mL for IVF and to 1 × 106 cells/mL for ICSI. Study 2 intended to compare the
efficacy of sperm preparation using DGC, swim-up and SeaforiaTM, and therefore, sperm
preparations for this particular study were performed by the research student according to the
protocols listed below with no variations made between samples.
The types of medium in which the final (processed) samples were resuspended
depended on the intended use of the samples (e.g. for IVF or ICSI). Following sperm
preparation, the final (processed) samples for IVF were prepared to 5-15 × 106 cells/mL in
sequential Fert™ fertilising media (Origio, Denmark), and were incubated in a 6% CO2
incubator at 37oC until use. Processed samples for ICSI were prepared to 1 × 106 cells/mL in
5% human serum albumin (Origio, Denmark) in Quinns Advantage Medium with HEPES
(Origio, Denmark) and incubated at 37oC until use. These adjustment steps were added to the
basic sperm preparation protocol outlined in the following sections.
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2.3.3.1

Density gradient centrifugation (DGC)

A density gradient column was prepared using two different concentrations of
PureSperm®100 colloidal silica suspension (NidaCon Laboratories AB, Sweden): 40% (w/v)
and 80% (w/v), diluted in Quinns Advantage Medium with HEPES (Origio, Denmark). Using a
glass pipette, 1 mL of 40% PureSperm®100 was firstly placed into a 15 mL centrifugation tube.
1 mL of 80% PureSperm®100 was then underlaid under the 40% suspension whilst maintaining
a distinctive layer of the two suspensions. 1 mL of neat semen sample was then carefully
layered on top of the column by pipetting the sample from the side of the tube, followed by
centrifugation at 1640 rpm (300 g) for 15 minutes. The resultant pellet was recovered and
resuspended in 2 mL of media containing 5% human serum albumin (Origio, Denmark) in
Quinns Advantage Medium with HEPES (Origio, Denmark), and was centrifuged at 2120 rpm
(500 g) for 5 minutes. Some of the supernatant was carefully removed without disturbing the
pellet, stopping at the 0.5 mL mark. The pellet was then resuspended in the remaining media.

2.3.3.2

Swim-up method

Using a glass pipette, 1 mL of neat semen sample was pipetted on the bottom of a 15
mL Eppendorf tube containing 2 mL of 5% human serum albumin (Origio, Denmark) in Quinns
Advantage Medium with HEPES (Origio, Denmark). The tube was placed in a heating block
(set at 37oC) for 30 minutes. Following incubation, the processed sample was obtained by
carefully aspirating the top 1 mL of the media which was placed into a 15 mL conical flask,
followed by centrifugation at 2120 rpm (500 g) for 5 minutes. The supernatant was carefully
removed without disturbing the pellet, stopping at the 0.5 mL mark. The final
centrifugation/washing step was excluded for Study 2 to eliminate the potential effects of
centrifugation. The implication of this modification is further discussed within the relevant
chapter (see Section 4.5).

2.3.3.3

Spin direct

In a 15 mL conical flask, the entire volume of semen sample was mixed with an equal
volume of sterile media containing 5% human serum albumin (Origio, Denmark) in Quinns
Advantage Medium with HEPES (Origio, Denmark), followed by centrifugation at 1810 rpm
(400 g) for 10 minutes. Without disturbing the pellet, the supernatant was removed as close as
possible to the pellet. The pellet was then resuspended in the same media. The volume of media
added depended on the type of procedure (IVF or ICSI) and the required sperm concentration.
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2.3.3.4

SeaforiaTM

Sperm preparation using SeaforiaTM was performed using 1 mL SeaforiaTM disposable
separators according to the manufacturer’s protocol (LotusBio, 2009). Using a disposable
syringe, 1 mL of neat semen sample was loaded into the disposable separator, followed by the
loading of 0.8 mL of 5% human serum albumin (Origio, Denmark) in Quinns Advantage
Medium with HEPES (Origio, Denmark) through the indicated channels. The disposable
separator was then incubated in the pre-heated heating device provided with the kit (Figure 2.4).
After 30 minutes of incubation, 0.8 mL media containing motile spermatozoa was aspirated
from the indicated channel.

Figure 2.4 SeaforiaTM Sperm Separation System.

Figure 2.4 is not available in this version of the thesis

Note. Semen sample and media were loaded into a SeaforiaTM disposable separator (a), which
was then mounted on to the SeaforiaTM heating device (b) for incubation. Adapted from
“SeaforiaTM Sperm Separation System Product Catalog,” Copyright 2009 by LotusBioTM.

Ovarian stimulation
Prior to ovarian stimulation downregulation of the female patients’ cycle was achieved
using gonadotrophin releasing hormone (GnRH) agonist or a GnRH antagonist according to the
agonist long protocol, agonist flare protocol or antagonist protocol. Ovarian stimulation was
achieved by administration of recombinant follicle stimulating hormone (FSH), combined
FSH/human chorionic gonadotropin (hCG) or recombinant luteinizing hormone (LH). The type
and dose of stimulation regimen was adjusted for patients’ age, Anti-Müllerian Hormone
(AMH) level and risk factors for ovarian hyperstimulation syndrome. The cycle was monitored
through ultrasound and/or serum hormone levels commencing on cycle day 8, for agonist cycle,
and on cycle day 6, for antagonist regimen. Ovulation was triggered using hCG, followed by
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oocyte retrieval 36 h after hCG was administered and an embryo transfer was performed two to
five days after oocyte retrieval.

Detection of sperm cell biological markers
The rationale behind the measurement of intracellular ROS levels and apoptosis was
based on the interrelationship between the two parameters; as well as with sperm DNA damage
and its consequences on sperm parameters and clinical outcomes, as previously described in the
Literature Review (see Chapter 1). In light of the existing literature, the analyses and
interpretations of the two parameters in conjunction with other semen parameters are discussed
in the latter chapters dedicated to relevant studies in which these tests were implemented (see
Chapter 3 and Chapter 4) as well as in the General Discussion (see Chapter 6).

Apoptosis detection by Annexin V
In this doctoral research project, sperm apoptosis was detected using Muse™ Annexin
V & Dead Cell Reagent (Millipore, USA) in a Muse™ Cell Analyzer (Millipore, USA). Flow
cytometric analysis of Annexin V-positive sperm has been commonly used to quantify the
proportion of a sperm population undergoing apoptosis (Grunewald et al., 2009; Sheikhi et al.,
2013; Talarczyk-Desole et al., 2016; Zorn et al., 2012). Muse™ Annexin V & Dead Cell
Reagent (Millipore, USA) contains Annexin V, which binds to externalised PS from the inner
leaflet of the plasma membrane during the process of apoptosis; and 7-aminoactinomycin D (7AAD), which stains the nucleus of a necrotic cell or cell with disintegrated cell membrane
during the late stage of apoptosis (Rieger et al., 2011). Based on this complementary staining,
the outputs of the analysis were displayed as an apoptotic profile that consists of four quadrants
determined by cells’ viability (y-axis) and the presence of apoptotic marker (x-axis) (Figure 2.5
Immediately after the sample was available for research use, the semen sample was
prepared to 0.3 × 106 cells/mL in 10% human serum albumin (Origio, Denmark) in Quinns
Advantage Medium with HEPES (Origio, Denmark). In a 1.5 ml Eppendorf tube, 0.1 mL of
Muse™ Annexin V & Dead Cell Reagent (Millipore, USA) was added to 0.1 mL of the cell
suspension. The mixture of the solutions was vortex mixed and was incubated in the dark at
room temperature for 20 minutes. Once incubation was complete, the samples were analysed
using the Muse™ Cell Analyzer (Millipore, USA) with minimum number events set at 3000
events per run. Before the initial run of the assay, a gate was setup to determine the population
profile. For the gate setting, a normospermic semen sample was processed using the swim-up
method (see Section 2.3.3.2) and split into two aliquots: the first aliquot was used as a negative
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control whereas the second aliquot was treated with liquid nitrogen and was used as a positive
control.
Figure 2.5 An Example Output of Apoptosis Analysis Using Muse™ Cell Analyzer.

Figure 2.5 is not available in this version of the thesis

Note. The sample was classified into AnnV-/7-AAD-, AnnV-/7-AAD+, AnnV+/7-AAD- and
AnnV+/7-AAD+ populations. Adapted from “MuseTM Annexin V & Dead Cell Kit User’s
Guide,” Copyright 2013 by EMD Millipore Corporation.

ROS detection by DHE
The detection of ROS-generating sperm populations was performed using the Muse®
Oxidative Stress Kit (Millipore, USA), which is based on dihydroethidium (DHE). As
implemented elsewhere (Aitken, Smith, et al., 2013; Moazamian et al., 2015), the oxidation of
DHE by intracellular superoxide was used to quantify the population of sperm exhibiting ROS
production. In preparation for the assay, an intermediate solution was prepared from a 1:100
dilution of Muse® Oxidative Stress Reagent stock solution in 1x assay buffer. Aliquots of 2 µL
intermediate solution were pipetted into 0.2 mL PCR tubes and were stored at -20oC in the
absence of light until use. On the day of experiment, both the neat and the processed samples
were prepared to 3 × 106 cells/mL in 1x assay buffer. Immediately before use, a working
solution was prepared from a 1:80 dilution of the intermediate solution in 1x assay buffer. A
190 µL aliquot of this working solution was then added to 10 µL of semen sample and was
incubated at 37oC for 30 minutes. Samples were then analysed using the Muse™ Cell Analyzer
(Millipore, USA) with the minimum number events set at 3000 per run. Prior to the first
analysis, a negative control for the gate setting was prepared as previously described for sperm
apoptosis analysis (see Section 2.4.1). For the positive control, a normospermic semen sample
was processed with DGC (see Section 2.3.3.1). The immotile and abnormal spermatozoa
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contained in the upper layer of the density gradient column (40% PureSperm®100 solution)
were collected and were further washed in 5% human serum albumin (Origio, Denmark) in
Quinns Advantage Medium with HEPES (Origio, Denmark) for 20 minutes at 600 g. This
method was adapted from previous works by Aitken et al. (2010) and Koh et al. (2016).

Statistical approach
All statistical analyses in this thesis were performed using IBM SPSS Statistics for
Windows, Version 25.0 (Armonk, NY: IBM Corp.). The statistically significant value for all
analyses was set at P < 0.05. Non-significant values (P ≥ 0.05) are indicated as “not significant”
(NS).
Prior to other statistical analyses, descriptive statistics, including normality tests, were
performed on the raw dataset. The descriptive tests performed on the raw dataset included the
measure of frequency (e.g. sample size or N and percentage), mean value and variation (SD).
Normality testing of the data was performed using the Kolmogorov-Smirnov test to assess the
normal distribution of the continuous variables. This was done to ensure that the assumption
about normal data distribution in various statistical analyses including correlation, regression
and t-tests was not violated (Mishra et al., 2019). If normal distribution was confirmed, the
mean value was considered representative of the data and parametric tests could be carried out.
In cases where the raw data was not normally distributed, mathematical data transformation
(e.g. log and square root transformation) was performed on the raw (untransformed) data as an
attempt to improve the normality of the data. Alternatively, non-parametric methods were used
as indicated.
Various statistical tests were performed to test for a statistically significant difference
between the mean value of two or more sample groups. Independent t-test and Mann-Whitney U
test (non-parametric) were used to analyse the statistical difference between two independent
sample groups. This includes the comparison in descriptive statistics of maternal age, paternal
age, fertility status and sperm parameters between IVF and ICSI groups (Study 1 and Study 3)
(Allen et al., 2014). To test for significant difference between three or more independent sample
groups, such as the difference in apoptosis levels following three sperm preparation methods
(Study 2), one-way repeated measures analysis of variance (ANOVA) or Friedman’s two-way
analysis of variance (non-parametric) was performed. This statistical analysis was
complemented by Fisher’s Least Significant Difference (LSD) post-hoc multiple comparison
test to identify the source of the variation (Allen et al., 2014). Similarly, a two-way ANOVA
was used to test for statistically significant difference in the mean proportion of apoptotic or
ROS markers in patients with different procedure types (IVF or ICSI) and pregnancy outcomes
(no pregnancy, hCG pregnancy and biochemical pregnancy). Chi-Square test for goodness of fit

55
was performed to test the presence or absence of statistically significant differences in
percentage/frequency between categorical variables such as hCG, clinical and biochemical
pregnancy.
One of the main objectives of this thesis was to investigate the correlations between
independent variables such as levels of apoptosis, ROS levels (Study 1) and time interval (Study
3); and clinical outcomes including fertilisation rate, embryo quality and pregnancy rates. The
analyses of these correlations were achieved using different statistical tests depending on the
types of variable and the consideration of other potential confounding variables. Pearson and
Spearman’s correlations (non-parametric) tests were performed to investigate bivariate
correlations between two continuous variables. The significance of these correlations was tested
between semen parameters, levels of apoptosis or ROS and clinical outcomes (Study 1); and
between time intervals, semen parameters, fertility status and year of cycle (Study 3). As an
extension of these analyses, regression testings were performed using GLMs, at which the effect
of continuous variables on a dependent variable was analysed whilst potential confounding
variables including patients’ age and fertility status were introduced and controlled for. The
independent effect of an independent variable on a dichotomous dependent variable was
analysed using logistic regressions. This approach was particularly useful in determining the
independent effect of semen parameters, apoptosis or ROS levels (Study 1) and of prolonged
time intervals (Study 3) on the probability of having an hCG pregnancy, clinical pregnancy and
biochemical pregnancy. At the preliminary stage of GLMs and logistic regression analysis,
initial regression models were constructed to include all variables with potential confounding
effects as well as relevant interaction terms between the independent variables. The latter was
done to test whether the effect of the independent variable of interest on the dependent variable
varied with other predictors (e.g. procedure type and year of cycle). Non-significant predictors
and interaction terms were excluded from the initial models in a stepwise manner until only
significant predictors were left in the model.
In addition to the statistical tests mentioned above, proportional hazard (Cox) regression
and linear mixed regression models were performed to complement the main statistical
analyses. The rationales for including these tests as well as other tests mentioned above, will be
discussed in detail in the relevant chapters of this thesis.
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Study 1: The correlation between sperm apoptosis,
ROS and ART outcomes
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Chapter 3: Study 1- The correlation between sperm apoptosis, ROS and ART outcomes
Research background
A progressive increase in the utilisation of ART in Australia and New Zealand reached
82,215 treatment cycles in 2017. Of these initiated cycles, clinical pregnancy and a successful
live birth were only observed in 22.9% and 18.1% of the cycles, respectively. Within this
particular year, in Australian clinics, women undergo an average of 1.9 fresh and/or thaw cycles
per woman. This figure includes 52.3% of women who had two or more autologous treatment
cycles and 10.6% of women who had four or more cycles (Newman et al., 2019). Together,
these figures indicate that although there is a constant increase in the total number of cycles
from the previous years, a satisfactory success rate is yet to be achieved (Fitzgerald et al., 2017;
Fitzgerald et al., 2018).
The existing literature shows a growing interest in understanding the aetiology of sperm
DNA damage and its consequences on clinical outcomes (Rex et al., 2017). This is primarily
driven by the observed limitations of conventional semen analysis to accurately predict sperm
fertility potential (Agarwal et al., 2016; Casanovas et al., 2019). Normal conventional
parameters including sperm count, motility and morphology are observed in 15% of infertile
men, suggesting the role of other nuclear or subcellular factors that limit normal fertilising
capacity (Selvam & Agarwal, 2017). Parallel to this notion, various techniques such as the
TUNEL assay, SCSA, SCD, and the Comet assay have been developed to measure sperm DNA
damage (Rex et al., 2017). Whilst the importance of assessing sperm DNA damage in addition
to the conventional semen analysis has been acknowledged in many publications (Lopez et al.,
2013; Pabuccu et al., 2017; Selvam & Agarwal, 2017), the clinical implications of this novel
diagnostic approach are yet to be confirmed (Simon et al., 2017). Some of the concerns that may
limit the clinical use of these techniques are lack of standardised cut-off values, inter-observer
and inter-laboratory variability, skill-intensive and lack of reproducibility, especially when
fluorescent microscopy is used (Agarwal et al., 2016; Selvam & Agarwal, 2017).
The inevitable interrelation of sperm apoptosis and ROS with sperm DNA damage has
also made these two markers an attractive approach for male infertility diagnosis and prognosis
(Aitken, Bronson, et al., 2013; Aitken, Smith, et al., 2013). The detection of sperm apoptotic
and ROS markers is commonly performed using flow cytometry (Gosalvez et al., 2017; Ko et
al., 2014; Oosterhuis et al., 2000), which in comparison to microscopy analysis, is considerably
more reproducible and allows for simultaneous analysis of thousands of cells (Oosterhuis et al.,
2000). In addition, the detection of biomarkers of ROS and apoptosis may offer advantages over
sperm DNA damage detection as the processes that lead to ROS and apoptosis take place in the
earlier stage of sperm DNA damage before it is detectable by TUNEL assay (Aitken et al.,
2012). In the context of ART, the applications of apoptosis and ROS analyses as both diagnostic
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and prognostic markers could assist couples and clinicians in making clinical decisions such as
in determining the most effective fertility treatment for couples with previous recurrent
spontaneous abortion (RSA) or idiopathic infertility who might benefit more from IVF or ICSI
than from IUI. The prognostic value of testing these sperm biomarkers may also be useful in
indicating the use of testicular sperm, lifestyle modifications, or varicocelectomy in cases where
semen parameters are within the borderline to normal range (Agarwal et al., 2016).

Aims and hypotheses
The first study of this thesis (Study 1) investigates the relationship between sperm
apoptosis and ROS and ART clinical outcomes including fertilisation, hCG pregnancy, clinical
pregnancy and biochemical pregnancy rates. Deriving from the existing knowledge regarding
the close relationship between sperm quality, apoptosis, ROS and DNA damage, as previously
outlined in the Literature Review (see Chapter 1), it is hypothesised that sperm apoptosis and
ROS will negatively correlate with desirable ART outcomes. Secondly, it is also predicted that
sperm apoptosis and ROS will be negatively correlated with sperm motility.

Materials and methods
Study population
Semen samples for this project were collected through masturbation from men whose
partner underwent IVF/ICSI at Concept Fertility Centre, Perth, Western Australia (between
March 2017 and December 2017). Only semen samples with sperm concentrations above 1 ×
106 cells/mL, which is the minimum sperm count required to run the flow cytometric analysis,
were included in the study regardless of their quality (N = 201). The clinical data of the
participating male patients was then merged to the data of their partner from the Concept
Fertility Centre patient database. For couples with repeated cycles (N = 26), each cycle was
included in the study as an individual case. From this data set the following were excluded: (1)
cases with both IVF and ICSI; and (2) cases where female patients were 40 years old or above
and had less than four oocytes retrieved. Exclusion criteria (2) were adapted from the Bologna
criteria for poor ovarian response (POR) (Ferraretti et al., 2011), and was applied to minimise
the potential confounding effect of female factors on the overall clinical outcomes. Of the 201
cases initially included in this study, 170 cases remained after applying the exclusion criteria
and were analysed.
The proportions of patients with successful fertilisation, fresh embryo transfer and
positive clinical outcomes are presented in Figure 3.1. Of the 170 cases that were included in
the current study, successful fertilisation of at least one oocyte was observed in a total of 165
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cycles, including 95.5% of IVF and 98.1% of ICSI patients. Following fertilisation, a fresh
embryo transfer procedure was attempted in 90 cycles, which were 69.8% of IVF and 45.1% of
ICSI cycles; whereas in 45 and 30 cycles of the remaining 75 cycles, patients underwent
preimplantation genetic diagnosis and screening and frozen embryo transfer, respectively. The
stage of embryonic development at which embryo transfer or freezing took place was based on
various factors including embryo quality and clinical outcomes from the past cycles. The
clinical decision was made after a discussion with the medical practitioner, embryologists and
the patients. Of the total of 165 cases with at least one fertilised oocyte, the data of only day 3
embryo quality was reported in 79 cases. This indicates that either fresh embryo transfer
procedure or embryo freezing was performed on day 3; or the embryo did not survive the
following developmental stages., The information on day 5 embryo quality was available in 86
out of 165 cases and was used as an indicator of embryo quality. Among the 90 cycles with
fresh embryo transfer, 40.9% and 26.1% of IVF and ICSI cycles, respectively, resulted in an
hCG pregnancy characterised by blood hCG levels > 9 IU/L at 14 days after oocyte retrieval.
Clinical pregnancy was achieved in 25.0% of IVF and 10.9% of ICSI cycles. hCG pregnancy
that was not followed by a successful clinical pregnancy was defined as a biochemical
pregnancy (Zegers-Hochschild et al., 2009). Biochemical pregnancy was observed in 15.9% of
IVF and 15.2% of ICSI patients with at least one embryo transferred.

Data collection
On the day of oocyte retrieval, couples presented to the clinic at the same time and the
time of semen sample collection coincided with oocyte retrieval in the surgery theatre.
Following semen sample collection (see Section 2.3.1) and liquefaction at room temperature,
semen analysis (see Section 2.3.2) and sperm preparation (see Section 2.3.3) were performed by
the Concept Fertility Centre embryologists. Once sufficient neat and processed samples for
clinical use were assured, the remaining samples were set aside for research use. Neat samples
were tested for apoptosis (see Section 2.4.1) and oxidative stress (see Section 2.4.2)
immediately after they were available (approximately 30 minutes after ejaculation); processed
samples were also tested for the same parameters 4-6 h after the oocyte retrieval, which
coincided with the time the sample was used in an IVF or ICSI procedure. During the 4-6 h
interval, the processed samples were stored according to the clinic regular protocol. Processed
samples for ICSI were washed in 5% human serum albumin (Origio, Denmark) in Quinns
Advantage Medium with HEPES (Origio, Denmark) and were incubated at 37oC until use;
whereas processed samples for IVF were resuspended in Sequential Fert™ fertilising media
(Origio, Denmark), and were incubated in a 6% CO2 incubator at 37oC. The availability of the
processed samples for research use was dependent on the availability of sufficient sample after
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clinical use. It should be noted that ROS measurement was introduced to the study later in the
data collection process and consequently sample sizes for ROS analyses are smaller than those
for apoptosis analyses (see Section 3.4.1).
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Figure 3.1 The Number of IVF and ICSI Patients Included in the Study at Different Clinical
Endpoints (Study 1).
Whole cohort
Patients included
in the study

170

IVF

ICSI

66

104

IVF

ICSI

63
(95.5%)

102
(98.1%)

IVF

ICSI

44
(69.8%)

46
(45.1%)

IVF

ICSI

18
(40.9%)

12
(26.1%)

5
(10.9%)

11
(25.0%)

7
(15.9%)

Patients with at
least one oocyte
fertilised

Patients with at
least one fresh
embryo transferred

Patients with hCG
pregnancy

Patients with
clinical pregnancy

7
(15.2%)

Patients with
biochemical
pregnancy

Note. The proportions of patients with hCG pregnancy, clinical pregnancy and biochemical
pregnancy presented above were calculated per embryo transfer procedure and only included
cycles with fresh embryo transfer procedures.

63
Embryo evaluation and grading system
To investigate the potential effects of sperm apoptosis and ROS on embryo quality, the
quality of 892 embryos evaluated on day 5 after insemination/sperm injection were analysed in
this study. The day 5 embryos were evaluated using a grading system adapted by the clinic from
the Gardner and Schoolcraft (1999) blastocyst grading system, which considers three criteria:
(1) blastocyst expansion (Table 3.1); (2) inner cell mass (ICM) (Table 3.2); and (3)
trophectoderm (TE) (Table 3.3). The main difference between the clinic’s grading system and
the Gardner and Schoolcraft (1999) blastocyst grading system is the clinic’s system did not
differentiate between a blastocyst that is hatching out of the shell and a blastocyst that has
already hatched out of the shell. In the original blastocyst grading system, a blastocyst that has
already hatched out of the shell is considered a grade 6 blastocyst.
Prior to statistical analysis, a score was allocated for each of these criteria (Table 3.1,
Table 3.2, and Table 3.3). The scores allocated are based on the existing literature on the role of
each criterion in embryonic development, successful implantation and clinical outcomes
(Ahlstrom et al., 2011; Hardarson et al., 2012; Zhao et al., 2019). The cumulative D5EQ was
calculated as the sum of the scores for each of these criteria. The average D5EQ score was
calculated as the mean cumulative score of embryos per cycle. Embryos with grade 4AA, 4AB
or 4BA and above according to the Gardner and Schoolcraft (1999) blastocyst grading system
(i.e. 4AA, 4AB, 4BA, 5AA, 5AB or 5BA) were considered to be “good” embryos. This
classification was adapted from previous studies by Holschbach et al. (2017) and Kaye et al.
(2017). Blastulation rate was calculated as the number of blastocysts (day 5) per total number of
oocytes fertilised.
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Table 3.1 Day 5 Embryo Evaluation Based on Blastocyst Expansion Adapted from Gardner
and Schoolcraft (1999).

Table 3.1 is not available in this version of the thesis

Table 3.2 Day 5 Embryo Evaluation Based on Inner Cell Mass (ICM) According to Gardner
and Schoolcraft (1999).

Table 3.2 is not available in this version of the thesis

Table 3.3 Day 5 Embryo Evaluation Based on Trophectoderm (TE) According to Gardner
and Schoolcraft (1999).

Table 3.3 is not available in this version of the thesis
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Statistical analyses
All statistical analyses, including descriptive statistics, were performed using IBM SPSS
Statistics for Windows, Version 25.0 (Armonk, NY: IBM Corp.) with a statistically significant
value set at a P < 0.05.
The raw data for all variables were not normally distributed except for paternal age,
maternal age and mean D5EQ score as tested by the Kolmogorov-Smirnov test. Log
transformation was used to improve the normality of neat and processed AnnV+/7-AAD- (%),
AnnV+/7-AAD+ (%), total AnnV+ (%) and ROS+ (%), as well as number of oocytes retrieved.
Square root transformation successfully improved normality of neat sperm count. The normality
of neat sperm progressive motility (%), processed sperm progressive motility (%), fertilisation
rate (%) and blastulation rate (%) were not improved by a simple data transformation. For these
non-normally distributed data, non-parametric statistical tests were performed on raw
(untransformed) data as indicated.
To explore the demographic characteristics of the participants in this study, independent
t-tests and a Mann-Whitney U test (non-parametric) were performed to determine the statistical
differences in age, semen parameters, number of oocytes retrieved, apoptotic markers, ROS,
fertilisation rate, mean D5EQ score and blastulation rate between IVF and ICSI patients. In this
chapter, paternal age, maternal age and number of oocytes retrieved are collectively referred to
as the confounding variables. To investigate the potential correlations between semen
parameters, apoptotic or ROS markers and clinical outcomes including fertilisation rate and
embryo quality, Pearson and Spearman correlations (non-parametric) were performed.
GLMs were then performed to further identify the independent effect of apoptosis and
ROS on fertilisation rate. Separate models were generated for apoptosis and ROS due to
different sample sizes. The initial regression models included interaction terms between the
apoptotic or ROS markers and the procedure type (IVF or ICSI). No interaction term was
significant indicating the relationship of apoptosis and ROS on fertilisation rate did not differ by
procedure type. Therefore, results show only the final regression models without the interaction
terms.
To examine the effect of apoptosis or ROS on D5EQ, the participants were classified into
two groups based on the presence of a “good” embryo (embryo with grade 4AA, 4Ab or 4BA
and above). The difference in the proportion of sperm with apoptotic or ROS markers between
the group with no “good” embryo and the group with at least one “good” embryo was then
analysed by using an independent t-test and Mann-Whitney U test (non-parametric).
To further investigate the independent effect of apoptosis or ROS on D5EQ scores, linear
mixed regression models were performed. For this analysis, each day 5 embryo was treated as
an individual case and, D5EQ score, as a dependent variable, was regressed against apoptotic or
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ROS markers and other covariate variables whilst controlling for the type of procedure (IVF or
ICSI). Treatment cycle number, which was unique to each cycle, was included as a random
effect to account for likely correlation among embryos from the same treatment cycle and
hence, parental origin. After testing for correlations between apoptotic and ROS markers, four
initial linear mixed regression models were constructed (Appendix C-1, Appendix C-2,
Appendix C-3 and Appendix C-4). In the initial models, the significance of interactions between
procedure type (IVF or ICSI) and other variables were tested. Non-significant variables were
then excluded from the subsequent models in stepwise manner until only significant variables
were left.
The initial analysis of the effect of sperm apoptosis or ROS on pregnancy outcomes was
performed by using a two-way analysis of variance (ANOVA). The outcomes indicated the
presence or absence of a significant difference in the mean proportion of apoptotic or ROS
markers in patients with different procedure types (IVF or ICSI) and pregnancy outcomes (no
pregnancy, hCG pregnancy and biochemical pregnancy). In an attempt to determine the role of
sperm apoptosis or ROS in increasing or decreasing the probability of hCG pregnancy, clinical
pregnancy and biochemical pregnancy, logistic regression models were constructed. However,
the interpretation of the outcome of this analysis was subject to several limitations, and
therefore was not included in this study: (1) a very small proportion of patients achieved hCG or
clinical pregnancy through a fresh cycle; (2) the effect of some apoptotic or ROS markers varied
with procedure type and independent analyses for the IVF and the ICSI group further reduced
the sample size available for the analysis. Instead, a proportional hazard (Cox) regression was
performed to determine the effect of sperm apoptosis or ROS in increasing or decreasing the
time to clinical pregnancy, as indicated by the number of cycles undertaken to achieve clinical
pregnancy. This statistical analysis enabled the prediction of the cumulative probability of all
treatment cycles including cycles with fresh or/and frozen embryo transferred whilst taking into
account censored observations, which in this context could be the cessation of the treatment
cycles before successful pregnancy was achieved (Sanders & Bruce, 1999). Covariate variables
and interaction terms between type of procedure and other variables were entered into the initial
regression models (Appendix C-5, Appendix C-6, Appendix C-7 and Appendix C-8).
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Results
Fertility status and semen samples in IVF and ICSI groups
Demographic and independent variables that may be indicative of patients’ fertility
status including age, number of oocytes retrieved, semen parameters and fertilisation rate are
reported separately for the IVF and ICSI groups in Table 3.4 . The average male and female
patients’ age, number of oocytes retrieved, fertilisation rate, mean D5EQ, good embryo rate and
blastulation rate did not differ between the IVF and ICSI groups. On average, neat
(unprocessed) sperm count and the percentage of progressive motility were higher in the IVF
group compared to the ICSI group; as was processed sperm total motility.
As the measurement of ROS was introduced later in the data collection process, sample
size is lower for analyses containing ROS markers. There were no significant differences in age,
number of oocytes retrieved or fertilisation rate between patients whose samples were tested for
both apoptotic and ROS markers and those who were tested only for apoptosis. Neat sperm
count (million/mL) was lower in the group of patients who were tested for both apoptotic and
ROS markers; whereas processed progressive motility (%) was higher in patients who were
tested only for apoptotic marker (Table 3.6).
The proportion of sperm populations with apoptotic or ROS markers in the IVF and
ICSI patients are shown in Table 3.5. The average proportion of neat AnnV+/7-AAD-, neat total
AnnV+ and processed AnnV+/7-AAD+ were significantly higher in the ICSI group than in the
IVF group. There was no significant difference in the proportion of neat AnnV+/7-AAD+ sperm,
processed AnnV+/7-AAD- sperm and processed total AnnV+ sperm between the two groups.
The fraction of ROS+ sperm in processed samples, but not in neat samples, was significantly
higher in the ICSI group compared to the IVF group. Sperm preparation significantly reduced
the level of AnnV+/7-AAD-, AnnV+/7-AAD- and AnnV+/7-AAD+ sperm in the neat samples
regardless of the type of procedure. Sperm preparation reduced the proportion of ROS+ sperm in
the IVF but not in the ICSI group.
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Table 3.4 Comparison of Age, Semen Parameters, Number of Oocytes Retrieved, Fertilisation Rate (%)
and Embryo Quality Indicators in IVF and ICSI Patients.
IVF

ICSI

Mean

SD

Mean

SD

P value

Paternal age

36.85 (66)

5.23

38.24 (104)

5.06

NS

Maternal age

35.19 (66)

4.09

36.33 (104)

4.95

NS

Neat (unprocessed) sperm count (million/mL)

73.09 (66)

49.01

50.31 (104)

50.87

0.001

Neat (unprocessed) progressive motility (%)

85.42 (66)

12.28

77.37 (104)

21.16

0.022

Processed sperm total motility (million/mL)

9.05 (66)

2.88

1.50 (104)

1.81

0.001

Processed progressive motility (%)

89.86 (66)

9.30

85.25 (104)

14.97

NS†

Number of oocytes retrieved (per cycle)

9.95 (66)

5.34

8.95 (104)

5.51

NS

Fertilisation rate (%)

67.66 (66)

27.02

65.24 (104)

23.61

NS†

Mean D5EQ score

6.14 (33)

2.34

5.54 (53)

2.502

NS

Good embryo rate (%)

25.50 (33)

22.01

18.14 (53)

24.91

NS†

Blastulation rate (%)

77.23 (33)

20.70

73.05 (53)

26.01

NS†

Note. Sample sizes are presented in parentheses.
†

Non-parametric Mann-Whitney U test was performed on untransformed (raw) data.
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Table 3.5 Comparison of Apoptotic and ROS+ Sperm Population in Neat and Processed
Samples Between IVF and ICSI Patients.
IVF
Mean
+

-

Neat total AnnV /7-AAD (%)

4.42 (66)

Neat AnnV+/7-AAD+ (%)

ICSI
Mean

SD
a

a

SD

P value

4.51

0.001

3.01

6.17 (104)

10.70 (66) b

6.56

12.11 (104) b

7.88

NS

Neat total AnnV+ (%)*

15.12 (66) c

8.15

18.27 (104) c

10.52

0.015

Neat ROS+ (%)

21.43 (41) d

9.55

19.40 (63)

9.60

NS

2.59 (60)

1.43

2.86 (101)

1.47

NS

Processed AnnV+/7-AAD+ (%) 4.52 (60)

4.84

7.15 (101)

10.48

0.023

Processed total AnnV+ (%)**

7.63 (60)

6.21

10.01 (101)

10.95

NS

9.01 (35)

6.95

16.47 (41)

13.97

0.001

Processed AnnV+/7-AAD- (%)

+

Processed ROS (%)

Note. Sample sizes are presented in parentheses.
*

Neat total AnnV+ (%) is calculated as the total of neat AnnV+/7-AAD- (%) and neat

AnnV+/7-AAD+ (%).
**

Processed total AnnV+ (%) is calculated as the total of processed AnnV+/7-AAD- (%) and

processed AnnV+/7-AAD+ (%).
a

Significant compared to Processed AnnV+/7-AAD- (%), P < 0.001

b

Significant compared to Processed AnnV+/7-AAD+ (%), P < 0.001

c

Significant compared to Processed total AnnV+ (%), P < 0.001

d

Significant compared to Processed ROS+ (%), P < 0.001
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Table 3.6 Comparison of Age, Semen Parameters, Number of Oocytes Retrieved and
Fertilisation Rate (%) Between Patients Who Were Tested for Only Apoptotic Markers and
Patients Who Were Tested for Both Apoptotic and ROS Markers.

Samples tested for
apoptotic markers

Samples tested
for apoptotic
and ROS
markers

Mean

SD

Paternal age

37.24 (66)

5.20

37.99 (104) 5.13

NS

Maternal age

35.92 (66)

4.60

35.87 (104) 4.71

NS

73.62 (66)

61.05

49.97 (104) 41.66

0.007

77.12 (66)

22.31

82.63 (104) 15.56

NS

4.14 (85)

4.42

4.64 (76)

Processed progressive motility (%) 84.84 (85)

14.37

89.68 (76) 11.07

0.019

8.79 (66)

5.36

9.69 (104) 5.50

NS

63.74 (66)

27.58

67.73 (104) 23.11

NS

Neat (unprocessed) sperm count
(million/mL)
Neat (unprocessed) progressive
motility (%)
Processed sperm total motility
(million/mL)

Number of oocytes retrieved
(per cycle)
Fertilisation rate (%)

Note. Sample sizes are presented in parentheses.

Mean

SD

4.24

P-value

NS
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Correlations between sperm apoptosis, ROS, paternal age and semen parameters
The correlations between apoptotic or ROS markers and other variables concerning
male patients’ fertility status, including paternal age and semen parameters are summarised in
Table 3.7. Advanced paternal age is associated with an increase in neat AnnV+/7-AAD-, neat
AnnV+/7-AAD+, neat AnnV+, processed AnnV+/7-AAD+ and processed ROS+ sperm (Table
3.7); and is inversely correlated with neat progressive motility (%) and processed sperm total
motility (Table 3.8). Further, neat sperm count is significantly and positively associated with
neat and processed progressive motility (%) as well as with processed sperm total motility
(Table 3.8).
In general, an increasing proportion of sperm with apoptotic markers (AnnV+/7-AAD-,
AnnV+/7-AAD+and AnnV+) in both neat and processed samples was associated with lower neat
sperm count, neat sperm progressive motility percentage and processed sperm motility. Lower
processed sperm progressive motility (%), however, was only associated with increased
proportion of AnnV+/7-AAD+ and total AnnV+ sperm in processed samples (Table 3.7).
The proportion of ROS+ sperm in neat samples was not associated with any semen
parameters but was associated with increased neat AnnV+/7-AAD+ sperm (Table 3.7). On the
contrary, higher ROS+ sperm in processed samples was associated with reduced neat
progressive motility percentage, processed sperm total motility and processed sperm
progressive motility percentage. ROS+ sperm in processed samples was also positively
correlated with AnnV+/7-AAD+and total AnnV+ sperm in both neat and processed samples
(Table 3.7).

Effects of apoptosis and ROS on fertilisation rate
As shown in Table 3.9, sperm apoptosis or ROS markers in both neat and processed
samples were not correlated with fertilisation rate. Similarly, the final linear regression models
(Table 3.10) also showed that AnnV+/7-AAD- sperm, AnnV+/7-AAD+ sperm, total AnnV+
sperm and ROS+ sperm in both neat and processed samples did not have a significant effect on
fertilisation rate in IVF and ICSI patients.
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Table 3.7 Correlations Between Sperm Apoptotic or ROS Markers, Paternal Age and Semen Parameters in IVF and ICSI Patients.

Paternal
age

Neat sperm
count
(million/mL)

Neat sperm
progressive
motility (%)

Processed
sperm total
motility
(million/mL)

Processed
sperm
progressive
motility (%)

.178a
(170)
.222b
(170)
.225 b
(170)
0.072
(104)
0.097
(161)
.166 a
(161)
0.144
(161)
.256 a
(76)

-.381b
(170)
-.244b
(170)
-.332b
(170)
0.065
(104)
-.191 a
(161)
-.307 b
(161)
-.298 b
(161)
-0.185
(76)

-.240 b†
(170)
-.193 a†
(170)
-.249 b†
(170)
0.056†
(104)
-0.152†
(161)
-.225 b†
(161)
-.218 b†
(161)
-.231 a†
(76)

-.283 b†
(170)
-.245 b†
(170)
-.285 b†
(170)
0.043†
(104)
-.260 b†
(161)
-.343 b†
(161)
-.312 b†
(161)
-.545 b†
(76)

-0.098†
(170)
-0.093†
(170)
-0.122†
(170)
-0.034†
(104)
-0.119†
(161)
-.174 a†
(161)
-.157 a†
(161)
-.267 a†
(76)

Neat AnnV+/7-AAD- (%)
Neat AnnV+/7-AAD+ (%)
Neat total AnnV+ (%)
Neat ROS+ (%)
Processed AnnV+/7-AAD- (%)
Processed AnnV+/7-AAD+ (%)
Processed total AnnV+ (%)
Processed ROS+ (%)

Neat
ROS+ (%)

Processed
ROS+ (%)

0.047
(104)
.227 a
(104)
0.187
(104)

0.111
(76)
.399 b
(76)
.327 b
(76)
0.024
(75)
0.194
(76)
.676 b
(76)
.570 b
(75)

0.177
(95)
0.029
(95)
0.118
(95)
0.024
(75)

Note. Values shown are Pearson’s and Spearman’s rho (indicated) correlation coefficients with sample sizes (N) presented in parentheses.
a

Correlation is significant at the 0.05 level (2-tailed). b Correlation is significant at the 0.01 level (2-tailed).

†

Indicated values are Spearman’s rho
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Table 3.8 Correlations Between Semen Parameters and Paternal Age in IVF and ICSI Patients.

Neat sperm count
(million/mL)

Neat sperm progressive
motility (%)

Processed sperm total
motility (million/mL)

Processed sperm
progressive motility (%)

Neat sperm count (million/mL)
Neat progressive motility (%)

.394 b†
(170)

Processed motile sperm
(million/mL)

.400 b†
(170)

.189 a†
(170)

Processed progressive motility (%)

.184 a†
(170)

.325 b†
(170)

0.074†
(170)

Paternal age

−0.126
(170)

−.186 a†
(170)

−.171 a†
(170)

−0.009†
(170)

Note. Values shown are Pearson’s (indicated) and Spearman’s rho correlation coefficients with sample sizes (N) presented in
parentheses.
a

Correlation is significant at the 0.05 level (2-tailed).

b

Correlation is significant at the 0.01 level (2-tailed).

†

Indicated values are Spearman’s rho
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Table 3.9 Correlations Between Sperm Apoptotic or ROS Markers, Fertilisation Rate (%),
Embryo Quality Indicators and Other Potential Confounding Variables in IVF and ICSI
Patients.

Neat AnnV+/7-AAD- (%)
Neat AnnV+/7-AAD+ (%)
Neat total AnnV+ (%)
Neat ROS+ (%)
Processed AnnV+/7-AAD- (%)
Processed AnnV+/7-AAD+ (%)
Processed total AnnV+ (%)
Processed ROS+ (%)
Neat sperm count (million/mL)
Neat sperm progressive motility (%)
Processed sperm total motility (million/mL)
Processed sperm progressive motility (%)
Maternal age
Paternal age
Number of oocytes retrieved

Fertilisation
rate (%)

Blastulation
rate (%)a

Mean D5EQ

0.030†
(170)
0.039†
(170)
0.051†
(170)
0.104†
(104)
0.079†
(161)
0.053†
(161)
0.105†
(104)
0.127†
(76)
0.101†
(170)
−0.006†
(170)
0.089†
(170)
−0.074†
(170)
−0.062†
(170)
−0.071†
(170)
0.002†
(170)

0.074†
N = 86
0.003†
N = 86
0.042†
N = 86
−0.188†
N = 56
0.072†
N = 80
−0.045†
N = 80
−0.022†
N = 80
−0.366†*
N = 37
0.121†
N = 86
−0.004†
N = 86
0.145†
N = 86
0.012†
N = 86
−0.160†
N = 86
−0.204†
N = 86
0.031†
N = 86

−0.071†
N = 86
−0.038†
N = 86
−0.025†
N = 86
−0.014†
N = 56
0.075
N = 80
−0.075†
N = 80
−0.041†
N = 80
−0.200†
N = 37
0.088†
N = 86
0.019
N = 86
0.177†
N = 86
0.051†
N = 86
0.096
N = 86
−0.081
N = 86
0.007†
N = 86

Note. Values shown are Pearson’s and Spearman’s rho (indicated) correlation
coefficients with sample sizes (N) presented in parentheses.
†

Indicated values are Spearman’s rho. * Correlation is significant at the 0.05 level (2-

tailed).
a

Blastulation rate was calculated as the number of blastocysts (day 5) per total number

of oocytes fertilised.
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Table 3.10 General Linear Models to Analyse the Independent Effect of Apoptosis and ROS on Fertilisation Rate (%) in IVF and
ICSI Patients.

Variables

F

Corrected Model
Intercept

Model Ia
P-value

P-value

0.772

0.268

0.930

0.201

0.961

15.734

0.001

6.273

0.015

0.731

0.394
0.033

0.857

0.370

0.545

13.129

0.001

-

0.304

0.582

+

+

0.792

0.375

Neat AnnV /7-AAD (%)

F

+

Neat total AnnV (%)
+

Neat ROS (%)
+

-

1.443

0.232

+

+

1.490

0.224

Processed AnnV /7-AAD (%)
Processed AnnV /7-AAD (%)

Model IIIc
F
P-value

0.579

+

Neat AnnV /7-AAD (%)

Model IIb

+

Processed total AnnV (%)

0.195

0.660

Processed ROS+ (%)
Maternal age

0.444

0.506

0.347

0.557

0.021

0.885

Paternal age

0.013

0.911

0.020

0.889

0.172

0.680

Number of oocytes retrieved

0.033

0.856

0.004

0.947

0.320

0.574

a

Dependent variable: Fertilisation rate (%). R2 = .026 (Adjusted R2 = − .019).

b

Dependent variable: Fertilisation rate (%). R2 = .009 (Adjusted R2 = −.023).

c

Dependent variable: Fertilisation rate (%). R2 = .014 (Adjusted R2 = −.057).
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Effects of apoptosis and ROS on embryo quality
The quality of embryos evaluated on day 5 post insemination/sperm injection was
expressed as mean D5EQ and blastulation rate (%). These embryo quality predictor variables
were significantly and positively correlated with each other (P < 0.05). The correlations
between embryo quality predictors, sperm apoptotic or ROS markers, semen parameters and
other confounding variables are shown in Table 3.9. Mean D5EQ was not associated with any
apoptotic markers, ROS, semen parameters or other confounding variables. Except with
processed ROS+ (%), blastulation rate (%) was not correlated with sperm apoptosis, ROS,
semen parameters or other confounding variables. Processed ROS+ (%) was significantly and
negatively correlated with blastulation rate (%).
When the participants were stratified into groups based on the presence or absence of
“good” embryo, processed AnnV+/7-AAD- (%) and processed sperm total motility were higher
in patients with at least one good embryo compared to those with no “good” embryo (Table
3.11). In addition, the proportion of neat ROS+ sperm was higher in patients with no good
embryo compared to those who had at least one good embryo (Table 3.11). The initial and final
linear mixed regression models to investigate the effect of sperm apoptosis or ROS on mean
D5EQ are presented in Appendix C-1, Appendix C-2, Appendix C-3 and Appendix C-4. None
of the apoptotic and ROS markers had a significant effect on D5EQ score either in the initial or
the final models. The significant effect of procedure type (IVF or ICSI) was consistently
observed in all four models. Conception through ICSI was associated with a higher D5EQ score
compared to IVF.
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Table 3.11 Comparison of Apoptotic or ROS Sperm Population, Semen Parameters, Age
and Number of Oocytes in Patients with Different Mean Day 5 Embryo Quality (D5EQ).
Good embryo*
Variables
Neat AnnV+/7-AAD- (%)
Neat AnnV+/7-AAD+ (%)
Neat total AnnV+ (%)
Neat ROS+ (%)
Processed AnnV+/7-AAD- (%)
Processed AnnV+/7-AAD+ (%)
Processed total AnnV+ (%)
Processed ROS+ (%)
Neat sperm count (million/mL)
Neat sperm progressive motility (%)
Processed sperm total motility (million/mL)
Processed sperm progressive motility (%)
Maternal age
Paternal age
Number of oocytes retrieved
†

Not observed

Observed

5.12 (2.39)
N = 39
11.54 (8.74)
N = 39
16.66 (9.78)
N = 39
24.37 (10.75)
N = 25
2.25 (0.82)
N = 35
6.45 (13.52)
N = 35
8.70 (13.59)
N = 35
12.89 (9.10)
N = 14
56.00 (44.23)
N = 39
3.52 (3.84)
N = 39
3.52 (3.84)
N = 39
89.56 (9.43)
N = 39
36.63 (5.07)
N = 39
38.97 (5.26)
N = 39
9.69 (5.73)
N = 39

5.77 (3.83)
N = 47
12.12 (6.58)
N = 47
17.88 (8.45)
N = 47
18.39 (7.48)
N = 31
2.89 (1.26)
N = 45
5.53 (6.28)
N = 45
8.43 (6.59)
N = 45
10.84 (6.18)
N = 23
70.92 (50.48)
N = 47
5.72 (4.83)
N = 47
5.72 (4.83)
N = 47
87.36 (10.89)
N = 47
35.20 (4.56)
N = 47
36.83 (5.35)
N = 47
11.77 (5.72)
N = 47

P-value
NS†
NS†
NS†
0.018
0.007
NS†
NS†
NS†
NS†
NS†
0.018†
NS
NS
NS
NS†

P-values were calculated using Mann-Whitney U (non-parametric) test.

* Good embryo is an embryo with grade 4AA, 4Ab or 4BA and above according to Gardner
& Schoolcraft (1999) blastocyst grading system (i.e. 4AA, 4Ab, 4BA, 5AA, 5AB or 5BA).
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Effects of apoptosis and ROS on pregnancy outcomes
The comparison of the proportion of sperm with apoptotic or ROS markers between the
IVF and ICSI groups and between patients with different clinical outcomes is summarised in
Table 3.12. On average, the proportions of neat AnnV+/7-AAD- (%) sperm and processed
AnnV+/7-AAD+ (%) sperm were higher in the ICSI group compared to the IVF group regardless
of the clinical outcomes. The mean neat AnnV+/7-AAD+ (%) sperm was also higher in patients
with biochemical pregnancy compared to those without pregnancy regardless of the procedure
type. Other comparisons between patients with different clinical outcomes were not statistically
significant (Table 3.12).
When apoptosis and ROS were regressed against time to pregnancy which included
subsequent frozen embryo transfer cycles, none of the apoptotic or ROS markers were
significantly predictive of clinical pregnancy. A lower processed sperm total motility, however,
was associated with delayed clinical pregnancy. The initial and final models of these regression
analyses are presented in Appendix C-5, Appendix C-6, Appendix C-7 and Appendix C-8.
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Table 3.12 The Proportion of Sperm with Apoptotic or ROS Markers in IVF and ICSI Patients with Different Clinical Outcomes.

Not pregnanta
4.41 (2.92)
N = 26
10.37 (5.03)
Neat AnnV+/7-AAD+ (%)
N = 26
14.78
(6.36)
Neat total AnnV+ (%)
N = 26
23.37 (10.00)
Neat ROS+ (%)
N = 15
2.44 (1.21)
Processed AnnV+/7-AAD- (%)
N = 23
3.81
(2.71)
Processed AnnV+/7-AAD+ (%)
N = 23
7.44
(6.03)
Processed total AnnV+ (%)
N = 23
8.27 (3.37)
Processed ROS+ (%)
N = 12
Neat AnnV+/7-AAD- (%)

IVF
Biochemical
pregnancyb

Clinical
pregnancyc

5.96 (4.57)
N=7
13.91 (10.06)†
N=7
19.86 (12.91)
N=7
25.35 (10.64)
N=7
2.38 (1.32)
N=6
4.53 (4.81)
N=6
6.91 (5.07)
N=6
11.57 (11.56)
N=6

5.04 (3.41)
N = 11
11.67 (8.79)
N = 11
16.71 (10.47)
N = 11
22.37 (10.93)
N=4
3.64 (2.37)
N=9
6.40 (5.90)
N=9
10.47 (7.14)
N=9
16.60 (14.00)
N=2

P-valued

Not
pregnanta

ICSI
Biochemical
pregnancyb

Clinical
pregnancyc

7.04 (3.69)
N = 35
11.44 (4.48)
N = 35
18.48 (7.18)
N = 35
16.82 (8.70)
N = 22
3.06 (1.84)
N = 35
7.70 (6.65)
N = 35
10.76 (7.82)
N = 35
15.64 (10.40)
N = 17

6.00 (3.49)
N=7
17.20 (7.12)†
N=7
23.20 (6.46)
N=7
22.44 (5.67)
N=5
3.70 (2.26)
N=7
11.21 (10.87)
N=7
14.91 (11.21)
N=7
11.14 (3.30)
N=2

7.95 (7.49)
N=5
10.94 (6.82)
N=5
18.89 (11.38)
N=5
24.83 (9.92)
N=3
2.87 (1.18)
N=5
3.71 (2.65)
N=5
6.58 (3.51)
N=5
14.13 (6.93)
N=2

0.006
NS
NS
NS
NS
0.049
NS
NS

Note. Values presented are the mean and standard deviation (in parentheses). Pairwise comparisons between three different clinical outcomes within
the IVF or ICSI groups were not significant unless indicated otherwise (†).
a

Patients with blood hCG level below 9 IU/L at 14 days post oocyte retrieval. b Patients with blood hCG level above 9 IU/L at 14 days post oocyte

retrieval and absence of foetal heartbeat at six weeks post oocyte retrieval. c Patients with blood hCG level above 9 IU/L at 14 days post oocyte
retrieval and presence of foetal heartbeat at six weeks post oocyte retrieval. d Comparison between the IVF and ICSI groups. † Significant compared
to the “not pregnant” group, P < 0.05.
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Discussion
Although the existing literature nominates intracellular ROS and sperm apoptosis as the
main pathways of sperm DNA damage (Rex et al., 2017), the use of both of these markers as
diagnostic and prognostic tools in clinical practice remains arguable. Accordingly, the present
work aimed to examine the effect of intracellular ROS levels and sperm apoptosis on ART
clinical outcomes. It was hypothesised that both markers would negatively correlate with
desirable ART outcomes. Further, it was also predicted that sperm apoptosis and ROS would
also adversely affect sperm motility.
To test the first hypothesis, the proportions of sperm with different apoptotic and ROS
markers in both neat and processed samples were tested for correlations with various clinical
outcomes including fertilisation rate, blastulation rate, D5EQ and the time to clinical pregnancy.
The findings demonstrated that apoptosis did not correlate with fertilisation rate and mean
D5EQ score, which concurs with the findings of previous studies (Esbert et al., 2011; Romany
et al., 2014; Stimpfel et al., 2018). Nevertheless, mixed results have also been reported by other
authors. Sheikhi et al. (2013) found a significant improvement in fertilisation rate and embryo
quality after removal of apoptotic sperm following MACS compared to DGC-processed
samples; whereas Talarczyk-Desole et al. (2016) observed a negative correlation between
apoptosis and fertilisation in the IVF group, but not in the ICSI group. The current study also
did not observe any association between sperm apoptosis and clinical pregnancy, which has also
been reported in other publications (Esbert et al., 2011; Sheikhi et al., 2013; Zorn et al., 2012).
However, a comparison between patients with different clinical outcomes showed that mean
neat AnnV+/7-AAD+ (%) sperm was higher in patients with biochemical pregnancy (or
miscarriage) compared to those without pregnancy regardless of the procedure type. With
regard to the level of ROS, the present study observed no association between ROS and
fertilisation rate, D5EQ score and clinical pregnancy. In contrast, previous studies reported a
negative effect of sperm ROS on fertilisation rate (Das et al., 2008; Ghaleno, Valojerdi,
Hassani, et al., 2014; Zorn et al., 2003), as well as on day 2 and day 4 embryo quality in ICSI
cycles (Ghaleno, Valojerdi, Hassani, et al., 2014). However, the present work found a negative
correlation between ROS in the processed samples and blastulation rate, which was not reported
by those authors (Das et al., 2008; Ghaleno, Valojerdi, Hassani, et al., 2014). In addition, when
the patients were grouped based on the presence of a good embryo, patients with at least one
good embryo had significantly lower neat ROS levels, higher processed sperm total motility
and higher processed AnnV+/7-AAD- sperm proportion.
To investigate the effect of sperm apoptosis and ROS levels on the cellular level, the
proportion of sperm expressing these markers were tested for correlations with sperm
concentration and motility. Due to the significant volume of missing data on sperm

81
morphology, this particular parameter was excluded from the analysis. In agreement with
previous studies (Sharbatoghli et al., 2012; Talarczyk-Desole et al., 2016; Zhang et al., 2008),
the current study observed an inverse correlation between apoptosis in neat and processed
samples with sperm count, total motility and progressive motility. Similarly, an inverse
correlation was also observed between processed ROS levels and sperm count, total motility
and progressive motility, consistent with the findings of other studies (Das et al., 2008; Homa et
al., 2015; Takeshima et al., 2017; Zorn et al., 2003). Interestingly, this negative correlation
between the intracellular ROS level and sperm parameters was not observed in the neat
samples. This discrepancy may be because the seminal plasma of the neat sample contains
natural antioxidants that may alleviate the harmful effects of ROS (Leahy & Gadella, 2011).
The removal of these antioxidants through sperm preparation may therefore expose the sperm to
a greater risk of oxidative damage. Another plausible explanation to this observation may be the
fact that in the neat samples, ROS was measured immediately after ejaculation and liquefaction,
whereas in the processed samples, ROS level was measured 4-6 h after processing. As shown in
previous studies (Calamera et al., 2001; Drake-Brockman et al., 2018; Hossain et al., 2008;
Koyun et al., 2014; Mansour et al., 2008; Yavas & Selub, 2004), and discussed in detail in
Chapter 5 of this thesis, prolonged in vitro incubation after sperm preparation is associated with
increased sperm ROS, loss of sperm motility and suboptimal clinical outcomes. The present
study also demonstrated that sperm preparation effectively reduced apoptotic and ROS+ sperm
from the neat samples. However, in the ICSI group, the proportion of ROS+ sperm was not
reduced following sperm preparation. Of relevance, it is important to note that in IVF cycles,
the samples that were processed for IVF were prepared to a much higher concentration (5 to 15
million cells/mL) compared to those prepared for sperm injection for ICSI cycles (1 million
cells/mL). Therefore, even though the percentage of ROS+ sperm in the ICSI group did not
improve following sperm preparation, the absolute number of ROS+ sperm has reduced along
with the overall sperm count.
High levels of ROS may induce sperm motility loss through an oxidative attack on the
mitochondria and the sperm plasma membrane (Wagner et al., 2018). A microscopic
observation demonstrated that both PS externalisation and caspase-3 activation, hallmarks of
apoptosis, are localised in the midpiece region of the sperm where the mitochondria are
contained (Aitken, Bronson, et al., 2013; Talarczyk-Desole et al., 2016). Once apoptosis is
initiated, increased mitochondrial ROS production will then start a self-perpetuated oxidative
stress cascade (Aitken, Bronson, et al., 2013). Unregulated increase in this intracellular ROS
level will ultimately induce a lipid peroxidation cascade, affecting the main functions of the
fatty acids-rich plasma membrane including fluidity, permeability and signalling (Dutta et al.,
2019). Further, the activation of a lipid peroxidation cascade also produces electrophilic
aldehydes such as 4HNE, which can then cause rapid loss of motility through free radicals
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attack of the axonemal proteins essential for normal flagellar movement (Aitken et al., 2016;
Moazamian et al., 2015; Wagner et al., 2018). Alternatively, a progressive loss of motility may
also occur as a result of ROS-induced mitochondrial DNA and membrane damage, resulting in
depletion of ATP (Wagner et al., 2018). With regard to sperm concentration, the negative
correlation between sperm apoptosis and neat sperm concentration observed in the present study
can be explained by the previously proposed abortive apoptosis theory, which suggests that the
presence of sperm expressing apoptotic markers is as a result of incomplete senescence (Bejarno
et al., 2012; Zhang et al., 2008). The same negative correlation was also observed between
sperm apoptosis and processed sperm concentration, which seemed to confirm the role of
apoptosis in the induction of sperm DNA damage. This prediction can be concluded with the
assumption that defective sperm motility, morphology and cell death are the manifestations of
sperm DNA damage; and that sperm preparation can effectively eliminate sperm with such
features.
Although the present study showed evidence of the adverse association of high
intracellular ROS levels and sperm apoptosis on sperm motility, these markers seemed to have
minimal impacts on clinical outcomes. Proposed here are several possible rationales to explain
this observation. Firstly, whilst it is logical to think that ROS-induced sperm motility loss may
mediate suboptimal clinical outcomes associated with high levels of sperm DNA damage in
natural conception and in IUI cycles (Kim, 2018), this mechanism is unlikely to apply to IVF
and ICSI cycles. This is because the micromanipulation of the gametes in IVF and ICSI
minimise the physical challenges that will normally impede sperm with poor motility from
approaching and fertilising an oocyte (Lewis et al., 2013). Secondly, although sperm DNA is
thought to be more sensitive to oxidative stress compared to the observable sperm motility and
fertilisation capacity (Aitken, Bronson, et al., 2013), it is believed that sperm DNA damage
affects the latter stages of conception including cleavage and blastocyst stages (Seli et al., 2004;
Talarczyk-Desole et al., 2016; Zorn et al., 2003). Thus, it is possible for sperm with abnormal
DNA to undergo a successful fertilisation (Haghpanah et al., 2016; Liberman et al., 2017; Sedo
et al., 2017; Simopoulou et al., 2016). Similarly, as previously reported elsewhere, sperm
quality has no effect on day 2 or 3 embryo quality which are predominantly regulated by the
oocytes, but it affects embryonic development at the blastocyst stage, at which stage the
paternal genome is activated (Seli et al., 2004; Zorn et al., 2003). In the context of the present
study, this may explain the negative effect of ROS on blastulation rate and the presence of a
good embryo even though fertilisation rate was not affected. Thirdly, it has been postulated that
oocytes have the capacity to repair DNA damage, and therefore the extent to which defective
paternal DNA will affect subsequent embryo development also depends on the quality of the
oocytes (Esbert et al., 2011; Liang et al., 2019; Stimpfel et al., 2018; Sun et al., 2018). In the
present study, the attempt to control for the potential confounding factors from the maternal
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origin was performed by excluding female patients who were 40 years old or above and who
had less than four oocytes retrieved, indicative of POR according to the Bologna criteria for
POR (Ferraretti et al., 2011). In addition, maternal age and number of oocytes retrieved were
also included in the regression models as covariates. To isolate the independent effect of
paternal factors, future studies could use oocyte siblings from donors with selected criteria such
as age and fertility status as previously demonstrated by Gat et al. (2018) and Stimpfel et al.
(2018). Lastly, because the data collection for the current study was obtained in parallel with
actual patients’ treatment cycles, sperm with defective DNA might have been excluded, leaving
only the good quality sperm to be used for fertilisation (Sun et al., 2018). In addition to sperm
preparation, an additional selection step is applied in ICSI cycles where a single sperm with the
best observable characteristics is selected for injection into the oocyte (Osman et al., 2015).
Similarly, for the best possible outcomes, poor quality embryos might not be transferred (Sun et
al., 2018).
Despite the findings which suggested that apoptosis has an effect on semen parameters,
the interpretation of these markers has been controversial, and therefore, might be a limitation to
this study. The interpretation of PS externalisation and caspase-3 activation as apoptosis
markers needs to be done with caution as these markers are not exclusively observed during
apoptosis (Moustafa et al., 2004; Tavalaee et al., 2012). PS externalisation from the inner leaflet
of the cell plasma membrane is one of the hallmarks of early apoptosis that marks apoptotic
sperm for silent phagocytosis (Aitken et al., 2016; Boyraz et al., 2016). However, this marker is
also present during capacitation (Sheikhi et al., 2013; Tavalaee et al., 2012). Similarly, whilst
the activation of caspase-3 is considered as a late apoptotic marker or as an initiator or executor
for apoptosis, it is also thought to play a role in the cell maturation process (Sedo et al., 2017;
Talarczyk-Desole et al., 2016). Therefore, the detection of these markers should be interpreted
in conjunction with other parameters such as sperm motility. In the present study, AnnV+/7AAD- sperm seemed to exhibit a sign of early apoptosis rather than capacitation. This notion is
supported by a strong negative correlation between apoptotic markers and sperm motility. This
negative correlation clearly shows the opposite characteristic to the capacitation process
(Bejarno et al., 2012; Zhang et al., 2008). In addition, the present study also observed a higher
proportion of apoptotic sperm associated with advanced paternal age, which has been also
previously reported elsewhere (Colin et al., 2010; Emokpae & Chima, 2018; Ricci et al., 2002;
Zorn et al., 2012). The detection of intracellular superoxide by DHE was employed in the
present study to measure the levels of sperm ROS. Although this method has been previously
used in other studies (Aitken et al., 2014; Moazamian et al., 2015), the oxidation of DHE does
not only form a superoxide-specific product (2-OH-ethidium), but also other non-specific
oxidation products. High-performance liquid chromatography (HPLC) can be used to
differentiate the overlapping fluorescence of 2-OH-ethidium and a non-specific oxidation
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product, ethidium, in particular (Nazarewicz et al., 2013). This, however, could not be
implemented in our study because intracellular ROS was measured in real-time. Despite this
technical limitation, the level of background non-specific signal detected, if any, is predicted to
be consistent throughout the experiment and therefore should not affect the conclusion(s) of the
current study. Given the close interaction between apoptosis and ROS as described in the
existing literature (Aitken, Smith, et al., 2013; Moazamian et al., 2015), the observed positive
correlation between the two markers was expected. Interestingly, in both neat and processed
samples, only the correlation between AnnV+/7-AAD+ and ROS+ reached significance while the
correlation between AnnV+/7-AAD- and ROS did not. There are two possible explanations.
Firstly, both AnnV+/7-AAD+ and ROS+ may mark sperm cells that are dead. In AnnV+/7-AAD+
sperm, Annexin V+ and 7/AAD+ markers indicate the disintegration of the cell plasma
membrane, which normally occurs at the later stage of apoptosis or necrosis (Rieger et al.,
2011). The ROS+ marker, as detected by DHE, might also be misinterpreted as non-viable cells
instead of as ROS-generating cells (Moazamian et al., 2015). Even though a cell viability
marker could not be added to the detection of DHE in this study, this misinterpretation is
unlikely. This is because a significant proportion of AnnV+/7-AAD+ sperm and ROS+ sperm
were still detected following sperm preparation where the majority of the dead sperm would
have been removed. Secondly, AnnV+/7-AAD- may be a transient phase, which in the presence
of a high level of ROS, might progress to AnnV+/7-AAD+ (Drake-Brockman et al., 2018;
Muratori et al., 2003).
A limitation of the present study arises from the sample size available for analyses.
From a total of 165 cycles with successful fertilisation, only 90 cycles proceeded to a fresh
embryo transfer. In 45 of the remaining cycles, the embryo underwent preimplantation genetic
screening/diagnosis, and therefore were excluded from the analysis; and frozen embryo transfer
was performed in the remaining 30 cycles. As the current study is a prospective study, this
shortcoming was both unexpected and inevitable. Consequently, the amount of data that was
available for embryo quality and clinical outcomes analyses reduced significantly. One of the
adjustments made to respond was the use of proportional hazard (Cox) regression as an
alternative to logistic regression analysis to investigate the effect of apoptosis and ROS on time
to clinical pregnancy, which allows the inclusion of cycles with fresh or frozen embryo transfer.
In addition, in the present study, embryos that either did not progress to day 5 or were
transferred on day 3 were excluded from the analysis of embryo quality. Only embryos that
were evaluated on day 5 were analysed for mean D5EQ. The clinical decision of culturing,
transferring or freezing the embryo was taken based on various factors (e.g. embryo quality,
clinical outcomes from the previous cycle) in consultation with clinic’s doctors and therefore,
was difficult to control for the purpose of this research. Hence, to investigate the effect of sperm
apoptosis and ROS on embryonic development, blastulation rate, compared to mean D5EQ
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score, might be a more representative indicator to the overall quality of the embryos originating
from the same individual.
In addition, disproportionate sample sizes between a group of patients tested for
apoptotic markers and those tested for both apoptotic and ROS markers was reported (see
Section 3.4.1). The difference in sample size between the two group was a result of a sequential
data collection process before and after ROS levels measurement was introduced in the study
and therefore unlikely to bias the findings. Moreover, there were no differences between
patients measured for both apoptosis and ROS markers and those with only apoptotic markers
for paternal age, maternal age, number of oocytes retrieved and fertilisation rate as well as neat
progressive motility (%) and processed sperm total motility (million/mL). Given the similarity
in variables that were indicative of patients’ characteristics and fertility status the difference in
neat sperm count (million/mL) and processed progressive motility (%) between the two groups
is likely to be coincidental and did not affect the interpretation of the analyses.
In summary, the present study found no significant association between apoptosis and
clinical outcomes including fertilisation rate, blastulation rate, D5EQ and the time to clinical
pregnancy. Similarly, no correlation was observed between the level of sperm ROS and
fertilisation rate and the time to clinical pregnancy. However, high levels of ROS might have an
adverse effect on early stages of embryonic development as reflected in blastulation rate and
D5EQ. Although the effect on clinical outcomes was minor, higher levels of apoptosis and ROS
were significantly associated with poorer sperm motility. Whilst this adverse effect may reduce
the chance of pregnancy in natural conception, it may not be relevant in assisted conception. In
the context of ART, the observable decline in sperm motility can be interpreted as an indication
of the harmful effect of apoptosis and ROS on sperm health and that lowering the level of these
parameters may therefore favour better clinical outcomes.

86

This page is intentionally left blank.

87

Study 2: The effects of three different sperm
preparation methods on sperm apoptotic markers
and ROS
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Chapter 4: Study 2 - The effects of three different sperm preparation methods on sperm
apoptotic markers and ROS
Research background
ART involves a wide range of micromanipulation of either or both the female and male
gametes to assist with the conception process that otherwise would not have occurred naturally
(Liberman et al., 2017; Zegers-Hochschild et al., 2017). With regard to male infertility, this
effort includes sperm preparation that commonly precedes the introduction of the sperm to the
oocyte in IUI, IVF and ICSI. This preparation step is crucial to isolate motile and
morphologically normal mature sperm from the seminal fluids and other substances that can
be detrimental to the sperm’s normal physiological functions contained in the seminal fluid
(Aitken & De Iuliis, 2010). To optimise the primary objective of the sperm preparation
process, various methods have been developed and evaluated. Two of the most commonly
used sperm preparation methods are DGC and the swim-up method (Malvezzi et al., 2014;
Takeshima et al., 2017). DGC uses centrifugation to separate mature sperm from immature
sperm and non-germ cells; whereas swim-up selects for highly motile sperm based on their
active migration towards a layer of media (Malvezzi et al., 2014; Sharma et al., 2015;
Takeshima et al., 2017). Different basic principle of these two traditional methods attributes
each method with different advantages and limitations that can be useful in different infertility
cases (Henkel, 2013; Henkel & Schill, 2003)
The choice of sperm preparation method is strongly influenced by the initial quality of
the semen sample that is often determined by the sperm concentration, motility and
morphology (Natali, 2011). Thus, the efficacy of a sperm preparation method is often
measured by its ability to improve these parameters (Zhao et al., 2016). In addition to high
recovery rate and sperm motility, the ability of sperm preparation to isolate sperm with good
quality DNA has increasingly attracted attention (Mortimer, 2000). This concern is especially
relevant in clinical practice as sperm DNA damage has been linked to poor clinical outcomes
(Bareh et al., 2016; Simon et al., 2017). The current literature has shown that the major
pathways that lead to sperm DNA damage involves oxidative stress and apoptosis (Gupta et
al., 2009). An oxidative stress state can be induced by various sources of ROS including the
exogenous sources that the sperm may be exposed to during the process of ART. These
sources include centrifugation (Agarwal et al., 2014; Nadalini et al., 2014), prolonged
incubation (Drake-Brockman et al., 2018; Koyun et al., 2014; Nabi et al., 2013) and
contaminated media (Aitken et al., 2014).
Finally, practicality is another factor that cannot be underestimated when choosing a
sperm preparation method. This includes the cost, time and the requirement for a skilled
technician or other supporting equipment such as a centrifuge and an incubator (Henkel &
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Schill, 2003; Mortimer, 2000). Together, the emphasis on minimising ROS production and
sperm DNA damage, and the importance of practicality in clinical use has led to alternative
sperm preparation methods such as SeaforiaTM. This alternative sperm preparation method was
developed based on the principle of swim-up with some modifications that eliminate the need
for a centrifugation process. This may not only minimise the risk for centrifugation-induced
ROS production, but also allow simple fertility treatments such as IUI to be performed in
clinics that have limited to no access to advanced laboratory equipment. However, although
this novel method is expected to overcome the limitations of the two conventional methods,
comparisons between SeaforiaTM, DGC and the swim-up method are still lacking.

Aims and hypotheses
The second study of this doctoral thesis (Study 2) aimed to compare the efficacy of sperm
preparation using two traditional methods, namely DGC and the swim-up method, and
SeaforiaTM in reducing the proportion of apoptotic (Annexin V+) sperm and ROS-generating
(ROS+) sperm. In addition to these parameters, the study also aimed to determine whether
SeaforiaTM, in comparison to DGC and swim-up, could effectively isolate high concentrations of
motile sperm without centrifugation. It was hypothesised that sperm preparation using DGC,
would produce a final sample with a higher proportion of apoptotic sperm and sperm ROS
compared to swim-up and SeaforiaTM. Further, it was predicted that SeaforiaTM could produce
samples with sperm concentration and motility that are comparable to the swim-up method.

Materials and methods
Data collection
Semen samples were collected by masturbation from men presenting at Concept Fertility
Centre for a diagnostic semen analysis. Prior to sample collection, participants were provided
with an information sheet regarding the details of the study to ensure informed consent was
obtained. A signed consent to participation form for the use of semen remaining after semen
analysis was then obtained (Appendix A). Only samples with normal semen appearance,
volume, consistency, pH and sperm concentration according to the WHO laboratory manual (5th
edition) (WHO, 2010) were included in the study.
Following clinical use, the remaining semen samples were pooled to achieve the
minimum required volume of 3.5 mL per sample (N = 17). The semen samples that were pooled
were collected on the same day and < 12 h apart. Pooled semen samples were thoroughly mixed
by aspirating the samples ten times using a disposable transfer pipette. Three aliquots of 1 mL
were then taken from each pooled semen sample and processed using three different sperm
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preparation methods: DGC (see Section 2.3.3.1) and swim-up (see Section 2.3.3.2), as adapted
from the WHO guidelines (WHO, 2010), and SeaforiaTM (see Section 2.3.3.4), according to the
manufacturer’s guidelines. Analysis of sperm apoptosis (see Section 2.4.1) and ROS (see
Section 2.4.2) were performed on the neat sample (unprocessed) as a baseline, and on the
processed samples following the sperm preparation using the three different methods. Sperm
concentration and progressive motility percentage were also analysed on the neat and processed
samples following three sperm preparation methods; whereas sperm total motility count per
yield was compared between the processed samples from the three different sperm preparation
methods. The determination of these sperm parameters is detailed in Chapter 2 (see Section
2.3.2).

Statistical analyses
All statistical analyses, including descriptive statistics, were performed using IBM SPSS
Statistics for Windows, Version 25.0 (Armonk, NY: IBM Corp.) with a statistically significant
value set at a P < 0.05. Except for AnnV+/7-AAD- (%), the raw data for all variables were not
normally distributed as tested by Kolmogorov-Smirnov normality test and log transformation of
the raw data improved the normality of AnnV+/7-AAD+ (%) and ROS+ (%). Non-parametric
statistical tests were performed on raw (untransformed) data as indicated for other non-normally
distributed data.
One-way repeated measures ANOVA was used to identify differences in AnnV+/AAD(%), AnnV+/7-AAD+ (%) and ROS+ sperm before and after sperm preparation. Further, an LSD
post-hoc multiple comparison test was used to identify significant differences in the outcome
measures between the three different sperm preparation methods. Non-parametric Friedman’s
two-way analysis of variance was performed to analyse differences in sperm concentration and
progressive motility percentage in processed samples from the three different methods.
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Results
Effect of sperm preparation on sperm apoptotic markers and ROS
The proportions of sperm populations expressing apoptotic and ROS markers before
and after sperm preparation are summarised in Table 4.1. The proportions of AnnV+/7-AADand AnnV+/7-AAD+ sperm were significantly lower after processing with DGC, swim-up and
SeaforiaTM compared to neat (unprocessed) samples. For both parameters, the differences
between the three methods were not statistically significant. The proportion of ROS+ sperm in
the neat samples was significantly reduced after swim-up and SeaforiaTM, but not after DGC. In
comparison to DGC, both swim-up and SeaforiaTM produced samples with significantly lower
ROS+ sperm, with no significant difference between the two methods. A noticeable variation in
ROS+ population following DGC was also observed (Table 4.1).

Table 4.1 Comparison of AnnV+/7-AAD- (%), AnnV+/7-AAD+ (%) and ROS+ (%) Sperm
Populations Before and After Sperm Preparation Using DGC, Swim-up and SeaforiaTM.
AnnV+/7-AAD- (%)

AnnV+/7-AAD+ (%)

ROS+ (%)

Mean

SD

Mean

SD

Mean

4.14 b,c,d

1.39

11.26 b,c,d

5.09

17.30 c,d

7.00

DGC

2.36 a

1.06

5.42 a

4.61

18.71 c,d

13.68

Swim-up

2.87 a

1.45

4.93 a

3.51

9.51 a,b

5.18

SeaforiaTM

2.68 a

1.47

3.79 a

2.51

8.22 a,b

5.57

Neat (unprocessed)

a

Significant compared to neat (unprocessed) sample, P < 0.05

b

Significant compared to DGC, P < 0.05

c

Significant compared to swim-up, P < 0.05

d

Significant compared to SeaforiaTM, P < 0.05

SD

Effect of sperm preparation on sperm concentration and motility
Table 4.2Table 4.2 summarises sperm count and progressive motility in both neat and
processed samples after sperm preparation using three different methods. The total sperm
motility count per yield from each of the three methods is also presented in Table 4.2. A nonparametric analysis suggested that all sperm preparation methods significantly reduced sperm
concentration and improved sperm progressive motility from the neat samples. A pairwise
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comparison between the three methods also indicated that swim-up produced samples with a
higher proportion of sperm progressive motility but lower sperm concentration compared to
DGC. There was no significant difference in sperm concentration and progressive motility
between SeaforiaTM and DGC and between SeaforiaTM and the swim-up method. The
comparison between the three methods also revealed that both DGC and the swim-up method
produced a similar total sperm motility count per yield; whereas SeaforiaTM produced a
significantly higher total sperm motility count per yield than the other two methods.
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Table 4.2 Comparison of Sperm Concentration (million/mL), Progressive Motility (%)
and Total Sperm Motility Count (million/mL) Before and After Semen Processing Using
DGC, Swim-up and SeaforiaTM
Concentration
(106 cells/mL)
Mean

Progressive
motility (%)

SD

Mean

SD

Total motility per
yield (106 cells)
Mean

SD

Neat (unprocessed)

81.28 b,c,d

20.45

48.64 b,c,d

15.12

DGC

16.24 a,c

14.33

79.77 a,c

15.38

50.18 d

36.53

Swim-up

5.12 a,b

3.44

92.13 a,b

7.86

47.41 d

34.26

SeaforiaTM

12.72 a

10.45

86.55 a

16.37

84.66 b,c

69.00

a

Significant compared to neat (unprocessed) sample, P < 0.05

b

Significant compared to DGC, P < 0.05

c

Significant compared to swim-up, P < 0.05

d

Significant compared to SeaforiaTM, P < 0.05

Discussion
Various sperm preparation techniques that have been developed over time are based on
four basic principles: simple washing, selective washing such as DGC, sperm migration such
as swim-up and adherence or filtration such as glass wool (Henkel & Schill, 2003; Mortimer,
2000). The present work compares the level of Annexin V+ sperm and ROS+ sperm following
sperm preparation using three different methods: DGC, the swim-up method, and SeaforiaTM.
In addition, the efficacy of these sperm preparation methods in producing samples with both
high sperm concentration and progressive motility as well as practical advantages including
preparation time and cost have been considered. In light of the existing literature, the basis of
each method will be compared and possible rationales underlying the findings will be
discussed here.
Sperm concentration and progressive motility are two parameters that determine the
relative yield of a sperm preparation method. Although an adjustment to sperm concentration
is often made in a clinical setting depending on the type of procedure (i.e. for IVF or ICSI),
producing a sample with a high sperm concentration is considered one of the key priorities in
choosing a suitable preparation method for ART. This is particularly crucial considering that
men who undergo fertility treatment are more likely to have suboptimal semen parameters
(Mortimer, 2000). The present study demonstrated that DGC produces samples with higher
sperm concentrations compared to swim-up, confirming the findings of previous studies
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(Amiri et al., 2012; Ricci et al., 2009). With regard to sperm motility, the present study
showed that swim-up produces samples with higher sperm motility compared to DGC, which
was similar to a previous observation by Ricci et al. (2009) and Facio et al. (2016).
Considering the fact that the swim-up method relies solely on sperm migration and that the
swim-up method in the present study was performed without the centrifugation step, these
observations were fairly expected. With regards to the latter, previous studies by Zhao et al.
(2016) and Facio et al. (2016) found no significant difference in sperm concentration between
DGC and the swim-up method when centrifugation was added before and/or after swim-up.
To make a more clinically relevant comparison of the two methods, the present study
calculated and reported no significant difference in the total sperm motility count per yield of
1 mL semen samples between DGC and swim-up. This implied that the higher sperm
concentration in DGC-processed samples compensated for its lower sperm motility
percentage, and the opposite was observed in the swim-up samples. Although studies are
required for confirmation, the combination of the two methods may be beneficial for ART use
(Grunewald et al., 2009; Jayaraman et al., 2012).
The current study is one of the very few that reviewed the efficacy of SeaforiaTM in
comparison to other sperm preparation methods. It is reported that SeaforiaTM produces
samples with sperm concentrations that are higher than swim-up; and with sperm progressive
motility that is higher than DGC. As a result, the total sperm motility count per yield in
SeaforiaTM-processed samples were significantly higher than those of DGC and swim-up. In
addition, despite the lack of statistical significance, the final sperm concentration in
SeaforiaTM-prepared samples was double that compared to swim-up, which could be
appreciated in clinical settings as it eliminates the need for an additional centrifugation step to
concentrate the sample. The observed advantage may be attributed to the SeaforiaTM
disposable separator that has a greater diameter than a regular conical centrifugation tube,
which optimises the surface area for sperm migration. As seen in the diagram presented in
Chapter 2 (see Section 2.3.3.4), the disposable separator also includes a groove, designed to fit
the syringe tips, which seems to aid collection of concentrated processed sperm with minimum
seminal plasma contamination. It is important to note that the lower sperm concentration in the
swim-up samples might result from some of the modifications made to the protocol used in the
present study relative to the WHO recommendation or the regular clinic protocol. In the
current study, the incubation of the swim-up samples was done in a heating block and
therefore, the Eppendorf tube was not inclined at a 45o angle. These samples were also
incubated for 30 minutes, instead of 60 minutes as recommended by the WHO, to match the
incubation time used for the SeaforiaTM. In addition, to minimise seminal plasma
contamination during the final sample retrieval, the semen samples were overlayed with 2 mL
instead of 1.2 mL (as recommended by the WHO) of culture medium. Low final
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concentrations in swim-up samples in the current study may also be attributed to the fact that
no centrifugation step was included before and/or after swim-up. Therefore, direct swim-up,
instead of conventional swim-up, was used in this study. A lower sperm concentration
following direct swim-up in comparison to conventional swim-up has also been previously
observed by Ghaleno, Valojerdi, Janzamin, et al. (2014). In comparison to the current study,
an internal study by the manufacturer reported that SeaforiaTM produces a significantly lower
sperm concentration than DGC and swim-up, with no difference in sperm progressive motility
in comparison to the two traditional methods (LotusBio, 2009). In addition, the manufacturer
reported a significantly lower average number of motile sperm (8.59 × 106 cells/mL)
following sperm preparation with SeaforiaTM than that observed in the current study (12.06 ×
106 cells/mL). This was potentially because the semen samples used in the manufacturer’s
study had significantly lower motile sperm concentrations (between 8.13 to 22.2 × 106
cells/mL) compared to those used in the current study (mean = 43.33 × 106 cells/mL)
(LotusBio, 2009).
Setting sperm concentration and motility aside, the “safety” aspect of sperm preparation
that is often associated with ROS production during the process has become another key
consideration in selecting a sperm preparation method for ART (Mortimer, 2000). At low
levels, ROS appear to facilitate normal sperm physiological functions including capacitation,
hyperactivation, acrosome reaction and sperm-oocyte fusion (Agarwal et al., 2014); but in
excessive amounts, it can outweigh the protective capacity of the seminal antioxidants, leading
to an oxidative stress state (Aitken et al., 2015). In combination with defective sperm
maturation and apoptosis, oxidative stress has been shown to cause sperm DNA damage
(Muratori et al., 2015; Ni et al., 2016; Rex et al., 2017), which has been linked to poor clinical
outcomes including poor fertility, implantation and pregnancy rates (Bareh et al., 2016; Simon
et al., 2017; Zhao et al., 2014). Therefore, minimising sperm exposure to sources of ROS is
particularly critical in ART.
The current study provides evidence that the proportion of ROS+ sperm was
significantly lower following sperm preparation using swim-up or SeaforiaTM compared to the
neat samples and following DGC. The comparison between swim-up and DGC in the current
study aligned with previous work by Ghaleno, Valojerdi, Janzamin, et al. (2014). In
comparison, other studies did not observe a significant difference in ROS levels between
swim-up and DGC (Li et al., 2012; Zhao et al., 2016) and between swim-up and neat samples
(Asghar et al., 2014) when an additional centrifugation step was performed before and/or after
the swim-up method. This suggests that ROS may be induced during centrifugation. Further,
the current work also demonstrates that the level of ROS in DGC-processed sperm was
comparable to that of the neat samples. Although the initial and final percentage of the ROS+
population remained very similar, the initial percentage of the ROS+ population represents the
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whole sperm population in neat samples whereas the final percentage of the ROS+ population
represents only the pellet of mature sperm in the processed samples. In other words, the actual
total number of ROS+ sperm might have increased after DGC. This observation suggests two
possibilities: firstly, DGC may not be as efficient as the two other methods in isolating ROSsperm. This could be because sperm motility loss, in comparison to the density of
morphologically defective spermatozoa, is a more representative manifestation of sperm ROS;
secondly, DGC induced newly generated ROS. Of relevance to the latter, DGC-induced ROS
in healthy sperm has been observed by Agarwal et al. (1994). The present study also observed
a noticeable individual variance in final ROS level after DGC where increased ROS was
observed in 7 out of 17 samples. The uneven effect of DGC has previously been reported in
relation to sperm apoptosis (Li et al., 2012; Takeshima et al., 2017) and sperm DNA
fragmentation (Muratori et al., 2016; Zini et al., 2000). Together, this suggests that the
deleterious effect of DGC on sperm ROS might vary according to the initial sperm quality
(Muratori et al., 2016; Zini et al., 2000).
A possible negative correlation between sperm with apoptotic markers and poor semen
parameters, fertilisation rate and pregnancy rate has been postulated (Boyraz et al., 2016;
Talarczyk-Desole et al., 2016). For this reason, removal of apoptotic sperm has offered a
novel and promising approach to sperm preparation to improve ART outcomes (Degheidy et
al., 2015; Nadalini et al., 2014; Romany et al., 2014). To compare the efficacy of the three
sperm preparation methods in reducing apoptotic sperm, samples that were tested for ROS
were simultaneously tested for apoptotic markers. The results revealed that all three methods
equally and effectively reduced the proportion of both AnnV+/7-AAD- and AnnV+/7-AAD+
sperm compared to the neat sample. In agreement with this finding, a significant reduction in
apoptotic sperm after DGC and swim-up when used individually (Mahfouz et al., 2010; Ricci
et al., 2009), or in combination (Grunewald et al., 2009), has been well documented. To the
best of our knowledge, the present study is the first to report sperm apoptosis and ROS in
SeaforiaTM-processed sperm. As previously observed when the final level of ROS was
compared, the proportions of AnnV+/7-AAD- and AnnV+/7-AAD+ sperm were similar between
swim-up and SeaforiaTM. Considering the fact that both of these methods share similar
principles, the lack of significant difference between the two was expected. As described
elsewhere, the findings of the current work also suggest that DGC, swim-up and SeaforiaTM
may not necessarily induce sperm apoptosis, but they do not completely eliminate the
apoptotic sperm population (Drake-Brockman et al., 2018; Ricci et al., 2009). Of clinical
relevance, high levels of ROS are thought to facilitate the progression of early apoptosis to
late apoptosis, DNA damage and eventually, reduced fertilisation capacity in a series of
continuous events (Aitken, Bronson, et al., 2013; Drake-Brockman et al., 2018). An earlier
study demonstrated that prolonged incubation after sperm preparation with DGC decreased the
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proportion of live cells (indicated as AnnV-/7-AAD- sperm) and increased the late apoptotic
sperm (indicated as AnnV+/7-AAD+ sperm) fraction (Drake-Brockman et al., 2018). The
increase in late apoptosis after DGC may occur as a consequence of high levels of ROS that
was observed in the present study. Interestingly, unlike the other two methods, the elimination
of apoptotic sperm following DGC was not accompanied by elimination of ROS+ sperm. This
could be because apoptosis is a transient state that can be predictive of a necrotic sperm
population (Muratori et al., 2003). Thus, given this notion, it is predicted that if the processed
samples were to be incubated after preparation using DGC, swim-up and SeaforiaTM, then the
DGC-processed sample would have a higher proportion of late apoptotic or necrotic sperm
compared to swim-up or SeaforiaTM-processed samples.
The potential detrimental effect of the centrifugation step involved in simple sperm
washing, DGC and conventional swim-up has long been postulated (Agarwal et al., 1994;
Asghar et al., 2014; Ghaleno, Valojerdi, Janzamin, et al., 2014; Kedechi et al., 2017).
Centrifugation-induced ROS production is thought to result from high centrifugal force and
speed (Mortimer, 2000) as well as heat generation (Mahfouz et al., 2010) during the process.
In accordance, to rule out possible ROS production from centrifugation, direct swim-up,
instead of conventional swim-up, was intentionally used in the present study. Other possible
ROS-inducing mechanisms in DGC, independent of repeated centrifugation steps, include
close proximity of sperm to ROS-generating non-germ cells and immature or abnormal sperm
that can produce ROS (Aitken & Clarkson, 1988; Takeshima et al., 2017) and transition metal
contamination in the gradient media (Aitken et al., 2014). With regard to the latter, Aitken et
al. (2014) reported high levels of transition metals such as Fe, Cu, Al, Pb and Cd; and
observed a dose-dependent increase in sperm oxidative DNA damage upon incubation with
PureSperm® gradient media, which was predicted to be independent of its ability to eliminate
ROS-generating cells. These transition metals, in particular Fe and Cu, can catalyse the
generation of highly reactive hydroxyl radical (OH-) from hydrogen peroxide (H2O2) and
superoxide (O2-), promoting the initiation of a lipid peroxidation cascade (Dobrakowski et al.,
2017; Dutta et al., 2019). Despite the fact that both swim-up and SeaforiaTM were superior in
reducing ROS levels compared to DGC, ROS+ sperm were still detected in the final samples.
During sperm migration, ROS production may still occur through sperm cell-to-cell contact
with non-germ cells and abnormal or immature sperm (Takeshima et al., 2017), seminal
plasma component contamination (Bjorndahl et al., 2005), and prolonged in vitro incubation
with the culture medium (Li et al., 2012; Muratori et al., 2003). Similarly, a low level of
apoptosis was still detected after DGC, swim-up and SeaforiaTM. Arguably, Annexin V detects
early stages of apoptosis, where motility loss and altered morphological density might not
have been observed (Oosterhuis et al., 2000), and therefore, Annexin V+ sperm might still be
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selected by DGC and be able to swim through the seminal plasma during processing by swimup and SeaforiaTM.
In addition to the factors concerning final yield and sperm quality, an ideal sperm
preparation method must consider the cost, complexity and practicality in the context of
clinical setting (Henkel & Schill, 2003; Mortimer, 2000). Further, the choice of a preferred
method should also be based on the quality of the semen samples including viscosity, semen
volume, sperm count and motility (WHO, 2010). Between the two traditional methods, DGC
involves a more standardised procedure resulting in a more consistent yield compared to the
swim-up method. The centrifugation speed and time as well as density gradient volume used
in DGC can also be modified to accommodate semen samples with abnormal viscosity and
parameters (e.g. low sperm count, motility and normal morphology), whereas swim-up is
preferred for normal semen samples. Depending on the protocol used in the fertility clinic,
sperm preparation can take 20 to 40 minutes using DGC and up to 60 minutes using swim-up
(WHO, 2010). In terms of the cost of the procedure, internal data from our laboratory recorded
that swim-up is the most cost-effective method, followed by DGC and SeaforiaTM,
respectively (Appendix C-9). Both swim-up and DGC require equipment that is commonly
found in a regular established laboratory including a centrifuge, an incubator, pipettes and
centrifugation tubes. In comparison, SeaforiaTM aims to make fertility treatment more
accessible to healthcare professionals who have limited or no access to an established
andrology laboratory. In accordance, this product offers the option of incubating the sample in
a regular incubator or in a SeaforiaTM heating device that complements the kit and does not
require centrifugation. Hence, based on the observations performed in the present study,
SeaforiaTM has sufficiently delivered its main objective and can be a good alternative to the
two conventional methods.
Potential limitations of the present study might arise from the use of pooled samples
instead of individual semen samples. Consequently, it was not possible to control for the time
between sample collection and sperm preparation, which may have affected the quality of the
sperm prior to sperm preparation (Agrawal et al., 2018; Yavas & Selub, 2004). The
interpretation of the apoptotic markers used in this study may also be another source of
limitation. The complementary use of Annexin V, an apoptotic marker, and a viability marker
such as 7-aminoactinomycin D (7-AAD) enables the detection of viable, apoptotic or necrotic
cells based on the presence of PS externalisation and plasma membrane permeability (Rieger
et al., 2011). However, early apoptosis may be misinterpreted as capacitation as the
externalisation of PS has been observed in both events (Moustafa et al., 2004; Tavalaee et al.,
2012). In relation to this, reduced sperm motility was previously observed in sperm with
apoptotic markers (AnnV+/PI- and AnnV+/PI+) (Zhang et al., 2008), whereas successful
capacitation and subsequent acrosome reaction was observed in MACS-sorted non-apoptotic
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(Annexin V-) sperm (Grunewald et al., 2006). These support the notion that persistent ROS
generation during capacitation can eventually lead to apoptosis (Aitken et al., 2015). Lastly,
the findings of this study were obtained from semen samples with largely normal semen
parameters and viscosity and may not be applicable to samples with abnormal consistency and
lower sperm count. Further study is required to confirm the efficacy of using SeaforiaTM, in
comparison to DGC and swim-up, to process samples with reduced quality in the context of
ART.
In conclusion, to our knowledge, the present study is the first study to measure sperm
apoptosis and ROS in sperm processed with SeaforiaTM, in comparison to either DGC or the
swim-up method. The findings show that DGC, swim-up and SeaforiaTM effectively reduced
sperm apoptosis compared to the neat sample, but only swim-up and SeaforiaTM were effective
in reducing sperm ROS. This does not support the hypothesis since DGC-processed samples
contained higher levels of ROS, but similar levels of apoptosis compared to swim-up and
SeaforiaTM. The current study also demonstrated that SeaforiaTM produced samples with high
sperm concentrations and progressive motility, with no significant difference compared to the
two other methods. Secondary to that, DGC was shown to produce samples with higher sperm
concentrations, but lower progressive motility compared to the swim-up method. Briefly, this
study has provided evidence that SeaforiaTM has successfully delivered its main objective and
could potentially be a suitable alternative to the traditionally used methods (DGC and swimup). An extended experimental study of the current work would be required to investigate the
comparison of the three sperm preparation methods using semen samples with abnormal
semen parameters (e.g. oligozoospermic, asthenozoospermic, and teratozoospermic samples)
in the context of ART.
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Study 3: The effect of time intervals on ART
outcomes
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Chapter 5: Study 3 - The effect of time intervals on ART outcomes
Research background
During the process of ART, clinical decisions are discussed between the couples and the
clinicians to ensure the best possible outcomes as well as to accommodate the convenience of
both parties. These include the type of fertility treatment and the arrangement for time and
location of semen sample collection. According to the latest WHO laboratory guide (WHO,
2010), when semen sample collection is performed at home, the semen sample should be
transported to the laboratory within 1 h of ejaculation. Similarly, the guidelines also advise that
sperm preparation prior to a sperm functionality test should be performed within 1 h of
ejaculation (WHO, 2010).
Whilst these recommendations entail an underlying concern about the adverse effect of
prolonged time interval between ejaculation and sperm preparation, the application of these
recommendations in clinical practice would depend on other factors. For the couples’
convenience, oocyte collection and semen sample collection are often arranged to be performed
at the same time upon the couple’s arrival at the clinic. Although this arrangement may
accommodate the work schedule of the male partner in most cases, it results in an extended time
interval between sperm preparation and insemination (for IVF) or sperm injection (for ICSI)
(post-wash interval) and between ejaculation and insemination/ sperm injection (total interval).
In a busy andrology laboratory, heavy workload may also delay sperm preparation and therefore
prolong the ejaculation-to-sperm preparation time interval (pre-wash interval) (P. Burton,
personal communication, n.d.).
To date, guidelines for the acceptable time intervals are rare and provide limited
discussion about different time intervals during the process of ART and its consequences on the
clinical outcomes. Although the WHO guidelines (WHO, 2010) recommend that pre-wash
interval should be kept within 1 h prior to sperm function test, the application of this
recommendation seems to be limited to diagnostic purposes and is less relevant to clinical use in
the context of ART (Koyun et al., 2014; Yavas & Selub, 2004). Recommendations for both the
acceptable post-wash and total intervals are still lacking. In addition, the existing literature
mainly focuses on the negative effect of prolonged time interval on IUI outcomes (Agrawal et
al., 2018; Fauque et al., 2014; Jansen et al., 2017; Yavas & Selub, 2004) while studies on IVF
and ICSI cycles are still rare.

Aims and hypotheses
Study 3 aimed to examine the effects of prolonged pre-wash (time between ejaculation
and sperm preparation), post-wash (time between sperm preparation and insemination/sperm
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injection) and total (time between ejaculation and insemination/injection) intervals on sperm
motility and ART outcomes in IVF and ICSI cycles. It is hypothesised that after controlling for
potential confounding factors, prolonged pre-wash, post-wash and total intervals would be
associated with reduced sperm motility and lower chances of positive ART outcomes.

Materials and methods
Study population
The data used in this study were extracted from the patient database of Concept Fertility
Centre, Perth, Western Australia for IVF/ICSI cycles. A total of 5,331 IVF and 3,741 ICSI
cycles commenced between January 1995 and December 2016 were retrospectively extracted
and filtered through some exclusion criteria, as follows: (1) cases utilising both IVF and ICSI;
and (2) cases where female patients were 40 years old or above; and where the number of
oocytes retrieved were less than four. The latter was adapted from the Bologna criteria for POR
(Ferraretti et al., 2011) to minimise the confounding effect of female fertility status on the
overall clinical outcomes. In total, 5,033 IVF and 3,046 ICSI (N = 8,079) cycles were included
in the analysis.
As shown in Figure 5.1, 97.4% of IVF and 96.6% of ICSI patients who were included in
the study had at least one fertilised oocyte. Embryo transfer was performed in 79.9% of IVF and
72.1% of ICSI patients with successful fertilisation. Of this group of patients, 43.9% and 43.7%
of IVF and ICSI patients respectively, achieved hCG pregnancy, indicated by blood hCG > 9
IU/L at 14 days after oocyte retrieval. Clinical pregnancy, however, as indicated by detectable
fetal heartbeat at 6 weeks after oocyte retrieval, was only achieved in 29.2% of IVF and 26.8%
of ICSI patients. Biochemical pregnancy, also known as preclinical spontaneous abortion or
miscarriage, is defined as an hCG pregnancy that was not followed by a successful clinical
pregnancy (Zegers-Hochschild et al., 2009). Biochemical pregnancy was experienced by 14.6%
of IVF and 16.9% of ICSI patients.
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Figure 5.1 The Number of IVF and ICSI Patients Included in the Study at Different Clinical
Endpoints (Study 3).
Whole cohort
Patients included
in the study

8,079

IVF

ICSI

5,033

3,046

IVF

ICSI

4,901
(97.4%)

2,943
(96.6%)

IVF

ICSI

3,914
(79.9%)

2,123
(72.1%)

IVF

ICSI

1,717
(43.9%)

928
(43.7%)

1,144
(29.2%)

569
(26.8%)

573
(14.6%)

Patients with at
least one oocyte
fertilised

Patients with at
least one embryo
transferred

Patients with hCG
pregnancy

Patients with
clinical pregnancy

359
(16.9%)

Patients with
biochemical
pregnancy

Note. The percentages of patients with hCG, clinical and biochemical pregnancies were
calculated per embryo transfer cycle.
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Data collection
Prior to semen sample collection, male patients were given a data collection form
whereby they were instructed to record the time of ejaculation along with other information
(e.g. age and days of abstinence) (Appendix B). Following sample collection (see Section
2.3.1), semen samples were allowed to liquefy at room temperature and were analysed for basic
semen parameters by an embryologist (see Section 2.3.2), followed by sperm preparation (see
Section 2.3.3) for ART use. The start and end time of sperm preparation as well as time of
insemination (for IVF) or sperm injection (for ICSI) were noted. Pre-wash interval was
calculated as the time between ejaculation time and the start of sperm preparation; Post-wash
interval was calculated as the time between ending of sperm preparation and
insemination/sperm injection time; and total interval was calculated as the time from ejaculation
to insemination/sperm injection time. The relationships of these intervals with sperm parameters
and clinical outcomes were then analysed using the statistical approach elaborated in the
following section of this chapter. The determination of clinical outcomes and sperm parameters
are described in Chapter 2 (see Section 2.1.1).

106
Statistical analyses
All statistical analyses, including descriptive statistics, were performed using IBM SPSS
Statistics for Windows, Version 25.0 (Armonk, NY: IBM Corp.) with a statistically significant
value set at a P < 0.05.
Differences in maternal and paternal ages between the IVF and ICSI groups were
analysed using an independent t-test as these variables were normally distributed. A MannWhitney U test was performed to test the difference in pre-wash, post-wash and total intervals
as well as semen parameters, number of oocytes retrieved, and fertilisation rate in the IVF and
ICSI groups. These variables were not normally distributed, as tested by the KolmogorovSmirnov test, despite the use of data transformation in an attempt to improve the normality.
Differences in hCG pregnancy, clinical pregnancy and biochemical pregnancy rates between
IVF and ICSI groups were analysed using a Chi-square test.
As an initial step to examining the independent effect of pre-wash, post-wash and total
interval on sperm motility and pregnancy outcomes, the whole cohort was stratified into groups
based on the time intervals as presented in Table 5.1. The ranges of time interval for each group
was determined with consideration of the existing recommendations, current clinical practice
and the distribution of patients among groups. When semen analysis and sperm preparation
were carried out immediately after sample collection and liquefaction, for instance, it was
practically possible for the pre-wash interval to be less than 30 minutes. Alternatively, the WHO
recommends semen analysis to be performed within 60 minutes of sample collection. This
recommendation also suggests that the sample should be transported into the clinic within 60
minutes if sample collection is performed elsewhere other than the clinic (e.g. home) (WHO,
2010). Therefore, it is reasonable that the pre-wash interval can be more than 60 minutes.
Whilst recommended post-wash and total intervals have not been discussed in the WHO
guidelines, the time interval for post-wash and total interval groups were adapted from the time
intervals used in previous studies where significant changes in clinical outcomes were observed
(Fauque et al., 2014; Koyun et al., 2014; Yavas & Selub, 2004). As part of the clinical
procedure, oocyte retrieval was followed by 4-6 h of incubation before insemination/sperm
injection. Therefore, in the case where semen sample collection and oocyte retrieval were
carried out at approximately the same time, the post-wash interval may be > 4 h (240 minutes).
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Table 5.1 The Classification of Patients into Groups Based on Pre-Wash, Post-Wash and
Total Intervals Prior to Statistical Analysis.
Time intervals

Groups
pre-wash interval < 30 minutesa

Pre-wash interval

pre-wash interval 30 – 60 minutesb
pre-wash interval > 60 minutes
post-wash interval < 60 minutesc

Post-wash interval

post-wash interval 60 – 120 minutes
post-wash interval 120 – 240 minutes
post-wash interval > 240 minutes
total interval < 90 minutesd

Total interval

total interval 90 –180 minutes
total interval 180 – 360 minutes
total interval > 360 minutes

a

Pre-wash interval associated with a higher pregnancy rate (Yavas & Selub, 2004)

b

Pre-wash interval recommended by the WHO laboratory manual guide 5th edition (WHO,
2010)

c

Post-wash interval associated with a higher chance of positive clinical outcomes (Fauque et
al., 2014; Koyun et al., 2014; Yavas & Selub, 2004)

d

Total interval associated with a higher pregnancy rate (Yavas & Selub, 2004)

GLMs were used to examine the independent effect of pre-wash on sperm progressive
motility and fertilisation rate as well as the independent effect of post-wash and total intervals
on fertilisation rate. Only pre-wash interval, but not post-wash and total interval, was analysed
for its effect on sperm progressive motility because neat sperm progressive motility was
determined at the same time as sperm preparation; and processed sperm progressive motility
was determined immediately after sperm preparation. The independent effect of pre-wash, postwash and total intervals on other dichotomous clinical outcomes including hCG, clinical and
biochemical pregnancy rates were analysed using logistic regression.
For both general linear model and logistic regression analyses, an initial model
containing all variables with potential confounding effects was constructed; each for pre-wash,
post-wash and total interval with an exception for sperm progressive motility (as above). The
initial models also took into account the potential interaction between time interval (pre-wash,
post-wash or total interval) and procedure type (IVF or ICSI). Non-significance for this

108
interaction variable indicates that the effect of time interval on the dependent variable does not
vary with procedure type. If the interaction variable was significant, IVF and ICSI groups were
analysed separately. Other non-significant predictors were excluded from the initial model in a
stepwise manner until only significant predictors were left in the model. The dependent
variables, significant predictors and all excluded variables are presented in the following
sections. Interaction terms between time interval and year of cycle were included and reported
in the final regression models to observe whether the effect of the time intervals on clinical
outcomes varied with the year of cycle. Finally, the correlations between time intervals, semen
parameters, fertility status and year of cycle were analysed using non-parametric Spearman’s
correlation test.

Results
Study population and clinical information
Table 5.2 displays variables that may reflect the fertility status of participants including
age, semen parameters, number of oocytes retrieved, and fertilisation rate in IVF and ICSI
groups. On average, male and female patients were significantly older in the ICSI rather than
the IVF group. The average sperm concentration, total motility percentage of processed sperm
and progressive motility percentage of both neat and processed sperm were significantly higher
in the IVF group compared to the ICSI group. The IVF group also had a higher average number
of oocytes retrieved in each cycle and a higher fertilisation rate per embryo transfer compared to
the ICSI group.
The prevalence of clinical outcomes including fertilisation, hCG pregnancy, clinical
pregnancy and biochemical pregnancy in the IVF and ICSI groups is shown in Table 5.3. The
prevalence of successful fertilisation and clinical pregnancy was significantly higher in the IVF
group when compared to the ICSI group. Biochemical pregnancy, on the contrary, was higher in
the ICSI compared to the IVF group. No significant difference was observed in hCG pregnancy
levels between the two groups.
The pre-wash, post-wash and total intervals are reported separately for the IVF and
ICSI groups in Table 5.4. All time intervals were significantly shorter in the IVF group
compared to the ICSI group.

109

Table 5.2 Demographic Variables and Fertility Parameters of IVF and ICSI Patients Included in the Study.
IVF

ICSI

N = 5,033
Mean
SD

N = 3,046
Mean
SD

Paternal age

36.98

5.62

38.32

6.19

0.001

Maternal age

35.13

4.48

35.56

4.60

0.001

Neat (unprocessed) sperm concentration (million/mL)

65.22

43.77

31.55

37.95

0.001

Neat (unprocessed) progressive motility (%)

71.44

22.32

53.60

32.19

0.001

Processed sperm concentration (million/mL)

8.86

5.65

5.42

9.26

0.001

Processed motile sperm (million/mL)

8.15

4.54

4.35

7.34

0.001

Processed progressive motility (%)

89.05

13.79

72.08

26.22

0.001

Number of oocytes retrieved (per cycle)

9.23

5.32

8.72

5.06

0.001

Fertilisation rate (%)

72.69

25.72

69.29

25.46

0.001

P value
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Table 5.3 The Proportion of Patients with the Presence or Absence of Fertilisation, Pregnancy and Pregnancy Loss in the IVF and ICSI Groups.
Fertilisation

Observed (n)
Not observed (n)
Total (n)
%

IVF

ICSI

4,901

hCG pregnancy

P value

IVF

ICSI

2,943

1,717

132

103

5,033

3,046

97.38 a

96.62 a

0.049

P value

Clinical pregnancy

IVF

ICSI

569

573

359

2,770

1,554

1144

569

3,914

2,123

1,717

928

29.23 c

26.80 c

33.37 d

38.69d

IVF

ICSI

928

1,144

2,197

1,195

3,914

2,123

43.87 b

43.71 b

NS

Biochemical pregnancy

P value

0.048

P value

a

The percentage of patients with at least one fertilised oocyte.

b

The percentage of patients with at least one embryo transferred and blood hCG level above 9 IU/L at 14 days post oocyte retrieval.

c

The percentage of patients with at least one embryo transferred and observed foetal heart beat at six weeks post oocyte retrieval.

d

The percentage of patients with blood hCG level above 9 IU/L at 14 days post oocyte retrieval and absence of foetal heart beat at six weeks post
oocyte retrieval.

0.003
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Table 5.4 Comparison of Mean of Pre-Wash, Post-Wash and Total Intervals (Minutes) in
the IVF and ICSI Groups.
IVF

ICSI

N = 5,033

N = 3,046

Mean

SD

Mean

SD

P value

Pre-wash interval (minutes)a

52.81

49.60

71.09

54.66

0.001

Post-wash interval (minutes)b

115.37

92.05

168.77

80.08

0.001

Total interval (minutes)c

235.49

98.06

299.88

73.66

0.001

a

Pre-wash interval was calculated as the time between ejaculation and the start of sperm
preparation.

b

Post-wash interval was calculated as the time between end of sperm preparation and
insemination (for IVF) or sperm injection (for ICSI) time.

c

Total interval was calculated as the time between ejaculation time to insemination (for
IVF) or sperm injection (for ICSI) time.

Effects of pre-wash interval on sperm motility
The interaction between the pre-wash interval group and procedure type was
significant (Table 5.5), and therefore, separate general linear models were used to
analyse the effect of pre-wash interval on neat (Table 5.6) and processed (Table 5.7)
sperm progressive motility in IVF and ICSI groups. In the IVF group, both neat and
processed sperm progressive motility percentage were highest in samples processed
within 30 minutes and were lowest in those processed after > 60 minutes. The
differences between interval groups were statistically significant (Table 5.8 and Table
5.9).
In the ICSI group, longer pre-wash interval was associated with lower sperm
progressive motility in processed samples. The difference between each of the interval
groups were statistically significant (Table 5.9). No significant association was observed
between pre-wash interval and sperm progressive motility in the neat samples of the
ICSI group (Table 5.8). After the year of cycle was controlled for, however, no
significant association was observed between pre-wash interval and neat or processed
sperm progressive motility either in the IVF or ICSI groups (Table 5.8 and Table 5.9).
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Table 5.5 General Linear Models to Analyse the Independent Effect of Pre-Wash Interval on
Neat (Model I) and Processed (Model II) Sperm Progressive Motility (%) in IVF and ICSI
Patients.
Model Ia
Variables

Model IIb

F

P-value

F

P-value

Corrected Model

2906.86

0.001

506.464

0.001

Intercept

6774.31

0.001

1947.813

0.001

Pre-wash interval group

20.93

0.001

42.747

0.001

Paternal age

24.48

0.001

0.172

0.678

Neat sperm concentration (million/mL)

138.05

0.001

5.201

0.023

19059.72

0.001

2489.283

0.001

Processed sperm concentration
(million/mL)

121.004

0.001

Processed sperm total motility (%)

107.873

0.001

139.289

0.001

Neat sperm non-progressive motility (%)

Pre-wash interval × procedure type

195.44

0.001

Note. Significant interaction between pre-wash intervals and procedure type is shown.
a

Dependent variable: neat sperm progressive motility (%); N = 8,079. R2 = .742 (Adjusted R2
= .742).

b

Dependent variable: processed sperm progressive motility (%); N = 8,079. R2 = .386
(Adjusted R2 = .385).

113
Table 5.6 General Linear Models to Analyse the Independent Effect of Pre-Wash Interval on Neat Sperm Progressive Motility (%) In IVF
(Model Ia and Ib) and ICSI (Model Ic and Id) Patients.
Model Iaa
Variables

Model Ibb

Model Icc

Model Idd

F

P-value

F

P-value

F

P-value

F

P-value

Corrected Model

4197.27

0.001

1106.463

0.001

1145.40

0.001

239.823

0.001

Intercept

9590.46

0.001

11700.348 0.001

1336.33

0.001

1334.352

0.001

Pre-wash interval group

175.61

0.001

0.434

0.648

0.71

0.492

1.139

0.320

Paternal age

22.07

0.001

5.523

0.019

8.20

0.004

3.027

0.082

Neat sperm concentration (million/mL)

48.97

0.001

92.593

0.001

95.02

0.001

172.721

0.001

20145.61

0.001

5222.07

0.001

2617.57

0.001

Neat sperm non-progressive motility (%)
Year of cycle

19056.433 0.001
70.816

0.001

5.173

a

Dependent variable: neat sperm progressive motility (%); N = 5,033. R2 = .807 (Adjusted R2 = .807). Procedure type = IVF.

b

Dependent variable: neat sperm progressive motility (%); N = 5,033. R2 = .852 (Adjusted R2 = .851). Procedure type = IVF.

c

Dependent variable: neat sperm progressive motility (%); N = 3,046. R2 = .653 (Adjusted R2 = .653). Procedure type = ICSI.

d

Dependent variable: neat sperm progressive motility (%); N = 3,046. R2 = .674 (Adjusted R2 = .671). Procedure type = ICSI.

0.001
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Table 5.7 General Linear Models to Analyse the Independent Effect of Pre-Wash Interval on Processed Sperm Progressive Motility
(%) in IVF (Model IIa and IIb) and ICSI (Model IIc and IId) Patients.

Variables
Corrected Model

Model IIaa
F
P-value

Model IIbb
F
P-value

Model IIcc
F
P-value

Model IIdd
F
P-value

290.410

0.001

110.152

0.001

235.145

0.001

60.196

0.001

12052.555

0.001

11419.782

0.001

3495.385

0.001

2983.983

0.001

107.364

0.001

0.004

0.996

3.426

0.033

0.504

0.604

0.387

0.534

2.274

0.132

14.974

0.001

12.852

0.001

1187.231

0.001

663.781

0.001

1124.531

0.001

618.801

0.001

Processed sperm concentration
(million/mL)

97.566

0.001

80.448

0.001

47.753

0.001

42.051

0.001

Processed sperm total motility (%)

27.335

0.001

117.729

0.001

53.020

0.001

70.75

0.001

43.808

0.001

7.29

0.001

Intercept
Pre-wash interval group
Neat sperm concentration
(million/mL)
Neat sperm progressive motility (%)

Year of cycle
a

Dependent variable: Processed sperm progressive motility (%); N = 5,033. Variable excluded (non-significant): paternal age. R2 =
.257 (Adjusted R2 = .257). Procedure type = IVF. b Dependent variable: Processed sperm progressive motility (%); N = 5,033.
Variable excluded (non-significant): paternal age. R2 = .373 (Adjusted R2 = .369). Procedure type = IVF.

c

Dependent variable: Processed sperm progressive motility (%) N = 3,046. Variable excluded (non-significant): paternal age. R2 =
.317 (Adjusted R2 = .316). Procedure type = ICSI. d Dependent variable: Processed sperm progressive motility (%) N = 3,046.
Variable excluded (non-significant): paternal age. R2 = .350 (Adjusted R2 = .344). Procedure type = ICSI.
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Table 5.8 Comparison of Neat Sperm Progressive Motility (%) in Samples Processed <
30, Between 30 – 60 and > 60 Minutes After Sample Collection.
Neat progressive motility (%)

Pre-wash intervals groups

ICSI

IVF

†

Mean‡ Std. Error

Mean

Std. Error

< 30 minutes (N = 2,415)

74.11 b,c

0.200

70.895

0.206

30 – 60 minutes (N = 1,092)

69.80 a,c

0.297

70.889

0.266

> 60 minutes (N = 1,526)

68.38 a,b

0.253

71.185

0.251

< 30 minutes (N = 883)

52.99

0.642

54.741

0.676

30 – 60 minutes (N = 767)

53.66

0.685

55.649

0.748

> 60 minutes (N = 1,396)

53.96

0.510

56.056

0.664

Note. Values are corrected means and standard errors from general linear Model Ia, Ib, Ic
and Id (Table 5.6).
a

Significant compared to group I, P < 0.05. b Significant compared to group II, P < 0.05

c

Significant compared to group III, P < 0.05.

†

Mean values are corrected for paternal age, neat sperm concentration and neat sperm
non-progressive motility (%).

‡

Mean values are corrected for paternal age, neat sperm concentration, neat sperm nonprogressive motility (%) and year of cycle.
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Table 5.9 Comparison of Processed Sperm Progressive Motility (%) in Samples Processed
< 30, Between 30 – 60 and > 60 Minutes After Sample Collection.

ICSI

IVF

Pre-wash intervals groups

Processed progressive motility (%)
Mean†

Std. Error

Mean‡

Std. Error

< 30 minutes (N = 2,415)

91.64 b,c

0.249

88.81

0.262

30 – 60 minutes (N = 1,092)

87.95 a,c

0.361

88.83

0.338

> 60 minutes (N = 1,526)

85.73 a,b

0.315

88.84

0.319

< 30 minutes (N = 883)

73.13 b,c

0.735

74.09

0.774

30 – 60 minutes (N = 767)

72.92 a,c

0.783

75.13

0.859

> 60 minutes (N = 1,396)

70.96 a,b

0.583

74.40

0.765

Note. Values are corrected means and standard errors from general linear Model IIa, IIb,
IIc and IId (Table 5.7). a Significant compared to group I, P < 0.05. b Significant compared
to group II, P < 0.05. c Significant compared to group III, P < 0.05.
†

Mean values are corrected for paternal age, neat and processed sperm concentration, neat
sperm progressive motility (%) and processed sperm total motility (%).

‡

Mean values are corrected for paternal age, neat and processed sperm concentration, neat
sperm progressive motility (%), processed sperm total motility (%) and year of cycle.
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Effects of time intervals on fertilisation rate
Regression models that were constructed to investigate the independent effect of prewash, post-wash and total intervals on fertilisation rate are presented in Table 5.10 and Table
5.13. The interaction variables of time intervals (pre-wash, post-wash or total, independently)
with the year of cycle and with procedure type (IVF or ICSI) were tested and found to be nonsignificant, indicating that the effect of these time intervals on fertilisation rate did not differ
according to the year of cycle or procedure type.
On average, a pre-wash interval < 30 minutes resulted in a significantly higher
fertilisation rate compared to 30 – 60 and > 60 minutes. When the year of cycle was controlled
for, the pattern remained, although a significant difference was only observed between < 30 and
> 60 minutes groups (Table 5.11).
After adjusting for other confounding variables, fertilisation rates were higher when the
post-wash interval was < 60 and between 60 – 120 minutes compared to 120 – 240 minutes and
> 240 minutes. Pairwise comparisons between interval groups showed no statistically
significant difference between the < 60 minutes and 60 – 120 minutes groups, and between 120
– 240 minutes and > 240 minutes groups. The observed inverse associations, however,
diminished when year of cycle was included in the model (Table 5.12).
The average fertilisation rate was significantly higher when total interval < 90 and
between 90 – 180 minutes was compared to between 180 – 360 and > 360 minutes. There was
no significant difference between < 90 and 90 – 180 minutes, and between 180 – 360 and > 360
minutes. Following inclusion of year of cycle in the regression model, however, the previously
observed correlation was no longer significant (Table 5.14).
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Table 5.10 General Linear Models Analysing the Independent Effect of Pre-Wash and Post-Wash Intervals on Fertilisation Rate (%) in IVF and
ICSI Patients.
Model IIIa
Variables

Model IIIab

Model IIIbc

F

P-value

F

P-value

F

P-value

6.939

0.001

12.712

0.001

11.934

0.001

749.365

0.001

823.565

0.001

796.765

0.001

Pre-wash interval group

9.347

0.001

12.232

0.001

3.229

0.040

Post-wash interval group

4.397

0.004

5.466

0.001

1.216

0.302

Neat sperm concentration (million/mL)

9.739

0.002

14.294

0.001

10.863

0.001

Neat sperm progressive motility (%)

0.099

0.753

Processed sperm progressive motility (%)

5.209

0.022

11.252

0.001

20.681

0.001

Maternal age

11.823

0.001

15.384

0.001

15.049

0.001

Paternal age

0.145

0.704

Number of oocytes retrieved

11.476

0.001

11.293

0.001

16.897

0.001

11.453

0.001

Corrected Model
Intercept

Year of cycle
Pre-wash interval × procedure type

0.584

0.558

Post-wash interval × procedure type

0.31

0.818

Note. Non-significant interaction between pre- and post- wash intervals and procedure type (Model III) is shown.
a
Dependent variable: Fertilisation rate (%); N = 8,079. R2 = .014 (Adjusted R2 = .012).
b
Dependent variable: Fertilisation rate (%); N = 8,079. Variable excluded (non-significant): Neat sperm progressive motility (%) and paternal age.
R2 = .014 (Adjusted R2 = .013).
c
Dependent variable: Fertilisation rate (%); N = 8,079. Variable excluded (non-significant): Neat sperm progressive motility (%) and paternal age.
R2 = .043 (Adjusted R2 = .039).
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Table 5.11 Comparison of Fertilisation Rate (%) in Samples Processed < 30, Between
30 – 60 and > 60 Minutes After Sample Collection.

Pre-wash interval groups

Fertilisation rate (%)
Mean†

Std. Error

Mean‡

Std. Error

< 30 minutes (N = 3,298)

73.10 b,c

0.461

72.34c

0.481

30 – 60 minutes (N = 1,859)

70.89 a

0.608

70.90

0.614

> 60 minutes (N = 2,922)

69.81 a

0.510

70.39a

0.579

Note. Values are corrected means and standard errors from general linear Model IIIa and
IIIb (Table 5.10).
a

Significant compared to group I, P < 0.05. b Significant compared to group II, P < 0.05.

c

Significant compared to group III, P < 0.05.

†

Mean values are corrected for post-wash interval, neat sperm concentration, neat and
processed sperm progressive motility (%), paternal age, maternal age and number of
oocytes retrieved.

‡

Mean values are corrected for post-wash interval, neat sperm concentration, neat and
processed sperm progressive motility (%), paternal age, maternal age, number of oocytes
retrieved and year of cycle.
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Table 5.12 Comparison of Fertilisation Rate (%) in Samples Where Insemination/Sperm
Injection was Performed < 60, Between 60 – 120, 120 – 240 and > 240 Minutes After
Sperm Preparation.
Fertilisation rate (%)
Post- wash interval groups

Mean†

Std.
Error

Mean‡

Std.
Error

< 60 minutes (N = 2,045)

72.37 c,d

0.591

70.99

0.616

60 – 120 minutes (N = 1,776)

72.62 c,d

0.615

72.20

0.632

120 – 240 minutes (N = 3,269)

70.32 a,b

0.451

70.79

0.491

> 240 minutes (N = 989)

69.77 a,b

0.821

70.86

0.858

Note. Values are corrected means and standard errors from general linear Model IIIa and
IIIb (Table 5.10).
a

Significant compared to group I, P < 0.05. b Significant compared to group II, P < 0.05.

c

Significant compared to group III, P < 0.05. d Significant compared to group IV, P <
0.05.

†

Mean values are corrected for pre-wash interval, neat sperm concentration, neat and
processed sperm progressive motility (%), paternal age, maternal age and number of
oocytes retrieved.

‡

Mean values are corrected for pre-wash interval, neat sperm concentration, neat and
processed sperm progressive motility (%), paternal age, maternal age, number of
oocytes retrieved and year of cycle.
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Table 5.13 General Linear Models Analysing the Independent Effect of Total Interval on Fertilisation Rate (%) in IVF and ICSI Patients.
Model IVa
Variables

Model IVab

Model IVbc

F

P-value

F

P-value

F

P-value

8.255

0.001

14.157

0.001

12.539

0.001

714.843

0.001

830.435

0.001

785.552

0.001

Total interval group

5.17

0.001

9.276

0.001

0.91

0.435

Neat sperm concentration (million/mL)

9.575

0.002

14.389

0.001

11.192

0.001

Neat sperm progressive motility (%)

0.011

0.917

Processed sperm progressive motility (%)

6.26

0.012

11.364

0.001

19.477

0.001

Maternal age

12.571

0.001

16.607

0.001

15.006

0.001

Paternal age

0.09

0.764

11.587

0.001

10.481

0.001

16.726

0.001

11.866

0.001

Corrected Model
Intercept

Number of oocytes retrieved
Year of cycle
Total interval × procedure type

2.033

0.087

Note. Non-significant interaction between total interval and procedure type (Model IV) is shown.
a

Dependent variable: Fertilisation rate (%); N = 8,079. R2 = .013 (Adjusted R2 = .012). b Dependent variable: Fertilisation rate (%); N =
8,079. Variable excluded (non-significant): Neat sperm progressive motility (%) and paternal age. R2 = .012 (Adjusted R2 = .011). c
Dependent variable: Fertilisation rate (%); N = 8,079. Variable excluded (non-significant): Neat sperm progressive motility (%) and
paternal age. R2 = .042 (Adjusted R2 = .038).
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Table 5.14 Comparison of Fertilisation Rate (%) in Samples Where Insemination/Sperm
Injection was Performed < 90, Between 90 – 180, 180 – 360 and > 360 Minutes After
Sample Collection.

Total interval groups

Fertilisation rate (%)
Mean†

Std. Error

Mean‡

Std. Error

< 90 minutes (N = 516)

74.88 c,d

1.138

72.29

1.248

90 – 180 minutes (N = 1,275)

73.76 c,d

0.723

71.55

0.758

180 – 360 minutes (N = 5,395)

70.89 a,b

0.349

71.37

0.386

> 360 minutes (N = 893)

69.21 a,b

0.856

70.10

0.862

Note. Values are corrected means and standard errors from general linear Model IVa and
IVb (Table 5.13).
a

Significant compared to group I, P < 0.05. b Significant compared to group II, P < 0.05

c

Significant compared to group III, P < 0.05. d Significant compared to group IV, P <
0.05

†

Mean values are corrected for neat sperm concentration, neat and processed sperm
progressive motility (%), paternal age, maternal age and number of oocytes retrieved.

‡

Mean values are corrected for neat sperm concentration, neat and processed sperm
progressive motility (%), paternal age, maternal age, number of oocytes retrieved and
year of cycle.
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Effects of time intervals on hCG pregnancy rate
Regression model V, Va and Vb (Table 5.15) as well as model VI, VIa and VIb (Table
5.18) were constructed to determine the independent effect of time intervals on the prevalence
of hCG pregnancy. The associations between time interval groups and hCG pregnancy rate did
not differ with procedure type as tested by including interaction variables in the regression
models (Table 5.15 and Table 5.18).
Pre-wash intervals between 30 – 60 and > 60 minutes were significantly associated with
reduced probability of hCG pregnancy compared to pre-wash interval < 30 minutes. This
correlation remained after year of cycle was included in the logistic regression model (Table
5.16).
A lower probability of an hCG pregnancy was also found to be associated with post-wash
intervals between 60 – 120 and 120 – 240 minutes compared to < 60 minutes. This association,
however, diminished after adjusting for year of cycle. The probability of achieving hCG
pregnancy in patients with post-wash interval > 240 minutes was comparable to the reference
group (post-wash interval < 60 minutes) (Table 5.17).
Finally, a lower chance of hCG pregnancy was also observed when the total interval was
between 90 – 180 and 180 – 360 minutes compared to < 90 minutes. The latter remained
following adjustment for year of cycle. On the contrary, there was no significant difference
between total wash interval > 360 minutes and the reference group (total interval < 90 minutes)
(Table 5.19).
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Table 5.15 Logistic Regression Models Analysing the Independent Effect of Pre-Wash and Post-Wash Intervals on hCG Pregnancy Rate (%) in IVF and
ICSI Patients.
Model Va
Variables
Pre-wash < 30 minutes

B
Reference group

Model Vab

Model Vbb

P-value

B

P-value

B

P-value

0.122

Reference group

0.001

Reference group

0.002

Pre-wash 30 – 60 minutes

−0.283

0.11

−0.409

0.001

−0.214

0.003

Pre-wash > 60 minutes

−0.374

0.07

−0.320

0.001

−0.238

0.001

Reference group

0.074

Reference group

0.001

Reference group

0.135

Post-wash 60 – 120 minutes

−0.455

0.045

−0.414

0.001

−0.185

0.083

Post-wash 120 – 240 minutes

0.127

0.55

−0.223

0.028

−0.115

0.270

Post-wash < 240 minutes

0.053

0.781

−0.052

0.582

−0.021

0.826

Neat sperm concentration (million/mL)

0.001

0.113

0.001

0.037

0.001

0.051

Neat sperm progressive motility (%)

−0.002

0.083

−0.002

0.024

−0.003

0.005

Processed sperm progressive motility (%)

−0.002

0.146

Paternal age

−0.008

0.147

Maternal age

−0.046

0.001

−0.052

0.001

−0.054

0.001

Number of oocytes retrieved

0.053

0.001

0.054

0.001

0.057

0.001

0.034

0.001

Post-wash < 60 minutes

Pre-wash interval × procedure type

0.589

Post-wash interval × procedure type

0.208

Year of cycle
Note. Non-significant interaction between pre-wash and post-wash intervals and procedure type (Model V) is shown.
a

Dependent variable: hCG pregnancy (%); N = 6,037.

b

Dependent variable: hCG pregnancy (%); N = 6,037. Variable excluded (non-significant): Processed sperm progressive motility (%) and paternal age.
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Table 5.16 The Effect of Pre-Wash Interval on hCG Pregnancy Rate (%) in IVF and
ICSI Patients.

Pre-wash interval groups

hCG pregnancy rate (%)
OR†

95% CI†

OR‡

95% CI‡

< 30 minutes (N = 2,639)

Reference group

Reference group

30 – 60 minutes (N = 1,382)

0.664a 0.587 – 0.751

0.807b

0.701 – 0.929

> 60 minutes (N = 2,016)

0.726a 0.630 – 0.836

0.788a

0.682 – 0.910

Note Values are adjusted odds ratio (OR) and confidence interval (CI) calculated from
logistic regression model Va and Vb (Table 5.15).
a

P < 0.001. b P < 0.05.

†

Analyses are controlled for post-wash interval, neat sperm concentration, neat and
processed sperm progressive motility (%), paternal age, maternal age and number of
oocytes retrieved.

‡

Analyses are controlled for post-wash interval, neat sperm concentration, neat and
processed sperm progressive motility (%), paternal age, maternal age, number of
oocytes retrieved and year of cycle.
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Table 5.17 The Effect of Post-Wash Interval on hCG Pregnancy Rate (%) in IVF and
ICSI Patients.

Post-wash interval groups

hCG pregnancy rate (%)
OR†

< 60 minutes (N = 1,775)

95% CI†

Reference group

OR‡

95% CI‡

Reference group

60 – 120 minutes (N = 1,378)

0.661a

0.545 – 0.802

0.831

0.674 – 1.025

120 – 240 minutes (N =
2,293)

0.800b

0.655 – 0.977

0.892

0.728 – 1.093

> 240 minutes (N = 591)

0.949

0.788 – 1.143

0.979

0.812 – 1.181

Note. Values are adjusted odds ratio (OR) and confidence interval (CI) calculated from
logistic regression model Va and Vb (Table 5.15).
a

P < 0.001. b P < 0.05.

†

Analyses are controlled for pre-wash interval, neat sperm concentration, neat and
processed sperm progressive motility (%), paternal age, maternal age and number of
oocytes retrieved.

‡

Analyses are controlled for pre-wash interval, neat sperm concentration, neat and
processed sperm progressive motility (%), paternal age, maternal age, number of
oocytes retrieved and year of cycle.
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Table 5.18 Logistic Regression Models Analysing the Independent Effect of Total Interval on hCG Pregnancy Rate (%) in IVF and ICSI Patients.
Model VIa
Variables
Total interval < 90 minutes

B
Reference group

Model VIab

Model VIbb

P-value

B

P-value

B

P-value

0.020

Reference group

0.001

Reference group

0.002

Total interval 90 – 180 minutes

0.833

0.304

−0.269

0.04

0.121

0.391

Total interval 180 – 360 minutes

−0.622

0.011

−0.508

0.001

−0.267

0.018

Total interval > 360 minutes

0.095

0.497

−0.032

0.730

−0.036

0.699

Neat sperm concentration (million/mL)

0.001

0.078

0.001

0.046

0.001

0.123

Neat sperm progressive motility (%)

−0.001

0.276

Processed sperm progressive motility (%)

−0.003

0.055

−0.003

0.013

−0.002

0.073

Paternal age

−0.007

0.196

Maternal age

−0.044

0.001

−0.049

0.001

−0.053

0.001

Number of oocytes retrieved

0.052

0.001

0.053

0.001

0.059

0.001

0.042

0.001

Total interval × procedure type

0.291

Year of cycle
Note. Non-significant interaction between total interval and procedure type (Model VI) is shown.
a

Dependent variable: hCG pregnancy (%); N = 6,037.

b

Dependent variable: hCG pregnancy (%); N = 6,037. Variable excluded (non-significant): Neat sperm progressive motility (%) and paternal age.
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Table 5.19 The Effect of Total Interval on hCG Pregnancy Rate (%) in IVF and
ICSI Patients.
hCG pregnancy rate (%)
Total interval groups
< 90 minutes (N = 461)

OR†

95% CI†

Reference group

OR
‡

95%
CI‡

Reference group

90 – 180 minutes (N = 1,122)

0.764b

0.591 – 0.988

1.129 0.856 – 1.488

180 – 360 minutes (N = 3,885)

0.602a

0.487 – 0.743

0.766b 0.614 – 0.956

> 360 minutes (N = 569)

0.969

0.810 – 1.159

0.965 0.806 – 1.156

Note. Values are adjusted odds ratio (OR) and confidence interval (CI) calculated
from logistic regression model VIa and VIb (Table 5.18).
a

P < 0.001. b P < 0.05

†

Analyses are controlled for neat sperm concentration, neat and processed sperm
progressive motility (%), paternal age, maternal age and number of oocytes
retrieved.

‡

Analyses are controlled for neat sperm concentration, neat and processed sperm
progressive motility (%), paternal age, maternal age, number of oocytes retrieved
and year of cycle.
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Effects of time intervals on clinical pregnancy rate
Regression Models VII and VIII presented in Table 5.20 and Table 5.24, respectively,
showed that the interactions between pre-wash interval and procedure type and between total
interval and procedure type were not statistically significant, suggesting that the effects of prewash and total intervals on clinical pregnancy rate did not vary with the type of procedure.
Alternatively, the relationship between post-wash interval group and clinical pregnancy rate
varied with procedure type (Model VII; Table 5.20). Therefore, the independent effect of postwash interval on clinical pregnancy rate was analysed independently for the IVF and ICSI
groups (Table 5.21).
Increased pre-wash interval was associated with a lower probability of clinical
pregnancy. Pre-wash interval between 30 – 60 or > 60 minutes resulted in a lower chance of
successful clinical pregnancy compared to a pre-wash interval < 30 minutes. This association,
however, was no longer observed when year of cycle was considered (Table 5.22). On the
contrary, in both the IVF and ICSI groups, increased post-wash interval was not associated with
clinical pregnancy rate (Table 5.23).
Total interval between 180 – 360 minutes was shown to be correlated with a significantly
lower probability of clinical pregnancy than a total interval < 90 minutes. After inclusion of
year of cycle on the model, however, this inverse correlation diminished and total interval
between 90 – 180 minutes was shown to be associated with a higher chance of clinical
pregnancy than when it was less then 90 minutes (Table 5.25).
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Table 5.20 Initial Logistic Regression Models Analysing the Independent Effect of Pre-Wash and Post-Wash Intervals on Clinical Pregnancy (%).
Model VIIa
Variables

B

Pre-wash < 30 minutes
Reference group
Pre-wash 30 – 60 minutes
−0.576
Pre-wash > 60 minutes
−0.505
Post-wash < 60 minutes
Reference group
Post-wash 60 – 120 minutes
0.297
Post-wash 120 – 240 minutes
0.523
Post-wash < 240 minutes
0.670
Neat sperm concentration (million/mL)
0.001
Neat sperm progressive motility (%)
−0.003
Processed sperm progressive motility (%)
0.001
Paternal age
−0.013
Maternal age
−0.054
Number of oocytes retrieved
0.052
Pre-wash interval * procedure type
Post-wash interval * procedure type
Year of cycle

Model VIIab

Model VIIbb

P-value

B

P-value

B

P-value

0.006
0.003
0.025
0.009
0.241
0.027
0.001
0.175
0.031
0.995
0.043
0.001
0.001
0.215
0.004

Reference group
−0.269
−0.193
Reference group
−0.082
−0.050
0.147

0.001
0.001
0.014
0.007
0.451
0.657
0.162

Reference group
−0.043
−0.098
Reference group
0.181
0.077
0.183

0.477
0.578
0.224
0.206
0.127
0.506
0.083

−0.013
−0.053
0.054

0.036
0.001
0.001

−0.014
−0.055
0.058

0.022
0.001
0.001

0.040

0.001

Note. The interaction between pre-wash interval and procedure type was shown to be non-significant (Model VII). Hence, the independent effect of prewash interval on clinical pregnancy (%) was analysed in the IVF and ICSI groups simultaneously (Model VIIa and VIIb). The interaction between postwash interval and procedure type was significant (Model VII), and therefore, the independent effect of post-wash interval on clinical pregnancy (%) was
analysed independently for the IVF and ICSI groups (Table 5.21).
a

Dependent variable: Clinical pregnancy (%); N = 6,037. b Dependent variable: Clinical pregnancy (%); N = 6,037. Variable excluded (non-significant):

Neat sperm concentration and neat and processed progressive motility (%). Procedure type = IVF and ICSI.
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Table 5.21 Logistic Regression Models Analysing the Independent Effect of Post-Wash Intervals on Clinical Pregnancy Rate (%) in IVF (Model VIIc and
VIId) and ICSI (Model VIIe and VIIf) Patients.
Model VIIca
Variables

F

P-value

Reference group

0.001

Pre-wash 30 – 60 minutes

−0.376

Pre-wash > 60 minutes
Post-wash < 60 minutes

Model VIIda

Model VIIfb

P-value

F

P-value

F

P-value

Reference group

0.314

Reference group

0.400

Reference group

0.850

0.001

−0.063

0.530

−0.166

0.176

−0.074

0.569

−0.296

0.004

−0.158

0.132

−0.066

0.604

−0.026

0.838

Reference group

0.012

Reference group

0.339

Reference group

0.241

Reference group

0.467

Post-wash 60 – 120 minutes

−0.010

0.948

0.274

0.095

−0.149

0.466

−0.036

0.865

Post-wash 120 – 240 minutes

0.074

0.649

0.177

0.285

−0.216

0.196

−0.133

0.442

Post-wash < 240 minutes

0.265

0.092

0.241

0.127

0.031

0.832

0.073

0.619

Maternal age

−0.052

0.001

−0.056

0.001

−0.081

0.001

−0.082

0.001

Number of oocytes retrieved

0.044

0.001

0.048

0.001

0.071

0.001

0.074

0.001

0.051

0.001

0.022

0.048

Pre-wash < 30 minutes

Year of cycle
a

F

Model VIIeb

Dependent variable: Clinical pregnancy (%); N = 3,914. Variable excluded (non-significant): Neat sperm concentration and neat and processed progressive
motility (%) and paternal age. Procedure type = IVF.

b

Dependent variable: Clinical pregnancy (%); N = 2,123. Variable excluded (non-significant): Neat sperm concentration and neat and processed progressive
motility (%) and paternal age. Procedure type = ICSI.
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Table 5.22 The Effect of Pre-Wash Interval on Clinical Pregnancy Rate (%) in IVF and
ICSI Patients
Pre-wash interval groups

Clinical pregnancy rate (%)
OR†

95% CI†

OR‡

95% CI‡

30 – 60 minutes (N = 1,382)

0.764a

0.668 - 0.874

0.958

0.822 – 1.116

> 60 minutes (N = 2,016)

0.824b

0.706 - 0.962

0.907

0.774 – 1.062

< 30 minutes (N = 2,639)

Note. Values are adjusted odds ratio (OR) and confidence interval (CI) calculated from
logistic regression Model VIIa and VIIb (Table 5.20). a P < 0.001. b P < 0.05
†

Analyses are controlled for post-wash interval, neat sperm concentration, neat and
processed sperm progressive motility (%), paternal age, maternal age and number of
oocytes retrieved.

‡

Analyses are controlled for post-wash interval, neat sperm concentration, neat and
processed sperm progressive motility (%), paternal age, maternal age, number of
oocytes retrieved and year of cycle.
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Table 5.23 The Effect of Post-Wash Interval on Clinical Pregnancy Rate (%) in IVF and ICSI
Patients.

Post-wash intervals groups

IVF

< 60 minutes (N = 1,547)

OR†

95% CI†

Reference group

OR‡

95% CI‡

Reference group

60 – 120 minutes (N = 870)

0.99

0.73 – 1.342

1.315

0.953 – 1.814

120 – 240 minutes (N = 1,243)

1.077

0.782 – 1.484

1.193

0.863 – 1.561

> 240 minutes (N = 254)

1.303

0.958 – 1.773

1.273

0.934 – 1.734

< 60 minutes (N = 228)
ICSI

Clinical pregnancy rate (%)

Reference group

Reference group

60 – 120 minutes (N = 508)

0.862

0.578 – 1.285

0.965

0.637 – 1.461

120 – 240 minutes (N = 1,050)

0.805

0.580 – 1.118

0.876

0.624 – 1.229

> 240 (minutes N = 337)

1.031

0.777 – 1.369

1.076

0.807 – 1.434

Note. Values are adjusted odds ratio (OR) and confidence interval (CI) calculated from
logistic regression Model VIIc, VIId, VIIe and VIIf (Table 5.21).
†

Analyses are controlled for pre-wash interval, neat sperm concentration, neat and processed
sperm progressive motility (%), paternal age, maternal age and number of oocytes
retrieved.

‡

Analyses are controlled for pre-wash interval, neat sperm concentration, neat and processed
sperm progressive motility (%), paternal age, maternal age, number of oocytes retrieved
and year of cycle.
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Table 5.24 Logistic Regression Models Analysing the Independent Effect of Total Interval on Clinical Pregnancy Rate (%) in IVF and ICSI Patients.
Model VIIIa
Variables

Model VIIIbb

P-value

B

P-value

B

Reference group

0.019

Reference group

0.001

Reference group

0.001

Total interval 90 – 180 minutes

0.664

0.415

0.083

0.555

0.521

0.001

Total interval 180 – 360 minutes

−0.393

0.151

−0.279

0.018

−0.007

0.955

Total interval > 360 minutes

0.336

0.029

0.067

0.509

0.065

0.522

Neat sperm concentration (million/mL)

0.001

0.138

Neat sperm progressive motility (%)

−0.002

0.072

Processed sperm progressive motility (%)

−0.001

0.667

Paternal age

−0.012

0.058

Maternal age

−0.053

0.001

−0.061

0.001

−0.065

0.001

Number of oocytes retrieved

0.051

0.001

0.053

0.001

0.060

0.001

0.046

0.001

Total interval < 90 minutes

B

Model VIIIab

Total interval × procedure type

P-value

0.080

Year of cycle
Note. Non-significant interaction between total interval and procedure type (Model VIII) is shown.
a

Dependent variable: Clinical pregnancy (%); N = 6,037.

b

Dependent variable: Clinical pregnancy (%); N = 6,037. Variable excluded (non-significant): Neat sperm concentration, neat and processed sperm
progressive motility (%) and paternal age.
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Table 5.25 The Effect of Total Interval on Clinical Pregnancy Rate (%) in IVF and ICSI
Patients

Total interval groups
< 90 minutes (N = 461)

Clinical pregnancy rate (%)
OR†

95% CI†

Reference group

OR‡

95% CI‡

Reference group

90 – 180 minutes (N = 1,122)

1.086

0.826 – 1.428

1.683a

1.248 – 2.271

180 – 360 minutes (N = 3,885)

0.756a

0.600 – 0.953

0.993

0.778 – 1.267

> 360 minutes (N = 569)

1.069

0.877 – 1.303

1.067

0.874 – 1.302

Note. Values are adjusted odds ratio (OR) and confidence interval (CI) calculated from
logistic regression model VIIIa and VIIIb (Table 5.24).
a

P < 0.05

†

Analyses are controlled for neat sperm concentration, neat and processed sperm
progressive motility (%), paternal age, maternal age and number of oocytes retrieved.

‡

Analyses are controlled for neat sperm concentration, neat and processed sperm
progressive motility (%), paternal age, maternal age, number of oocytes retrieved and
year of cycle.
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Effects of time intervals on biochemical pregnancy rate
As presented in Table 5.26, the independent effects of pre-wash and post-wash intervals
on biochemical pregnancy rate varied with procedure type. Hence, logistic regression analyses
for IVF and ICSI were carried out separately (Table 5.27). A similar association, however, was
not observed in total interval as tested in Model X (Table 5.30).
No association was observed between increased pre-wash interval and biochemical
pregnancy rates both in the IVF and ICSI groups. The observed association did not change after
the inclusion of year of cycle (Table 5.28). In the IVF group, post-wash interval between 60 –
120, 120 – 240 and > 240 minutes were associated with a higher chance of biochemical
pregnancy compared to < 60 minutes. This effect remained after controlling for year of cycle.
No association was observed between post-wash interval and biochemical pregnancy rate in the
ICSI group (Table 5.29). In the whole cohort, total interval between 90 – 180 minutes was
associated with a higher chance of biochemical pregnancy compared to total interval < 90
minutes. After inclusion of year of cycle in the regression model, however, total interval
between 180 – 360 minutes, in addition to 90 – 180 minutes, resulted in a higher chance of
biochemical pregnancy (Table 5.31).
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Table 5.26 Logistic Regression Models Analysing the Independent Effect of
Pre-Wash and Post-Wash Intervals on Biochemical Pregnancy Rate (%) in
IVF and ICSI Patients.
Model IXa
Variables

B

P-value

Reference group

0.117

Pre-wash 30 – 60 minutes

−0.561

0.041

Pre-wash > 60 minutes

−0.330

0.303

Post-wash < 60 minutes

Reference group

0.001

Post-wash 60 – 120 minutes

1.210

0.001

Post-wash 120 – 240 minutes

0.747

0.017

Post-wash < 240 minutes

1.115

0.001

Neat sperm concentration (million/mL)

0.001

0.874

Neat sperm progressive motility (%)

−0.003

0.144

Processed sperm progressive motility (%)

0.004

0.144

Paternal age

−0.012

0.186

Maternal age

−0.043

0.001

Number of oocytes retrieved

0.029

0.001

Pre-wash < 30 minutes

Pre-wash interval × procedure type

0.047

Post-wash interval × procedure type

0.004

Note. Significant interaction between pre-wash and post-wash intervals and
procedure type is shown.
a

Dependent variable: Biochemical pregnancy (%); N = 2,645.
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Table 5.27 Regression Models Analysing the Independent Effect of Pre-Wash and Post-Wash Intervals on Biochemical Pregnancy Rate (%) in IVF (Model IXa
and IXb) and ICSI (Model IXc and IXd) Patients.
Model IXaa
Variables

Model IXba

P-value

B

P-value

Reference group

0.902

Reference group

0.366

Reference group

0.400

Reference group

0.394

Pre-wash 30 – 60 minutes

0.008

0.946

0.204

0.163

0.218

0.199

0.234

0.195

Pre-wash > 60 minutes

0.063

0.670

0.138

0.359

0.148

0.385

0.154

0.371

Post-wash < 60 minutes

Reference group

0.001

Reference group

0.001

Reference group

0.614

Reference group

0.649

Post-wash 60 – 120 minutes

0.943

0.001

1.080

0.001

−0.098

0.733

−0.077

0.799

Post-wash 120 – 240 minutes

0.647

0.001

0.667

0.001

−0.291

0.219

−0.274

0.265

Post-wash < 240 minutes

0.847

0.001

0.801

0.001

−0.219

0.290

−0.21

0.320

Maternal age

−0.040

0.001

−0.042

0.001

−0.072

0.001

−0.073

0.001

Number of oocytes retrieved

0.026

0.024

0.027

0.017

0.035

0.019

0.036

0.019

0.031

0.012

0.004

0.796

Year of cycle

B

P-value

Model IXdb

B

Pre-wash < 30 minutes

a

Model IXcb

B

P-value

Dependent variable: Biochemical pregnancy (%); N = 1,717. Variable excluded (non-significant): Neat sperm concentration, neat and processed sperm
progressive motility (%) and paternal age. Procedure type = IVF.

b

Dependent variable: Biochemical pregnancy (%); N = 928. Variable excluded (non-significant): Neat sperm concentration, neat and processed sperm progressive
motility (%) and paternal age. Procedure type = ICSI.
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Table 5.28 The Effect of Pre-Wash Interval on Biochemical Pregnancy Rate (%) in IVF
and ICSI Patients.

Pre-wash intervals groups

IVF

< 30 minutes (N = 806)

OR†

95% CI†

Reference group

OR‡

95% CI‡

Reference group

30 – 60 minutes (N = 353)

1.008

0.792 – 1.128

1.226

0.921 – 1.632

> 60 minutes (N = 558)

1.065

0.798 – 1.421

1.148

0.855 – 1.542

< 30 minutes (N = 258)
ICSI

Biochemical pregnancy rate (%)

Reference group

Reference group

30 – 60 minutes (N = 235)

1.244

0.891 – 1.595

2.945

1.981 – 4.378

> 60 minutes (N = 435)

1.160

0.830 – 1.621

1.949

1.306 – 2.908

Note. Values are adjusted odds ratio (OR) and confidence interval (CI) calculated from
logistic regression Model IXa, IXb, IXc and IXd (Table 5.27).
†

Analyses are controlled for post-wash interval, neat sperm concentration, neat and
processed sperm progressive motility (%), paternal age, maternal age and number of
oocytes retrieved.

‡

Analyses are controlled for post-wash interval, neat sperm concentration, neat and
processed sperm progressive motility (%), paternal age, maternal age, number of
oocytes retrieved and year of cycle.
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Table 5.29 The Effect of Post-Wash Interval on Biochemical Pregnancy Rate (%) in IVF
and ICSI Patients

Post-wash intervals
groups

IVF

< 60 minutes (N = 586)

OR†

95% CI†

Reference group

OR‡

95% CI‡

Reference group

60 – 120 minutes (N = 395)

2.567a

1.755 – 3.754

2.945a

1.981 – 4.378

120 – 240 minutes (N = 597)

1.911b

1.282 – 2.848

1.949b

1.306 – 2.908

> 240 minutes (N = 139)

2.334a

1.594 – 3.416

2.228a

1.519 – 3.269

< 60 minutes (N = 92)
ICSI

Biochemical pregnancy rate (%)

Reference group

Reference group

60 – 120 minutes (N = 208)

0.906

0.515 – 1.595

0.926

0.514 – 1.669

120 – 240 minutes (N = 486)

0.748

0.470 – 1.189

0.761

0.470 – 1.231

> 240 (minutes N = 142)

0.803

0.535 – 1.206

0.811

0.536 – 1.225

Note. Values are adjusted odds ratio (OR) and confidence interval (CI) calculated from
logistic regression Model IXa, IXb, IXc and IXd (Table 5.27).
a

P < 0.001. b P < 0.05.

†

Analyses are controlled for pre-wash interval, neat sperm concentration, neat and
processed sperm progressive motility (%), paternal age, maternal age and number of
oocytes retrieved.

‡

Analyses are controlled for pre-wash interval, neat sperm concentration, neat and
processed sperm progressive motility (%), paternal age, maternal age, number of
oocytes retrieved and year of cycle.
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Table 5.30 Regression Models Analysing the Independent Effect of Total Interval on Biochemical Pregnancy Rate (%) in IVF and ICSI Patients.
Model Xa
Variables

Model Xbb

P-value

B

P-value

B

Reference group

0.176

Reference group

0.004

Reference group

0.001

Total interval 90 – 180 minutes

−19.318

0.999

0.723

0.001

0.939

0.001

Total interval 180 – 360 minutes

0.240

0.552

0.275

0.096

0.395

0.021

Total interval > 360 minutes

0.473

0.026

0.134

0.320

0.125

0.355

Neat sperm concentration (million/mL)

0.000

0.840

Neat sperm progressive motility (%)

−0.003

0.145

Processed sperm progressive motility (%)

0.003

0.208

Paternal age

−0.012

0.184

Maternal age

−0.044

0.001

−0.051

0.001

−0.053

0.001

0.031

0.001
0.197

0.032

0.001

0.034

0.001

0.022

0.010

Total interval < 90 minutes

B

Model Xab

Number of oocytes retrieved
Total interval × procedure type
Year of cycle

P-value

Note. Non-significant interaction between total interval and procedure type (Model X) is shown.
a

Dependent variable: Biochemical pregnancy (%); N = 2,645.

b

Dependent variable: Biochemical pregnancy (%); N = 2,645. Variable excluded (non-significant): Neat sperm concentration, neat and processed sperm
progressive motility (%) and paternal age.
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Table 5.31 The Effect of Total Interval on Biochemical Pregnancy Rate (%) in IVF and ICSI
Patients.

Total interval groups
< 90 minutes (N = 185)

Biochemical pregnancy rate (%)
OR†

95% CI†

Reference group

OR‡

95% CI‡

Reference group

90 – 180 minutes (N = 404)

2.06b

1.355 – 3.132

2.557a

1.631 – 4.011

180 – 360 minutes (N = 1,786)

1.316

0.953 – 1.819

1.485b

1.061 – 2.078

> 360 minutes (N = 270)

1.144

0.878 – 1.491

1.133

0.869 – 1.477

Note. Values are adjusted odds ratio (OR) and confidence interval (CI) calculated from
logistic regression model Xa and Xb (Table 5.30).
a

P < 0.001. b P < 0.05

†

Analyses are controlled for neat sperm concentration, neat and processed sperm progressive
motility (%), paternal age, maternal age and number of oocytes retrieved.

‡

Analyses are controlled for neat sperm concentration, neat and processed sperm progressive
motility (%), paternal age, maternal age, number of oocytes retrieved and year of cycle.
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Effects of time intervals varies with year of cycle
As reported previously (see Section 5.4), the effects of time intervals (pre-wash, postwash and total intervals) varied with year of cycle. Inclusion of year of cycle as an ordinal
variable reduced or diminished the observed effects of time intervals on sperm motility,
fertilisation rate, hCG pregnancy rate and clinical pregnancy rate. On the contrary, controlling
for the year of cycle seemed to magnify the effect of time intervals on biochemical pregnancy
rate.
Further analyses on the confounding effects of year of cycle showed that there was an
increase in pre-wash interval, post-wash interval, total interval, neat sperm progressive motility,
paternal age and maternal age over the years. Conversely, a decline in neat sperm concentration,
processed sperm progressive motility and number of oocytes retrieved was also observed over
the years (Table 5.32). When pre-wash, post-wash and total intervals as categorical variables
were individually plotted against the year of cycle, the sample size in each group greatly varied
over the years. In general, groups with longer time intervals became more populated in the later
years. This shift was particularly true for post-wash and total intervals where post-wash interval
between 120 – 240 minutes and total interval between 180 – 360 minutes were predominantly
more populated compared to other groups (Figure 5.2).
Table 5.32 Correlations Between Year of Cycle and Independent Variables in IVF
and ICSI Patients.
Year of cycle
Pre-wash interval (minutes)

.452*

Post-wash interval (minutes)

.459*

Total interval (minutes)

.491*

Neat sperm concentration (million/mL)

−.042*

Neat sperm progressive motility (%)

.119*

Processed progressive motility (%)

−.263*

Number of oocytes retrieved

−.071*

Maternal age

.101*

Paternal age

.112*

Note. Values are Spearman’s rho with 8,079 cases included in the analyses.
* Correlation is significant at the 0.01 level (2-tailed).
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Figure 5.2 The Distribution of Sample Size Among Pre-Wash Interval Groups (a), Post-Wash
Interval Groups (b) and Total Interval Groups (c) Varied with Year of Cycle.
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Discussion
A prolonged interval between ejaculation and sperm preparation (pre-wash interval)
inevitably occurs in a busy andrology laboratory and therefore, the investigation of its effects is
clinically relevant. The WHO guidelines (WHO, 2010) have acknowledged the potential
detrimental effect of prolonged pre-wash interval and therefore recommends that seminal
plasma should be removed within 1 h of ejaculation prior to sperm function testing. In the case
where sample collection is performed at home the WHO guidelines also recommend that the
semen sample should be transported to the laboratory within 1 h of ejaculation and be kept from
extreme changes of temperature (ideally maintained between 20 oC and 37 oC). In testing this
concern, Licht et al. (2008) found no significant difference in semen parameters including
sperm concentration, motility and morphology between samples collected at home and at the
clinic when the time interval and temperature were kept consistent. In addition to pre-wash
interval, time delay between sperm preparation and insemination/sperm injection (post-wash
interval) as well as between ejaculation and insemination/sperm injection (total interval) often
happen in clinical practice. Yet, to date, the acceptable post-wash and total intervals have not
been discussed in the existing guidelines. Different time intervals during the process of ART
including pre-wash, post-wash and total intervals and their consequences on sperm motility and
clinical outcomes were evaluated in this study and will be discussed here. Further, rationales for
the observed findings will also be proposed.
In the current study, a shorter pre-wash interval resulted in a higher percentage of sperm
with progressive motility. This effect was consistently observed in processed samples of both
the IVF and ICSI groups, and in neat samples of the IVF but not ICSI groups. Irrespective of
the type of procedure, the current study also demonstrated that prolonged pre-wash interval had
an adverse effect on fertilisation, hCG pregnancy and clinical pregnancy rates. These findings
are in agreement with a previous retrospective study on IUI clinical pregnancy (Yavas & Selub,
2004). The same group also reported higher clinical pregnancy rates in human menopausal
gonadotropin – intrauterine insemination (hMG- IUI) cycles when the post-wash interval was ≤
30 or between 30 – 60 minutes compared to ≥ 60 minutes (Yavas & Selub, 2004). On the
contrary, the present study did not observe any effect of post-wash interval on clinical
pregnancy, which agrees with a study by Jansen et al. (2017) who observed similar IUI clinical
pregnancy rates in cases where IUI was performed immediately after sperm preparation or on
the next day. Whilst the effect of prolonged time intervals on fertilisation and hCG pregnancy
rates were not discussed by the above-mentioned research groups, the present study found that
post-wash interval < 60 or between 60 – 120 minutes resulted in a higher fertilisation rate
compared to 120 – 240 or > 240 minutes; and that post-wash intervals between 60 – 120 or 120
– 240 minutes were associated with a lower chance of successful hCG pregnancy compared to <
60 minutes. Similarly, total interval was also shown to be inversely correlated with fertilisation
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rate and a total interval of 90 – 180 and 180 – 360 minutes resulted in a lower chance of hCG
pregnancy compared to < 90 minutes. Similar effects of post-wash and total intervals on hCG
pregnancy may be explained by the fact that total interval was only moderately correlated with
pre-wash interval (r = 0.426, P = 0.001) and was strongly correlated with post-wash interval (r =
0.762, P = 0.001), indicating that the observed effect of total interval on clinical outcomes will
be more strongly influenced by the effect of post-wash interval.
Interestingly, the current study observed that patients with a post-wash interval between
60 – 120 minutes and between 120 – 240 minutes had a significantly lower chance of achieving
hCG pregnancy, whereas those with a post-interval > 240 minutes had a similar probability of
achieving hCG pregnancy to the reference group (post-wash interval < 60 minutes). In addition,
the present study reported that prolonged post-wash interval in IVF patients and prolonged total
interval in both IVF and ICSI patients were associated with a higher risk of biochemical
pregnancy (or miscarriage). Together, this might suggest that the population of sperm that
survived the extended incubation following sperm preparation (post-wash interval > 240
minutes) and resulted in a successful fertilisation and in an hCG pregnancy, might have an
increased likelihood of subsequent pregnancy failure as evidenced by biochemical pregnancy.
This observation is aligned with the theory that although oocytes have the ability to detect and
repair oxidative sperm DNA fragmentation, this mechanism is limited. Ineffective oocyte repair
mechanisms may still permit early stages of embryonic development with a possibility of
affecting the subsequent stages of embryonic development and the health of the offspring
(Gavriliouk & Aitken, 2015). In the present study, advanced maternal age was associated with
lower fertilisation rate and lower probability of positive hCG pregnancy and clinical pregnancy,
which may be indicative of the contribution of the oocyte repair mechanism. On the contrary,
advanced maternal age was also associated with a lower likelihood of biochemical pregnancy,
which suggests the possibility of other mechanisms involved that require further research.
Prolonged exposure of sperm to endogenous sources of ROS contained in the seminal
plasma can be one explanation of the observed effects associated with prolonged pre-wash
interval. It has been postulated that ROS-generating cells not only induce oxidative DNA
damage to themselves but also to the neighbouring cells (Koh et al., 2016). Extending this coincubation period will therefore amplify the pro-oxidative effect and its consequences including
the loss of sperm motility (Koh et al., 2016; Yavas & Selub, 2004). ROS-induced motility loss
may occur through a direct alkylation of axonemal proteins by electrophilic aldehydes (e.g.
4HNE) generated from lipid peroxidation (Aitken et al., 2016; Moazamian et al., 2015; Wagner
et al., 2018). In the present study, this may explain the motility loss observed in neat samples
after prolonged pre-wash interval as this pathway has previously been shown to be independent
of mitochondrial ROS production (Moazamian et al., 2015) and to cause a rapid immobilisation
(Aitken et al., 2016). In line with the findings of the current study, the Cairo Consensus
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Guidelines for ART practices recommended that sperm preparation is performed immediately
after semen sample collection and liquefaction. However, the rationale behind this
recommendation is not specified in the report (Cairo 2018 Consensus Group, 2020).
Alternatively, motility loss can also occur through a gradual depletion of intracellular
ATP as a result of a self-perpetuating oxidative stress cycle (Wagner et al., 2018). Unlike direct
protein alkylation, the consequences of this pathway can develop within a few hours (Aitken et
al., 2016; Wagner et al., 2018), which makes it a plausible explanation for impaired sperm
motility in processed samples. During the post-wash interval, processed samples are supposedly
free of ROS from endogenous sources including abnormal or immature sperm and leukocytes
(Bui et al., 2018; Gharagozloo & Aitken, 2011). However, sperm preparation also removes
antioxidants naturally present in the seminal plasma, which when coupled with limited sperm
intracellular antioxidant capacity, makes processed sperm more prone to oxidative stress
(Aitken et al., 2016; Balasuriya et al., 2012; Bromfield, 2014; Kedechi et al., 2017). Further, as
discussed in Chapter 4 of this thesis, sperm preparation may not completely eliminate ROS and
may even elicit ROS production (Agarwal et al., 1994; Agarwal et al., 2014; Aitken &
Clarkson, 1988; Aitken et al., 2014; Malvezzi et al., 2014). Increased levels of ROS (Calamera
et al., 2001), accompanied by sperm motility loss during in vitro incubation in the culture media
have been reported by other studies (Calamera et al., 2001; Hossain et al., 2008; Koyun et al.,
2014). Other groups have also previously reported a time-dependent increase in DNA
fragmentation after sperm preparation, which was thought to be mediated by ROS rather than
by nuclease activity (Cambi et al., 2013; Nabi et al., 2013). Conversely, supplementation with
antioxidants during post-wash in vitro incubation has been shown to improve sperm parameters
and to minimise oxidative DNA damage (Kedechi et al., 2017).
Sperm preparation also removes glucose and sucrose as sources of energy, as well as
decapacitation factors contained in the seminal plasma (Koyun et al., 2014). With regard to the
latter, in vivo capacitation naturally occurs promptly as sperm approach an oocyte ready for
fertilisation. This timely momentum is achieved by antagonistic actions of decapacitation
factors that coat and stabilise the sperm membrane and an in vivo environment that induces
capacitation. To mimic this process in vitro, decapacitation factors are removed through sperm
preparation and sperm are often incubated in media containing capacitating agents such as
albumin and bicarbonate (Leahy & Gadella, 2011). As part of the regular procedure in the clinic
at which this study was conducted, semen samples that were prepared for IVF were resuspended
in a fertilising medium and incubated in a CO2 incubator at 37oC until use; whereas those
prepared for ICSI were resuspended in a regular buffered medium. Consequently, prolonged in
vitro incubation may lead to premature and spontaneous capacitation and acrosome reaction,
which hinder the sperm from underdoing further subsequent structural changes (Koyun et al.,
2014; Mortimer, 2000; Yavas & Selub, 2004). Of relevance, the latest Cairo Consensus
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Guidelines (Cairo 2018 Consensus Group, 2020) suggested that in order to prevent premature
acrosome reaction, in cases where extended post-wash interval (> 2.5 h) is expected, the
processed sperm should be resuspended in a regular buffered medium, incubated at room
temperature and resuspended in fertilisation medium 120 minutes prior to IVF use. This
practice, however, will not be applicable for ICSI procedures as the need for sperm capacitation
is bypassed by a direct injection of sperm into the oocyte (Cairo 2018 Consensus Group, 2020).
The process of capacitation is also thought to be mediated by ROS production, which may
persist even after capacitation is completed and may overwhelm sperm antioxidative capacity,
leading to an oxidative stress state (Leahy & Gadella, 2011). In agreement, Mansour et al.
(2008) demonstrated that despite a time-dependent acrosome reaction, a higher fertilisation rate
was observed when the post-wash interval was 3 h as compared to 1 h and 5 h. The effect of
post-wash interval on sperm motility could not be analysed in this study because the processed
sperm motility was determined immediately after the sperm preparation according to the clinic
protocol. Nevertheless, post-wash interval adversely affected fertilisation and hCG pregnancy in
a similar way as it was observed with pre-wash interval. This, together with the findings of the
previous studies and the rationales elaborated above lead to the prediction that prolonged postwash interval would also reduce sperm motility in the processed samples.
Generally, sperm motility can be a good indication of overall sperm quality. In the ART
setting, however, sperm motility may not provide an accurate prediction of sperm fertilising
capacity and the clinical outcomes (Lewis et al., 2013). Within the context of this study, this
means that the observed adverse effect of prolonged time intervals on clinical outcomes was not
necessarily facilitated by sperm motility loss. In confirmation of this hypothesis, when pre-wash
interval was statistically regressed to clinical outcomes, both pre-wash interval and sperm
motility were shown to be significant predictors in the regression models, indicating that
motility loss may not be the only cause of suboptimal clinical outcomes associated with
prolonged pre-wash interval. Alternatively, the findings of Study 1 (see Chapter 3) indicate that
the levels of intracellular ROS and sperm apoptosis may influence different stages of clinical
outcomes. Hence, it is plausible that increased intracellular ROS levels and apoptosis induced
by prolonged time intervals had an adverse effect on the clinical outcomes in the present cohort
(Study 3). To confirm this proposed mechanism, a further prospective study involving a
measurement of sperm apoptosis and ROS levels across varying time intervals as well as the
analysis of various stages of clinical outcomes, including fertilisation, embryonic development
and pregnancy rates, is required.
The retrospective data used here allowed the analysis of not only a large cohort of
cycles, but also the effect of different time intervals during ART on a series of clinical outcomes
including semen parameters, fertilisation rate and pregnancy rates. This approach has added
strategic value to this study for several reasons: (1) prolonged pre-wash and post-wash intervals

150
commonly occur in the preparation for ART and is therefore a relevant concern in clinical
practice; (2) the independent effect of pre-wash and post-wash intervals on clinical outcomes
may involve different mechanisms; (3) the analysis of both sperm motility and clinical
outcomes have shown that prolonged time intervals, independent of sperm motility loss, may
affect clinical outcomes through other mechanisms, perhaps increased intracellular ROS
production. However, the present study may also be subject to several limitations. Despite the
exclusion of couples with POR symptoms and the inclusion of maternal age and number of
oocytes retrieved into the regression models, other confounding maternal factors might still be
present in the current study. The current study also found that the effects of time intervals on
sperm motility and clinical outcomes seemed to vary with the year in which the procedure was
performed. The year of cycle may influence the previously observed effect of prolonged time
intervals in two ways. Firstly, pre-wash, post-wash and total intervals increased over the years
as indicated by a moderate, positive linear correlation between time intervals and year of cycle.
This trend results in an uneven distribution of sample sizes among time interval groups, which
might, in turn, affect the validity of the statistical tests performed (Herrera & Gómez, 2007).
This effect was especially obvious in total interval groups, where in the latest seven years, total
interval was predominantly between 180 – 360 minutes and there was no case with a total
interval < 90 minutes. Secondly, the fact that time intervals are closely correlated with year of
cycle could also mean that the effect of time intervals on clinical outcomes might overlap with
the effect of year of cycle on clinical outcomes. In reference to the latter, we also reported
subtle, but significant, correlations between year of cycle and semen parameters which were
included in our models, indicating that these factors varied with year of cycle and are predictors
of clinical outcomes. The confounding effect of year of cycle on the dependent variables may
also include other factors that we could not possibly account for such as improved clinical
training and technology, changes in laboratory consumable items and clinical regime.
In conclusion, the current study has provided evidence that prolonged pre-wash, postwash and total intervals may have an adverse effect on sperm motility and clinical outcomes
including fertilisation rate and pregnancy outcomes. The findings of this study, alongside the
review of the existing literature, have also shown that the independent effect of pre-wash, postwash and total intervals may involve different mechanisms, which may include increased ROS
cellular production. Whilst the significance of the effect of the time intervals varied with
different procedure type and clinical endpoints, in general, shorter pre-wash, post-wash and total
intervals seem to favour better sperm motility and positive clinical outcomes. It is recommended
that the observed effects should be confirmed by a further controlled prospective study to
eliminate the impact of year of cycle in the analysis.
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Chapter 6: General discussion
Overview
This doctoral thesis examined different aspects of clinical practices that intend to alleviate
male infertility and to support desirable clinical outcomes. To deliver this main objective, three
independent studies were performed, each of which used a different approach to investigate the
relationship between oxidative stress, sperm physiological function and clinical outcomes.
Study 1 examined the effects of ROS levels and sperm apoptosis on sperm motility and clinical
outcomes in an IVF/ICSI prospective cohort. Study 2 was an experimental study designed to
compare the efficacy of three sperm preparation methods, namely density gradient
centrifugation (DGC), the swim-up method and SeaforiaTM, in reducing the levels of ROS and
sperm apoptosis while producing samples with high sperm concentration and motility. Using
retrospective analyses, Study 3 investigated the effect of prolonged time intervals during the
process of ART on sperm parameters and clinical outcomes. The methods and results of these
studies have been elaborated and discussed in detail in earlier chapters (see Chapter 3-5);
whereas the key findings of each individual study and their interpretation as an overall thesis are
presented in this chapter.
Together, the three studies aimed to contribute to the existing knowledge surrounding
male infertility and to address some of the relevant issues in clinical practice. The importance of
testing sperm fertilising capacity or oxidative stress level to complement a regular semen
analysis has been raised and widely accepted (Lopez et al., 2013; Pabuccu et al., 2017; Selvam
& Agarwal, 2017). Regardless, the existing studies have shown mixed results and the
implications of these tests are still very limited (Agarwal et al., 2016; Selvam & Agarwal, 2017;
Simon et al., 2017). Sperm preparation holds an essential role in ART clinical practice. In
accordance, substantial research has been performed to review the efficacy of conventional
sperm preparation methods such as DGC and the swim-up method. However, parallel to the
growing knowledge regarding the consequences of ROS, the potential of sperm preparation
methods to generate harmful effects becomes equally as important as its ability to produce
samples with high sperm count and motility. The innovation of alternative sperm preparation
methods such as SeaforiaTM may offer a solution to some of the limitations presented with the
conventional methods. Nevertheless, studies confirming the advantages of SeaforiaTM are
lacking. In addition to sperm preparation method, time arrangement between sample collection,
sperm preparation and insemination/sperm injection are other factors of concern that may
influence the quality of the processed sample, and consequently, ART outcomes. In an actual
clinical situation, the time intervals between sample collection and sperm preparation (pre-wash
interval); between sperm preparation and insemination/sperm injection (post-wash interval); and
between sample collection and insemination/sperm injection (total interval) can be highly
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variable depending on the daily workload in the laboratory and the desire to minimise
inconvenience to the couple in terms of time commitment. To date, guidelines and literature
regarding the consequences of prolonged incubation time on sperm quality and ART outcomes
are scarce and in need of further investigation.
To understand the role of oxidative stress in sperm physiological function and in overall
clinical outcomes, Study 1 and Study 2 employed a biochemical measurement of intracellular
ROS levels and sperm apoptosis. The rationale behind the use of these tests was based on the
roles of ROS production and apoptosis in sperm DNA damage. As discussed in the Literature
Review (see Chapter 1), the production of intracellular ROS and the induction of apoptosis
interact in a cyclic manner and collectively lead to sperm physiological dysfunction and
oxidative DNA damage (Aitken, Smith, et al., 2013; Moazamian et al., 2015), which is
considered the main type of DNA damage found in human sperm (Aitken, Bronson, et al.,
2013). In Study 1, the analyses of these biomarkers allowed for the confirmation of the role of
ROS levels and apoptosis in sperm motility and the clinical outcomes. The measurement of the
same biomarkers was also performed on semen samples before and after sperm preparation (i.e.
neat and processed samples, respectively) in Study 2. This analysis provided information about
the ability of different sperm preparation methods to eliminate apoptotic and/or ROS-generating
sperm or whether newly generated ROS and apoptosis were induced during the process. The
flow cytometric analysis of both biomarkers using the Muse® cell analyser, a benchtop flow
cytometer, grouped the sperm samples into different sperm populations: ROS+ and ROSpopulations for intracellular ROS levels; and AnnV-/7-AAD-, AnnV-/7-AAD+, AnnV+/7-AADand AnnV+/7-AAD+ for sperm apoptosis. As key variables, the interpretation of these
biomarkers in conjunction with other parameters such as sperm concentration and motility was
particularly important because as discussed in Chapter 3 and Chapter 4, the detection and
interpretation of ROS levels and apoptosis in sperm may be subject to some limitations. A
comprehensive interpretation of the overall findings is elaborated in the following sections of
this chapter.

The induction of sperm apoptosis and ROS through sperm preparation in ART
To understand the role of sperm preparation in lowering or inducing sperm intracellular
ROS and apoptosis, the levels of both markers before and after sperm preparation with varying
procedure type and sperm preparation methods were analysed. Intracellular ROS that was
detected in both neat and processed samples may have originated from either endogenous or
exogenous sources. Regardless, when either or both sources collectively produce enough ROS
to exhaust the seminal antioxidant capacity, oxidative stress will be induced, leading to sperm
apoptosis and DNA damage (Gupta et al., 2010). In the case of neat samples, ROS can originate
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from germ and non-germ cells of the ejaculate, with the most prominent cells being leukocytes
and immature sperm (Sabeti et al., 2016). Pre-existing conditions such as genitourinary
infections, varicocele and psychological stress, longer ejaculatory abstinence as well as lifestyle
factors including diet, cigarette smoking, alcohol and recreational drug use may also lead to
elevated levels of ROS in the seminal fluid (Bui et al., 2018; Marshburn et al., 2014). In the
present study, the presence of ROS+ sperm in the neat samples was also accompanied by a
detectable population of apoptotic (Annexin V+) sperm. According to the abortive apoptosis
theory, the presence of these markers in the ejaculated sperm is as a result of incomplete sperm
elimination through either extrinsic or intrinsic apoptosis pathways during spermiogenesis and
is negatively correlated with sperm concentration (Bejarno et al., 2012; Taylor et al., 2004). In
agreement with this, the current findings also demonstrated that these apoptosis markers were
negatively correlated with sperm concentration and motility; but were positively correlated with
paternal age. With regard to the latter, although the exact mechanisms are still unknown,
suboptimal semen parameters and sperm DNA damage have been linked to advancing paternal
age (Koh et al., 2016; Sharma, Agarwal, et al., 2015).
The significant reduction of apoptotic sperm numbers in the processed samples
following the removal of dead or immature sperm and other non-germ cells through sperm
preparation, confirmed that sperm expressing apoptosis markers also exhibit dysfunctional
motility and altered morphological density, and therefore were eliminated by sperm preparation
such as DGC and swim-up. Whilst sperm preparation successfully lowered sperm apoptosis
levels regardless of the sperm preparation methods (i.e. DGC, swim-up and SeaforiaTM) and
procedure type (i.e. IVF and ICSI), the removal of ROS-generating sperm was only successful
in IVF patients or when swim-up or SeaforiaTM was used. In these cases, it appeared that the
intracellular ROS that was detected in the neat samples had indeed originated from dead or
immature sperm and other non-germ cells. When the method of sperm preparation is
considered, logical interpretations of these findings might indicate that (1) sperm motility loss,
in comparison to defective morphological density, is a more representative manifestation of
sperm ROS and that (2) the swim-up method and SeaforiaTM induce a much lower ROS
compared to DGC. To support the first proposition, the levels of ROS in the processed samples
were shown to be negatively correlated with sperm total motility and progressive motility. With
regard to the second proposition, a low level of ROS remained detectable in the processed
samples following swim-up and SeaforiaTM despite the significant reduction, indicating a
possible mild ROS generation during the process. In an attempt to pinpoint the potential feature
of sperm preparation that may induce sperm ROS, some adjustments were made to the regular
clinic protocol and the protocol recommended by the WHO. Firstly, 2 mL instead of 1.2 mL (as
recommended by the WHO) of culture medium was used in the swim-up method to minimise
seminal plasma contamination, which could have contributed to ROS production during the
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process (Bjorndahl et al., 2005). Secondly, during the process of swim-up, the samples were
incubated for 30 minutes, instead of 60 minutes (as recommended by the WHO), to equate with
the incubation period of SeaforiaTM. Lastly, the final washing step at the end of the swim-up
method recommended by the WHO and the clinic protocol was excluded to preclude the
potential effects of centrifugation. Despite these adjustments, ROS production may still be
induced during sperm preparation with swim-up or SeaforiaTM through a proximate contact of
sperm with ROS-generating cells during their movement towards the culture medium (Aitken &
Clarkson, 1988; Takeshima et al., 2017) and/or from prolonged co-incubation with the seminal
plasma content during the incubation period (Li et al., 2012; Muratori et al., 2003).
With the adjustments made to the protocols for swim-up and SeaforiaTM, it becomes
apparent that the main differences that set DGC apart from the other two methods are
centrifugation and the use of a gradient medium. This, therefore, presents the possibility that the
increased ROS in the DGC-processed samples observed in the present study was a consequence
of either or both of these factors. This prediction was also made based on the existing literature
that has documented the production of ROS associated with centrifugation (Agarwal et al.,
1994; Ghaleno, Valojerdi, Janzamin, et al., 2014; Mahfouz et al., 2010; Mortimer, 2000) and
transition metal contamination in the gradient media (Aitken et al., 2014; Dobrakowski et al.,
2017; Dutta et al., 2019). Interestingly, similar levels of ROS before and after sperm preparation
were observed in the ICSI group as opposed to the IVF group. This comparison, however,
should be interpreted carefully with the consideration that ICSI patients have a significantly
lower sperm count in the ejaculate compared to the IVF patients, and that the semen samples for
ICSI are prepared to a much lower concentration for sperm injection than those for IVF (1
million/mL vs 5-15 million/mL). This could mean that the levels of ROS in the ICSI group do
not necessarily increase after sperm preparation. In addition, as discussed in Study 2, the
adverse effect of DGC on sperm ROS levels may vary according to the initial sperm quality
(Muratori et al., 2016; Zini et al., 2000). As observed in our findings, ICSI patients had
significantly lower sperm total motility and progressive motility compared to IVF patients
which may support the view that ICSI patients are more likely to have poorer semen quality
when compared to IVF patients (Alshahrani et al., 2017; Tournaye, 2012). This difference in
semen sample quality may explain the uneven effect of sperm preparation on sperm ROS levels
between IVF and ICSI groups. Another noticeable pattern was observed where unlike the neat
samples, the levels of ROS in the processed samples was positively and statistically
significantly correlated with paternal age. This observation suggests that the effect of ROS
induction during the sperm preparation process, as demonstrated in Study 2, may vary
depending on the paternal age. Of relevance, a previous study showed a significantly lower
number of viable sperm after DGC and a significantly higher proportion of sperm with
oxidative DNA damage in men aged ≥ 40 compared to younger men aged < 40, with no
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significant differences in other oxidative stress markers such as ROS production, lipid
peroxidation, and total antioxidant capacity level. The authors proposed that the sperm of older
men may be more susceptible to oxidative damage as a consequence of defective chromatin
remodelling during spermiogenesis or ineffective DNA repair mechanisms associated with
ageing (Koh et al., 2016).
As an extension of the study on sperm preparation method (Study 2), the potential
effects of prolonged time intervals during the process of ART on sperm motility and clinical
outcomes were investigated in Study 3. This study demonstrated that prolonged time intervals
were associated with poorer sperm motility and pregnancy outcomes. Although oxidative stress
marker measurement was not performed in this particular study, the findings of Study 1 and
Study 2 suggest that these observed effects may be facilitated by oxidative stress. During the
incubation period between ejaculation time and the beginning of sperm preparation (pre-wash
interval), healthy sperm are continuously exposed to the sources of ROS that are present in the
neat samples (as above). Thus, during a prolonged pre-wash interval, the sperm endure a longer
exposure to ROS, leading to depletion of antioxidant reserves. A similar concern also applies to
the extended in vitro incubation between the end of sperm preparation and the use of sperm for
IVF or ICSI (post-wash interval). Sperm preparation does not completely eliminate sperm with
oxidative stress markers from the neat samples and may even induce intracellular ROS
production. This may also be aggravated by the removal of antioxidants contained in the
seminal fluid, diminishing the protective capacity against oxidative attack (Gupta et al., 2010).
Supporting the findings of this thesis, an increase in ROS levels and DNA fragmentation after
sperm preparation has previously been reported elsewhere (Calamera et al., 2001; Muratori et
al., 2003; Nabi et al., 2013).

The effects of sperm apoptosis and ROS on sperm motility
Sperm motility, among other semen parameters, has been traditionally viewed as an
indicator of male fertility, and thus, the determination of abnormal sperm motility relative to
established reference values is often used to diagnose male infertility and to predict clinical
outcomes (Alshahrani et al., 2017). In a natural conception, sperm motility is a prerequisite for
successful fertilisation and therefore, predicts the likelihood of a pregnancy. In the context of
ART, however, this concept might not be relevant as the introduction of the sperm to the oocyte
is largely assisted, especially in the case of IVF and ICSI (Lewis et al., 2013). Regardless, the
observation of sperm motility in conjunction with other advanced parameters such as ROS
levels, apoptosis and DNA fragmentation markers can be used to help our understanding of the
mechanisms involved.
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Although the study of the mechanisms by which sperm ROS production or apoptosis
induces sperm motility loss is beyond the scope of this thesis, it has become apparent that such
correlation consistently occurred in Studies 1-3. The role of ROS in maintaining normal sperm
physiological function and in acquiring its fertilising capacity is well accepted. The oxidising
property of ROS enables the attainment of a capacitated and hyperactivated state, as well as
facilitates the acrosome reaction in which acrosomal enzymes are released from the tip of the
sperm head following its exposure to the extracellular layer of the oocyte (Du Plessis et al.,
2015; Moazamian et al., 2015). When excessive production of ROS overwhelms the natural
anti-oxidative capacity, however, the reaction can extend beyond capacitation and initiate lipid
peroxidation, leading to membrane dysfunction, apoptosis and eventually DNA damage (Leahy
& Gadella, 2011). Despite the fact that some sperm preparation methods can effectively reduce
the proportion of apoptotic and ROS-generating cells, sperm preparation also removes the
natural antioxidants contained in the seminal plasma, leaving the processed sperm more
vulnerable to oxidative attack (Gupta et al., 2010). As previously discussed (see Section 4.5),
ROS may also be generated during the process of sperm preparation, which increases the
likelihood of oxidative stress occurring in the processed samples. Together, this may therefore
provide an explanation for the negative correlation between ROS levels and sperm motility in
the processed samples that was not observed in the neat samples.
In addition to the elimination of apoptotic sperm and ROS-generating cells, sperm
preparation primarily aims to isolate mature sperm with optimal fertilising capacity, which is
typically characterised by their progressive motility. The findings of Study 2 showed that some
sperm preparation methods are superior to others in isolating motile sperm. Both the swim-up
method and SeaforiaTM rely on the active movement of the sperm towards an upper layer of
medium. Hence, it was expected that the two methods would produce samples with good sperm
motility. Alternatively, DGC employs different concentrations of colloidal suspension and
centrifugal force to separate sperm with different morphological density (Malvezzi et al., 2014;
Takeshima et al., 2017) and is well-known for its ability to aid sperm preparation of samples
with low sperm concentration and abnormal viscosity (Henkel & Schill, 2003; WHO, 2010).
Among these three methods, DGC also produces samples with the highest level of ROS, which
makes it plausible to hypothesise that DGC-induced ROS contributes to low sperm motility in
DGC-processed samples. ROS induction through sperm preparation may also facilitate a
decline in sperm motility observed in both the neat and processed samples after a prolonged
pre-wash interval. Although a direct measurement of the oxidative stress markers could not be
performed in the retrospective data of Study 3 to confirm this, increased ROS levels and sperm
DNA damage with prolonged incubation before and after sperm preparation has previously been
reported in other studies (Calamera et al., 2001; Muratori et al., 2003; Nabi et al., 2013).
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The effect of sperm apoptosis and ROS on clinical outcomes
Although the three studies performed here have provided evidence that high levels of
ROS and apoptosis are associated with sperm motility loss, both ROS and apoptosis seem to
have minimal effect on clinical outcomes including fertilisation rate, embryo quality and
pregnancy outcomes. In Study 3 it was observed that a lower fertilisation rate is associated with
longer pre-wash, post-wash and total intervals, which was proposed to be mediated by the
induction of ROS and apoptosis. With respect to pregnancy outcomes, the findings showed that
longer pre-wash and total intervals result in a lower chance of hCG and clinical pregnancy and
that prolonged post- and total intervals are associated with a higher chance of biochemical
pregnancy (or miscarriage). When tested in a separate study (Study 1), however, fertilisation
rate did not correlate with either ROS levels or apoptosis. To investigate the independent effect
of sperm ROS and apoptosis on embryo quality, the proportion of fertilised oocytes that form a
blastocyst on day 5 was calculated as blastulation rate; and the quality of D5EQ were analysed.
It was reported that processed ROS is negatively correlated with blastulation rate, but neither
apoptotic nor ROS marker was correlated with the mean D5EQ. Further, when the patients were
stratified based on pregnancy outcomes, a higher proportion of AnnV+/7-AAD+ sperm was
observed in patients who had a biochemical pregnancy compared to those who did not achieve
pregnancy. No significant difference was found between the biochemical pregnancy group and
the clinical pregnancy group as well as between the no pregnancy group and the clinical
pregnancy group. Whilst elevated ROS generation during in vitro incubation is one of the main
proposed mechanisms that could affect clinical outcomes, this thesis found that sperm ROS or
apoptosis appears to affect sperm motility but has a minimal effect on pregnancy outcomes.
The idea of investigating the diagnostic and prognostic value of apoptosis and ROS
levels derives from the proposed theories of the aetiology of sperm DNA damage and its
consequences. Aitken, Smith, et al. (2013) suggest that sperm DNA damage can be directly
induced through two possible pathways: enzymatic cleavage by nucleases and by oxidative
attack. The second mechanism predominantly causes DNA damage in sperm because unlike
somatic cells, the sperm midpiece, where nucleases are stored and released, is physically
separated from the sperm head where the DNA resides. This physical barrier keeps the
nucleases isolated in the midpiece whilst allowing mitochondrial ROS to penetrate the sperm
head. Elevated generation of mitochondrial ROS is one of the early signs of intrinsic apoptosis,
which through a cyclic production of free radicals and lipid peroxidation brings about the other
features of apoptosis such as PS externalisation, motility loss and oxidative DNA damage
(Aitken, Bronson, et al., 2013). The extension of this current understanding has led to the belief
that sperm DNA damage contributes to male infertility and suboptimal ART outcomes. In the
context of ART, the notion that sperm DNA damage affects clinical outcomes has been
confirmed by some studies (Bareh et al., 2016; Simon et al., 2017; Zhao et al., 2014) but it is

159
not supported by others (Esbert et al., 2011; Sheikhi et al., 2013). Compiling the findings of this
thesis, Study 3 shows a tendency for prolonged time intervals to negatively affect clinical
outcomes through mechanisms that may include increased generation of ROS and induced
sperm apoptosis; however, this interpretation does not appear to be confirmed by the findings of
Study 1, which found no direct correlation between sperm ROS or apoptosis and the clinical
outcomes. To address the discrepancy between Study 1 and Study 3, the absence of statistical
significance in Study 1 might be due to the limitations caused by insufficient sample sizes (total
of 170 cycles). In comparison, Study 3 involved a significantly larger sample size (a total of
8,079 cycles), which might have allowed for the observation of subtle but significant effects in
the analyses.
Although it appears that clinical outcomes are independent of sperm ROS levels or
apoptosis, recurrent findings of this thesis show the harmful effect of ROS and apoptosis on
sperm motility. Similar findings were previously reported by Sun et al. (2018), where the sperm
DNA fragmentation index was negatively correlated with sperm motility, but it was not
correlated with fertilisation, embryo quality or pregnancy rate of IVF and ICSI patients. This
thesis proposes several rationales that may explain the observed inconsistent effects of the two
markers on sperm motility and clinical outcomes.
Firstly, the lack of significant correlation with the clinical outcomes may be a result of
oocyte repair mechanisms (Esbert et al., 2011; Stimpfel et al., 2018). Sperm’s repair
mechanisms are limited to their maturation process prior to their transit in the epididymis and
ejaculation and thus, depending on the type and severity of the DNA damage, sperm DNArepair relies on the repair capacity of the oocytes that takes place after fertilisation (Esbert et al.,
2018). Maternal age is thought to predominantly affect the gene expression pattern essential for
oocyte regulation and thus, is one of the most prominent determinants of oocyte quality and
repair capacity (Liang et al., 2019). Recent studies by Stimpfel et al. (2018) and Liang et al.
(2019) found that improvements in clinical outcomes associated with a lower sperm apoptosis
and DNA fragmentation index were only observed when the maternal age was above 30 years
old, implying a more substantial role of the maternal factors. Whilst stratified analyses could not
be performed in the present studies, it was observed that when the maternal age and number of
oocytes retrieved from the IVF and ICSI patients were comparable, fertilisation rate, mean
D5EQ, good embryo rate and blastulation rate were similar (Study 1). In comparison,
fertilisation rate was shown to be significantly higher in the IVF compared to the ICSI patients
when the female partner was younger, and the number of oocytes retrieved was higher in the
IVF than the ICSI patients (Study 3). To control for these confounding female factors on the
overall clinical outcomes, maternal age as well as number of oocytes retrieved were set as
inclusion criteria and were included in the regression models in this thesis. This was also
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aligned with the effort to exclude the patients with POR according to the Bologna criteria
(Ferraretti et al., 2011).
Secondly, the effect of sperm apoptosis or ROS on the clinical outcomes can be further
masked by the careful selection for morphologically normal and motile sperm for both IVF and
ICSI (Sun et al., 2018). Particularly in ICSI, the selection of a single sperm with normal
apparent morphology is expected to result in the injection of sperm with good DNA quality
(Osman et al., 2015). This notion is confirmed by some studies that show that the effect of
sperm DNA fragmentation (Li et al., 2006; Liang et al., 2019; Osman et al., 2015) or apoptosis
(Talarczyk-Desole et al., 2016) is only observed in IVF but not in ICSI patients, indicating the
potential benefit of ICSI for men with high sperm DNA fragmentation or apoptosis. Similarly,
this present study found that a longer post-wash interval is a significant predictor of biochemical
pregnancy in the IVF but not ICSI group. Further, following fertilisation, only the best-quality
embryos are normally selected for implantation, which may also override the effect of sperm
DNA quality on the pregnancy outcomes (Sun et al., 2018). This possibility may provide an
explanation for the lack of correlation between ROS and hCG and clinical pregnancies
regardless of the negative correlation between ROS and blastulation rate. Lastly, it has been
postulated that the paternal genome contributes heavily to the latter stages of conception
including cleavage and blastocyst stages (Li et al., 2006; Seli et al., 2004; Zorn et al., 2003).
This makes it possible for impaired embryonic development to occur once the paternal genome
is activated despite prior successful fertilisation and therefore, is thought to underlie
unexplained recurrent pregnancy loss (Bareh et al., 2016). Of relevance, this thesis demonstrates
that ROS is negatively correlated with blastulation rate even though there was no correlation
with fertilisation rate; and that a higher proportion of AnnV+/7-AAD+ was found in patients with
biochemical pregnancy (or miscarriage) compared to those with no pregnancy. Also presented
here, longer post-wash and total intervals were associated with increased risk of biochemical
pregnancy (or miscarriage).

Clinical implications and recommendations
The findings of this thesis suggest that high levels of ROS and sperm apoptosis have a
negative impact on sperm motility. Although the observations of these adverse effects were both
repeatable and convincing, the effect of both biomarkers on the clinical outcomes including
fertilisation rate, embryo quality and pregnancy outcomes appeared to be minimal. The
interpretation of these findings might suggest that the levels of ROS and sperm apoptosis can be
useful diagnostic tools to predict the possible cause of unexplained or idiopathic male infertility;
but the measurement of these biomarkers does not seem to provide an accurate prediction of
ART clinical outcomes. The measurement of both intracellular ROS levels and sperm apoptosis
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in the present studies were performed using the Muse® cell analyser, a benchtop flow cytometer.
This method has proven to be quicker, more reproducible and require less specialised skill to
operate in comparison to other methods that employ advanced microscopy and flow cytometry
such as sperm DNA measurement using the TUNEL assay, SCSA, SCD, and the Comet assay.
Considering the practical advantages reported in this thesis, a benchtop flow cytometer such as
the Muse® cell analyser could be a valuable addition in an andrology laboratory. Accordingly,
future studies should aim to confirm the effect of ROS levels and apoptosis on sperm motility
and clinical outcomes in comparison to other commonly used assays such as TUNEL, SCSA,
SCD and Comet.
In agreement with many previous studies, the findings of this current research confirm the
harmful effects of high levels of ROS and apoptosis on sperm physiological functions, and
therefore the proportion of sperm expressing these biomarkers should be minimalised for best
possible clinical outcomes. In preparation for ART, different sperm preparation methods are
preferentially used to process semen samples with variable characteristics such as viscosity,
volume, sperm count and motility. A comparison between DGC, swim-up and SeaforiaTM in the
present study showed that all three methods were equally effective in eliminating apoptotic
sperm from the neat samples. However, the swim-up method and SeaforiaTM were better at
reducing ROS levels compared to DGC. The total yield, accounting for both sperm
concentration and progressive motility, of DGC and swim-up was comparable. In comparison,
SeaforiaTM had a better total yield than the other two methods as it produced samples with a
sperm concentration that was higher than the swim-up method and sperm motility that was
higher than DGC. In terms of the time and cost of performing these sperm preparation methods,
swim-up was shown to be the most cost-effective method, followed by DGC then SeaforiaTM;
and DGC requires the least time (25 minutes) compared to sperm preparation using the swim-up
method and SeaforiaTM (both 35 minutes). Apart from its efficacy, SeaforiaTM offers another
advantage as it does not require centrifugation and can be operated with a portable incubator
that comes with the kit. This may therefore benefit laboratories that have limited access to those
facilities.
Finally, in another attempt to optimise the clinical outcomes, the potential harmful effect
of prolonged time intervals that take place during the process of ART were reviewed. The
findings suggested that prolonged pre-wash interval had a negative effect on sperm motility.
Interestingly, this effect continued to be observed after sperm preparation and might be
mediated by prolonged exposure of sperm to ROS. Prolonged incubation in general also seemed
to affect clinical outcomes. Although the observed effect appeared to vary with procedure type
and the year in which treatment was undertaken (year of cycle), minimising pre-wash, postwash and total intervals may be beneficial in achieving optimal clinical outcomes. It is
important to note that the large sample size in the present study allowed for the detection of a
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subtle, yet significant, effect of prolonged intervals on clinical outcomes. This suggests that
whilst prolonged intervals during sperm preparation for ART may not be the major cause of
suboptimal clinical outcomes, the cumulative effect of prolonged intervals along with other
determining factors such as the choice of sperm preparation methods or culture media, can bring
about an important difference in the clinical outcomes. In clinical practice, shorter time intervals
can be achieved by arranging the arrival of male patients closer to the time of insemination/
sperm injection and by performing sperm preparation immediately after sample collection and
liquefaction. In anticipation of an extended post-wash interval, the benefits of antioxidant
supplementation in the culture media should be further investigated.
In conclusion, the three independent studies that collectively make up this doctoral
research aimed to explore the relationship between sperm apoptosis, ROS and ART outcomes,
as well as the potential role of sperm preparation methods and prolonged time intervals during
ART in achieving desirable clinical outcomes. Although the present study showed minimal and
inconsistent adverse effects of sperm apoptosis and ROS on clinical outcomes, reoccurring
findings of the current study demonstrated that both biomarkers were associated with poorer
sperm parameters. Further, a comparison between three different sperm preparation methods has
shown that whilst all three methods were effective in eliminating apoptotic sperm, DGC
resulted in samples with higher levels of ROS compared to swim-up and SeaforiaTM. In
addition, SeaforiaTM was shown to produce a higher total yield, indicating its potential as an
alternative to the traditional sperm preparation methods. Finally, a retrospective analysis of
different time intervals during ART demonstrated that shorter pre-wash, post-wash and total
intervals seem to favour better sperm motility and positive clinical outcomes. In correlation with
the other key findings of the current study, this effect may involve increased ROS cellular
production during prolonged incubation. Collectively, the key findings of this thesis are
indicative of the central role of ROS levels in normal sperm physiological functions and suggest
that minimising intracellular ROS production through sperm preparation techniques and time
optimisation may be beneficial to improving ART outcomes.
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Appendix A – Patient information sheet and participation consent form

Research Project Information sheet
Study of the role of apoptosis and sperm DNA damage in male infertility
Concept Fertility Centre and researchers in the School of Anatomy, Physiology & Human Biology at The
University of Western Australia (UWA) and School of Medical and Health Sciences, Edith Cowan
University (ECU) would like to use some of your surplus sperm for a research project. Usually only a
portion of your sperm is used for semen analysis or assisted reproductive technology (ART) procedures
such as in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI) and intrauterine insemination
(IUI) and the remainder is discarded. We would like to use this surplus sperm to investigate types of
sperm DNA damage and how these relate to male fertility. The data collected for this study will form
the basis of an Honours thesis for a Bachelor of Science student at UWA and a Master’s thesis for a
Master of Science student at ECU.
A basic semen analysis usually involves examining sperm count, sperm morphology and sperm motility.
Although these can indicate where a fertility problem may lie, normal results do not always guarantee
successful fertilisation and pregnancy outcomes. One reason for this is that some normal appearing
semen samples have a high proportion of sperm with damaged DNA, but this is not detected by a basic
semen analysis.
There are several types of DNA damage, arising from different processes. Most studies of sperm DNA
damage only assess one type and so little is known about the importance of the different types for
fertility and treatment. In this study we will measure DNA damage in sperm resulting from processes
called apoptosis and oxidative stress (explained below). We will look for associations among types of
damage and sperm count, morphology, motility and ART treatment outcomes (e.g. fertilization,
pregnancy).
Apoptosis is a process which normally removes cells that are damaged or stressed. Usually cells cannot
function after they have undergone apoptosis, but apoptosis in mature sperm cells is incomplete and
they may fertilise an egg even if their DNA is damaged. Oxidative stress is a condition whereby byproducts of sperm cells’ metabolism build up within the cell and lead to damage of the DNA and sperm
cell membrane. We will compare levels of sperm apoptosis and oxidative DNA damage to sperm count,
morphology and motility and ART treatment outcomes.
Sperm preparation is used in ART to optimize the number of motile sperm available for treatment. We
will compare levels of sperm apoptosis and oxidative DNA damage in samples before and after sperm
preparation. This will provide information as to whether sperm preparation techniques act to reduce
levels of different types of sperm DNA damage.
In order to account for factors that might influence the interpretation of these results, we would also
like to use the information you provide in your sample collection questionnaire (e.g. days of abstinence,
smoking status). All information that you provide will be coded and treated as strictly confidential.
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Please note the following:
♦ We will only use semen surplus to your semen analysis or preparation for ART.
♦ Your sample, questionnaire responses, and treatment outcome information will be coded prior
to use in this project and we will discard the sample immediately following use, following
standard protocols. All data will be stored securely and only available to researchers associated
with the project.
♦ Participation in this study is voluntary. If you choose not to participate or to withdraw your
consent to participate, this will not have any impact on the use of your sample for semen analysis
or preparation for ART.
♦ The results of the tests carried out specifically for this study do not have relevance for your
diagnosis or current treatment and we will not be providing feedback to you on study test results
for this reason. Participation in this study will not impact on the information normally provided
to you by the clinic.
♦ Completion of the participant consent form is considered to be consent to use your sample,
questionnaire information, and treatment outcome information in the study.
♦ You may choose to withdraw your consent at any time without justification or reason, in which
case any samples and information provided for the study will be destroyed, unless you agree that
we may retain this information.
♦ Data from this study will form the basis of an Honours thesis for a fourth year Bachelor of Science
student at UWA and a Master’s thesis for a Master of Science student at ECU.
♦ Results from this study may be presented at conferences and in scientific journals. Results will be
presented in summary form and it will not be possible to identify individuals.
If you have any questions or concerns about this study please refer them to Dr Peter Burton at Concept
Fertility Centre, Dr Katherine Sanders at The University of Western Australia or Associate Professor Peter
Roberts at Edith Cowan University as below:
Dr Peter Burton
Scientific Director
Concept Fertility Centre

Dr Katherine Sanders
Senior Lecturer
School of Anatomy, Physiology &
Human Biology,
The University of Western Australia

A/Prof Peter Roberts
Director of Medical Science
School of Medical & Health
Sciences
Edith Cowan University

Approval to conduct this research has been provided by The University of Western Australia, in accordance with its
ethics review and approval procedures. Any person considering participation in this research project, or agreeing to
participate, may raise any questions or issues with the researchers at any time. In addition, any person not
satisfied with the response of researchers may raise ethics issues or concerns, and may make any complaints about
this research project by contacting the Human Research Ethics Office at The University of Western Australia on (08)
6488 3703 or by emailing to humanethics@uwa.edu.au All research participants are entitled to retain a copy of the
Participant Information Form and Participant Consent Form relating to this research project.
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Research Project Consent Form
Study of the role of apoptosis and sperm DNA damage in male infertility

I………………………………………………………………………………………..…………………………..
(Given Names)
(Surname)
have read the information provided explaining the study entitled “Study of the role of apoptosis and
sperm DNA damage in male infertility”.
Any questions I have asked have been answered to my satisfaction. I agree to allow my surplus sperm
to be used for this research, realising that I may withdraw my consent at any time without reason and
without prejudice to my future fertility treatment.
I understand that all identifiable (attributable) information that I provide is treated as strictly
confidential and will not be released by the investigator in any form that may identify me. The only
exception to this principle of confidentiality is if documents are required by law.
I have been advised as to what data is being collected, the purpose for collecting the data, and what will
be done with the data upon completion of the research.
I agree that research data gathered for the study may be published provided my name or other
identifying information is not used.
…………………………………………………………………….………………….
Participant signature

Date

“Approval to conduct this research has been provided by The University of Western Australia, in accordance with its
ethics review and approval procedures. Any person considering participation in this research project, or agreeing to
participate, may raise any questions or issues with the researchers at any time. In addition, any person not
satisfied with the response of researchers may raise ethics issues or concerns, and may make any complaints about
this research project by contacting the Human Research Ethics Office at The University of Western Australia on (08)
6488 3703 or by emailing to humanethics@uwa.edu.au. All research participants are entitled to retain a copy of
the Participant Information Form and Participant Consent Form relating to this research project.”
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Appendix B – Patient semen analysis questionnaire
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Appendix C – Supplementary tables
Appendix C- 1
Initial and final linear mix regression models to analyse the effect of neat AnnV+/7-AAD- and AnnV+/7AAD+ on day 5 embryo quality (D5EQ) score.

F

Std.
P-value Estimate
Error

95% Confidence
Interval
Lower Upper
Bound Bound

Initial modela
Intercept

6.201

0.016

4.136

2.331

−0.559

8.830

Procedure type

2.884

0.095

2.928

1.724

−0.526

6.382

Neat AnnV+/7-AAD- (%)

0.376

0.543

0.083

0.118

−0.155

0.320

Neat AnnV+/7-AAD+ (%)

0.082

0.776

0.032

0.059

−0.087

0.151

Processed sperm total motility (million/mL)

0.158

0.692

0.052

0.123

−0.196

0.300

Maternal age

0.232

0.632

0.029

0.060

−0.092

0.151

Paternal age

0.828

0.368

−0.043

0.047

−0.139

0.052

Number of oocytes retrieved

0.452

0.505

0.126

0.067

−0.009

0.261

Procedure type × neat AnnV+/7-AAD-

0.251

0.618

−0.076

0.151

−0.380

0.228

Procedure type × neat AnnV+/7-AAD+

0.292

0.591

−0.043

0.079

−0.200

0.115

0.018

0.894

−0.026

0.197

−0.420

0.367

6.681

0.013

−0.200

0.078

−0.356 −0.044

698.539

0.000

6.454

0.325

5.802

4.819

0.032

−0.990

0.451

−1.894 −0.086

Procedure type × processed sperm total
motility
Procedure type × number of oocytes
retrieved
Final modelb
Intercept
Procedure type
(ICSI = 0 or reference group; IVF = 1)

7.105

Note. The analysis was performed on 453 embryos that were obtained from 72 couples in 86 cycles.
a

Dependent variable: D5EQ score. Akaike's Information Criterion (AIC) = 2496.543

b

Dependent variable: D5EQ score. Akaike's Information Criterion (AIC) = 2472.73
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Appendix C- 2
Initial and final linear mix regression models to analyse the effect of processed AnnV+/7-AAD- and
AnnV+/7-AAD+ on day 5 embryo quality (D5EQ) score.

F

P-value Estimate

95%
Confidence
Std.
Interval
Error
Lower Upper
Bound Bound

Initial modela
Intercept

12.066

0.001

7.583

2.552 2.444

12.722

Procedure type

0.608

0.439

1.811

2.322 −2.856

6.478

Processed AnnV+/7-AAD- (%)

0.991

0.324

0.261

0.321 −0.381

0.904

Processed AnnV+/7-AAD+ (%)

0.061

0.806

0.062

0.079 −0.098

0.222

Processed sperm total motility
(million/mL)

0.001

0.979

−0.020

0.121 −0.265

0.225

Maternal age

0.709

0.404

−0.057

0.068 −0.194

0.080

Paternal age

0.374

0.544

−0.030

0.049 −0.129

0.069

0.824

0.371

0.132

0.060 0.007

0.256

0.047

0.828

−0.096

0.443 −0.981

0.788

1.305

0.259

−0.103

0.090 −0.285

0.079

0.035

0.853

0.035

0.190 −0.348

0.419

7.212

0.011

−0.199

0.074 −0.350

−0.049

881.302 0.000

6.855

0.305 6.238

7.472

−1.313

0.418 −2.156

−0.469

Number of oocytes retrieved
+

Procedure type × processed AnnV /7AADProcedure type × processed AnnV+/7AAD+
Procedure type × processed sperm total
motility
Procedure type × number of oocytes
retrieved
Final modelb
Intercept
Procedure type
(ICSI = 0 or reference group; IVF = 1)

9.877

0.003

Note. The analysis was performed on 409 embryos that were obtained from 66 couples in 80 cycles.
a

Dependent variable: D5EQ score. Akaike's Information Criterion (AIC) = 2245.808

b

Dependent variable: D5EQ score. Akaike's Information Criterion (AIC) = 2224.686
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Appendix C- 3
Initial and final linear mix regression models to analyse the effect of neat and processed total AnnV+
on day 5 embryo quality (D5EQ) score.

F

P-value Estimate

Std.
Error

95%
Confidence
Interval
Lower
Upper
Bound
Bound

Initial modela
Intercept

13.331

0.001

7.858

2.547

2.719

12.997

Procedure type

0.688

0.411

1.625

1.960

−2.322

5.572

Neat total AnnV+ (%)

1.396

0.242

0.045

0.047

−0.050

0.139

Processed AnnV+ (%)
Processed sperm total motility
(million/mL)

0.048

0.827

0.031

0.089

−0.149

0.210

0.098

0.756

−0.068

0.125

−0.323

0.187

Maternal age

0.429

0.516

−0.044

0.067

−0.180

0.092

Paternal age

0.673

0.417

−0.043

0.052

−0.147

0.062

Number of oocytes retrieved

0.966

0.332

0.145

0.062

0.017

0.272

Procedure type × neat total AnnV+
Procedure type × processed total
AnnV+
Procedure type × processed sperm
total motility
Procedure type × number of oocytes
retrieved

0.017

0.896

−0.009

0.068

−0.146

0.128

0.636

0.430

−0.082

0.102

−0.289

0.125

0.157

0.694

0.076

0.192

−0.310

0.462

8.815

0.005

−0.218

0.074

−0.368

−0.069

Intercept

13.331

0.001

7.858

2.547

2.719

12.997

Procedure type
(ICSI = 0 or reference group; IVF = 1)

0.688

0.411

1.625

1.960

−2.322

5.572

b

Final model

Note. The analysis was performed on 409 embryos that were obtained from 66 couples in 80 cycles.
a

Dependent variable: D5EQ score. Akaike's Information Criterion (AIC) = 2224.686

b

Dependent variable: D5EQ score. Akaike's Information Criterion (AIC) = 2252.700
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Appendix C- 4
Initial and final linear mix regression models to analyse the effect of neat and processed ROS+
on day 5 embryo quality (D5EQ) score.

F

95% Confidence
Std.
Interval
P-value Estimate
Error Lower Upper
Bound Bound

Initial modela
Intercept

0.981

0.332

4.512

4.941

−5.638 14.661

Procedure type

0.007

0.934

−0.356

4.241

−9.269 8.557

Neat ROS+ (%)

0.420

0.522

−0.006

0.071

−0.153 0.141

Processed ROS+ (%)

0.985

0.329

0.046

0.114

−0.193 0.285

Processed sperm total motility
(million/mL)

0.850

0.365

−0.012

0.161

−0.361 0.337

Maternal age

0.022

0.884

−0.013

0.087

−0.192 0.166

Paternal age

0.157

0.695

0.032

0.082

−0.137 0.201

Number of oocytes retrieved

0.020

0.888

0.135

0.132

−0.147 0.417

Procedure type × neat ROS+

0.241

0.626

−0.054

0.109

−0.275 0.168

Procedure type × processed ROS+

0.135

0.716

0.055

0.149

−0.252 0.361

0.892

0.353

1.014

1.073

−1.190 3.217

2.408

0.139

−0.247

0.159

−0.581 0.088

415.837 0.000

7.034

0.395

6.217 7.851

Procedure type
10.284 0.003
(ICSI = 0 or reference group; IVF = 1)

−1.912

0.596

−3.134 −0.690

Procedure type × processed sperm
total motility
Procedure type × number of oocytes
retrieved
Final modelb
Intercept

Note. The analysis was performed on 189 embryos that were obtained from 35 couples in 37
cycles.
a

Dependent variable: D5EQ score. Akaike's Information Criterion (AIC) = 1051.884

b

Dependent variable: D5EQ score. Akaike's Information Criterion (AIC) = 1031.074
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Appendix C- 5
Proportional hazard (Cox) regression model to analyse the effect of processed AnnV+/7-AADand AnnV+/7-AAD+ sperm on the time to pregnancy in IVF and ICSI patients*.
Initial Model
Variables

B

P-value

Processed AnnV+/7-AAD- (%)

0.005

0.977

Processed AnnV+/7-AAD+ (%)

0.095

0.031

Processed sperm total motility (million/mL)

0.159

0.038

Maternal age

−0.077

0.103

Procedure type

0.217

0.871

Procedure type × processed sperm total
motility

0.211

0.189

Procedure type × processed AnnV+/7-AAD-

0.112

0.663

Procedure type × processed AnnV+/7-AAD+

−0.101

0.084

Final Model
B

P-value

0.084

0.021

* Time to pregnancy is indicated by the total number of cycles undertaken to achieve clinical
pregnancy. Fresh and/or frozen embryos were transferred in these cycles. N = 186.
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Appendix C- 6
Proportional hazard (Cox) regression model to analyse the effect of neat AnnV+/7AAD- and AnnV+/7-AAD+ sperm on the time to pregnancy in IVF and ICSI patients*
Initial Model
Variables

B

P-value

Neat AnnV+/7-AAD- (%)

−0.070

0.361

Neat AnnV+/7-AAD+ (%)

−0.005

0.883

Processed sperm total motility (million/mL)

0.098

0.161

Maternal age

−0.049

0.212

Procedure type

−1.170

0.264

Procedure type × processed sperm total
motility

0.220

Procedure type × neat AnnV+/7-AAD-

0.131

0.152

Procedure type × neat AnnV+/7-AAD+

0.018

0.713

Final Model
B

P-value

0.084

0.021

0.181

* Time to pregnancy is indicated by the total number of cycles undertaken to achieve
clinical pregnancy. Fresh and/or frozen embryos were transferred in these cycles.
N = 186.
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Appendix C- 7
Proportional hazard (Cox) regression model to analyse the effect of neat and processed
total AnnV+ sperm on the time to pregnancy in IVF and ICSI patients*
Initial Model
Variables

B

P-value

Neat total AnnV+ (%)

−0.032

0.195

Processed total AnnV+ (%)

0.056

0.029

Processed sperm total motility (million/mL)

0.139

0.067

Maternal age

−0.065

0.155

Procedure type

−0.011

0.993

Procedure type × processed sperm total
motility

0.207

0.216

Procedure type × neat total AnnV+

0.023

0.673

Procedure type × processed total AnnV+

−0.049

0.293

Final Model
B

P-value

0.084

0.021

* Time to pregnancy is indicated by the total number of cycles undertaken to achieve clinical
pregnancy. Fresh and/or frozen embryos were transferred in these cycles. N = 186.
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Appendix C- 8
Proportional hazard (Cox) regression model to analyse the effect of neat and processed
ROS+ sperm on the time to pregnancy in IVF and ICSI patients*
Initial Model

Final Model

B

P-value

B

P-value

−0.044

0.148

−0.019

0.401

Processed ROS (%)

0.031

0.528

Processed sperm total motility
(million/mL)

0.035

0.704

Maternal age

−0.098

0.152

Procedure type

2.083

0.447

Procedure type × processed sperm total
motility

−1.579

0.183

Procedure type × neat ROS+

0.069

0.315

Procedure type × processed ROS+

−0.129

0.172

Variables
Neat ROS+ (%)
+

* Time to pregnancy is indicated by the total number of cycles undertaken to achieve
clinical pregnancy. Fresh and/or frozen embryos were transferred in these cycles.
N = 115.
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Appendix C- 9
Comparison of cost (AUD) and time (minutes) required for sperm preparation using swim-up,
density gradient centrifugation (DGC) and SeaforiaTM.
Cost (AUD)*
Swim-up

DGC

SeaforiaTM

35 mins

25 mins

35 mins

Equipment and materials
Medium
Eppendorf tube/conical flask/ SeaforiaTM
disposable separator
Glass pipette/ syringe
total price per run
Time per run

Note. Figures presented are based on the cost and time required to process neat (raw) semen
with an initial volume of 1 mL.
* Prices were taken from the internal data of Concept Fertility Centre (August 2018) and may
vary with time and promotional offers.

